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Abstract

The control of biofilm formation is a major concern for industrial, environmental, and
public health. Undesirable biofilms can harbor different disease-causing pathogens and shorten
the operational life of different equipment. On the other hand, beneficial biofilms are also used
in various applications and managing its growth and activity can be desirable. Killing the biofilm
does not usually incorporate the removal of the dead biofilm structure that is adhered to the
surface. Therefore, the aim of this thesis is to control biofilm formation; to be able to remove,
inhibit, and enhance biofilm formation. This thesis investigated the use of norspermidine, Damino acids, and selected enzymes for the control of biofilm formation. Biofilm was pre-grown
in 96-well microtiter plates and the different treatments were applied for 24 h. Biofilm
formation was quantified before and after treatments using crystal violet stain. The results
obtained in this thesis showed that norspermidine had a dual effect on biofilms formation. A
concentration of 1 mM norspermidine removed 39% of nonactive biofilm, while for active
biofilm norspermidine enhanced the biofilm growth by 73%. D-amino acids can inhibit biofilm
growth at a low concentration of 5 µM. The two D-amino acids used in this study, D-tryptophan
(15 mM) and D-tyrosine (20 µM), removed 28% and 31% of biofilm, respectively. No clear
synergetic effects were noticed from mixed D-amino acids treatment. The enzymes Savinase
and Pectinex showed the highest biofilm removal among the different tested industrial
enzymes. Savinase removed 68% and 84% while Pectinex removed 74% and 55% of biofilm
formed by Bacillus species and Pseudomonas fluorescens, respectively. The optimized
I

enzymatic treatment containing both Savinase (19.6 and 23.7 U/mL) and Pectinase (63.8 and
48.8 U/mL) showed the highest biofilm removal for Bacillus sp. biofilm at pH 6 and P.
fluorescens at pH 8.
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Chapter 1 - Introduction
1.1 Research Background
Nosocomial infections obtained at dental clinics are a major rising concern (Shatokhin,
2010). There is a growing interest in the contamination of dental unit waterlines (DUWLs) in the
dental community due to rising awareness of infection control. Large quantities of water are
used daily in dental procedures for rinsing the mouth, cooling the instruments, and other
procedures. This water is being supplied to the dental units from the municipal water network
or in some other cases from a private water tank owned by the dental clinic (Pederson, 2002;
Rowland and Voorheesville, 2003). One old practice was warming the water to reach body
temperature for the comfort of the patient; this is not encouraged anymore because it provides
a favorable environment that will increase the microbial contamination. Biofilms are formed by
bacterial communities that adhere to surfaces where moisture and nutrients can be found.
Dental unit’s water lines are one good example of an optimal environment for bacterial
microorganisms to dwell (Rowland and Voorheesville, 2003). Noncoliform bacteria in
recreational and drinking water cannot exceed 500 CFU/mL according to Safe Drinking Water
Act standards. However, untreated DUWLs can contain anywhere between 104 and 105
CFU/mL, in fact, a study on DUWLs in a dental school revealed a value of 2×105 CFU/mL after 5
days only from the first use of newly installed DUWLs (Barbeau et al., 1996). The fact that
DUWLs are dramatically higher in bacterial load when compared with the municipal water
network comes from four main factors that act together to provide an optimal environment for
biofilms, these are nutrition, surface area to volume ratio, surface chemistry, and laminar flow
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(Rowland and Voorheesville, 2003). Drinking water supplied by municipal water network usually
contains minerals that deposit inside the DUWLs such as calcium carbonate (Mills, 2000). Free
bacterial cells in the water will then adhere to the minerals and create biofilms, this is more
promoted during the stagnation periods when dental units are turned off after working hours
(Pederson, 2002).
One of the main characteristics of biofilms is their higher resistance to antibiotic and other
chemical treatments due to the protective shield provided by the biofilm matrix to the cells
living underneath in what is called “the protective mode”, one study reported that biofilms can
be up to 1000-fold more resistant to chemical treatments (Gilbert and McBain, 2001). Another
characteristic of biofilms is the fact that they are multicellular communities that can contain
different types of microorganisms (Coleman et al., 2010). One interesting characteristic of
biofilm is quorum sensing, which is the cell-to-cell communication system used among bacteria
living within the biofilm through signaling molecules, this communication system is used to
coordinate the collective behavior of the biofilm community (Atkinson and Williams, 2009).
Biofilms can vary in their thicknesses depending on the shear forces exerted from the
surrounding flow, biofilm forming under higher shear conditions are denser and have less
permeability and are much harder to remove (Stoodley, Boyle and Lappin-scott, 1999).
Most of the bacterial microorganisms that dwell in DUWLs are harmless water bacteria,
the remaining harmful pathogenic microorganisms are obtained from patients during dental
procedures as a result of backflow in the suction devices. These pathogenic microorganisms can
cause serious health problems to dental staff and patients, especially those who are
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immunocompromised (Rowland and Voorheesville, 2003). A list of microorganisms that have
been detected in DUWLs is presented in Table 1–1.
Table 1–1. Microorganisms detected in DUWL (Rowland and Voorheesville, 2003).
Acanthamoeba
Lactobacillus
Legionella dumoffi
Actinomyces
Aeromonas
Moraxella urethalis
Alcaligenes faecalis
Bacillus subtilis
Bacteroides
Micrococcus luteus
Morabella osloensis
Serratia marcescens
Candida
Cephalosporium
Cladosporium
Cloaca
Enterococcus
Nocardia
Fusobacterium
Weillonella

Klebsiella aerogenes
Klebsiella pneumoniae
Achmmobacter xyloxidans
Acinetobacter calcoaceticus
Legionella pneumophila
Brevindimonas vesicularis
Burkholderia cepacia
Burkholderia pickettii
Alcaligenes dentrificans
Myroides odoramm
Streptococcus mitis
Flavobacterium odoratum
Flavobacterium indologenes
Pasteurella haemolytica
Pasteurella multocida
Pasteurella paucimobilis
Pasteurella pneumotropica
Pseudomonas acidovorans
Pseudomonas aeruginosa
Pseudomonas cepacia

Pseudomonas fluorescens
Pseudomonas maltophilia
Pseudomonas pickettii
Pseudomonas posimobilis
Pseudomonas putida
Pseudomonas testosteroni
Pseudomonas stutzeri
Pseudomonas vesicularis
Psychrobacter phenylpyruvica
Seromonas salmonicida
Moraxella phenylpyruvica
Sphingomonas paucimobilis
Staphylococcus capitus
Staphylococcus cohnii
Staphylococcus saprophyticus
Staphylococcus wameri
Streptococcus faecalis
Ochromobacterium anthropi
Streptococcus salivarius
Xanthomonas maltophilia

Some of the alarming pathogens that have been detected in DUWLs are Legionella sp.,
aquatic nontuberculosis mycobacterium, and Pseudomonas aeruginosa. Legionella sp. can cause
several diseases including the legionnaire’s disease, pontiac fever, and pneumonia (Bartram et
al., 2007). Each year between 10,000 and 15,000 cases caused by Legionella are reported in the
United States with mortality rates of 5 to 15% (Rowland and Voorheesville, 2003). Aquatic
nontuberculosis mycobacterium can cause respiratory diseases and are associated with wound
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infections (Griffith et al., 2007). Different types of infections can be caused by Pseudomonas
aeruginosa, in addition to pneumonia especially in individuals that suffer from cystic fibrosis
(Young and Armstrong, 1972). Gram-negative bacteria are the most common microorganisms
found in DUWLs and they are associated with endotoxins, which can lead to serious immune
reactions. Endotoxins have been reported in DUWLs with concentrations up to 500 endotoxin
units/mL and up to this day, there is no legislation on the standard levels of endotoxins in water
(Rowland and Voorheesville, 2003). Documented cases of infections that were related to
contaminated DUWLs are not abundant, in two cases patients with immunocompromised
conditions acquired wound infections caused by Pseudomonas aeruginosa, and both patients
completely recovered (Mills, 2000). In one other case, a dentist lost his life to Legionnaire’s
pneumonia caused by aerosols from DUWLs contaminated with Legionella dumoffii (Atlas and
Williams, 1995).
Although several organizations and governmental agencies provided guidelines for the
water used in dental clinics, there are no regulations or laws that set water quality standards
for water used in dental clinics. In 1993, the Center for Disease Control and Prevention
published their guidelines with three main relevant recommendations, the use of backflow
prevention valves (later proven not to be effective due to negative pressure), if the treatment is
associated with cutting bone sterile solutions should be used, and flushing the DUWLs for 20 to
30 sec between different patients and for several minutes at the end of each day (Kohn et al.,
2003). In 1996, following the results of a study on hemodialysis that found rapid colonization
occurs in fluids containing more than 200 CFU/mL heterotrophic bacteria; the American Dental
Association recommended that water used in dental treatments should not contain more than
4

200 CFU/mL heterotrophic bacteria (Depaola et al., 2002). The American Public Health
Association (APHA) are alert to DUWLs associated problems, they encouraged the CDC to
perform studies on the DUWLs associated health effects. It is worth mentioning that none of
the aforementioned recommendations was directed towards prevention or control of biofilms
in DUWLs.
Common cleaning procedures used to clean DUWLs can be summarised in four main
methods: drying or flushing DUWLs, chemical agents, filtration devices, and the use of
autoclavable or disposable water delivery systems (Rowland and Voorheesville, 2003). Drying
the DUWLs will not reduce the microorganism load in the DUWLs and had no effect on biofilms.
While flushing the DUWLs can reduce the microorganisms count in the DUWLs temporarily until
the microorganisms repopulate again, the process has no effect on biofilms in DUWLs
(Kettering et al., 2002). Flushing the DUWLs between consecutive treatments can discharge
microorganisms acquired during treatments from patients and help in preventing crosscontamination between patients (Cobb et al., 2002; Fiehn and Larsen, 2002). The most applied
method is the use of chemical agents to kill the microorganisms in DUWLs. Treatments are
applied either by the shock-treatment in intermittent periods at high concentrations or as a
continuous low concentration treatment. Dental units that use the shock treatment method
must have their own water reservoir, the germicidal treatment is applied for a certain period of
time and that is followed by a complete system flush with sterile water, in this way the
germicidal treatment is completely removed from the DUWLs before treating the patients
(Rowland and Voorheesville, 2003). Although the microorganisms that survive the germicidal
treatment will repopulate again between the treatments. These germicidal treatments have
5

negative effects on the DUWLs components and can impose toxicity risks on the staff due to
the harsh chemicals that are used in their manufacture (Rowland and Voorheesville, 2003). In
the continuous treatment, the germicidal treatment is applied at low concentrations, since
these germicidal treatments are continuously present in DUWLs, the chemicals used must be
chosen carefully as they must not impose any health effects on patients (Rowland and
Voorheesville, 2003). Moreover, these germicidal agents can also damage the DUWLs
components and they can interfere with the bonding agents used in dental treatments. One
common used germicidal agent is sodium hypochlorite (bleach). Other effective germicidal
agents used are sodium fluoride, hydrogen peroxide, and commercial mouth rinses (Wirthlin
and Marshall, 2001; Kettering et al., 2002; Tuttlebee et al., 2002; Rowland and Voorheesville,
2003).
The only method that can lower the microorganisms count to 200 CFU/mL or even
lower is filtration. Filters used are usually 0.22 µM pore size. The locations of the filters are
usually chosen to be as close as possible to the endpoint of the DUWLs (i.e. just before the
handpiece or the sonicator). The limitations on using filters can be summarised by DUWLs
clogging, biofouling, and no control on the release of the harmful endotoxins (Mills, 2000).
New research is now focused on developing novel methods for reducing the
microorganisms count and biofilm control in DUWLs. Germiphene corporation, the industrial
partner in this project, is a privately owned Canadian company located in Brantford, Ontario.
Germiphene is licensed by FDA and Health Canada. They are specialized in developing and
manufacturing medical devices, infection control products, and dental pharmaceuticals with a
special interest in the dental market. Germiphene started to implement a new development
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plan to improve a number of its current products to become more environmentally friendly.
One of their many products is a biofilm control product called Gobble, which has been in the
dental market for many years. In their product, Germiphene developed a new “out of the box”
method for the reduction of pathogenic microorganisms count and biofilm control in DUWLs. It
is a fact that biofilms are going to grow inside the DUWLs for the many reasons mentioned
previously, and since that is inevitable, a beneficial biofilm will be grown, using the
heterotrophic, cannibalistic, and yet non-pathogenic microorganism, that microorganism is a
gram-positive Bacillus species. Biofilms by Bacillus sp. will form inside the DUWLs and they will
cannibalize the pathogenic microorganisms they will get in contact with using self-secreted
toxins or antibiotics. Researchers discovered this phenomenon during a study on natural matrix
inducers. In their study, they co-cultured a Bacillus strain that contained a reporter for matrix
gene expression with other similar soil microorganisms. Although there were a variety of
bacterial microorganisms tested in the soil samples they used, the majority of matrix inducing
microorganisms were found to be Bacillus species (Liu et al., 2010; Shank et al., 2011; Vlamakis
et al., 2013).

1.2 Problem Description and Motivation
Dental clinics sanitation relies on chemical disinfectants to lower the microorganisms count
in their DUWLs, the presence of pathogenic biofilms in the DUWLs will make that extremely
hard to achieve (Barbeau, Bokum and Gauthier, 1998; Rowland and Voorheesville, 2003).
Pathogenic biofilms formation in dental units has been reported by several researchers.
Biofilms can form in tanks, pipes, tubing, sinks, suction hoses, hand pieces, air and water
syringes, and ultrasonic scalers (Barbeau, Bokum and Gauthier, 1998; Coleman et al., 2009,
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2010). Pathogenic biofilms can incorporate different mixtures of microorganisms such as
bacteria, viruses, fungi, algae, amoebae and protozoa (Coleman et al., 2010; Vasickova et al.,
2010). The biofilm extracellular matrix and the outer layers of cells form a shield that protects
the microorganisms living underneath, consequently resulting in a biofilm community that is
more resistant to disinfectants, antibiotics, and detergents. It has been reported that bacteria
are one thousand-fold more resistant when they live within a biofilm community (Barbeau,
Bokum and Gauthier, 1998; Coleman et al., 2010). In dental clinics, pathogenic biofilms are
responsible for high contamination levels in water used for invasive procedures (Barbeau et al.,
1996; Barbeau, Bokum and Gauthier, 1998). Pathogens released from the biofilms can be
passed around with aerosols from dental tools such as the hand piece (Barbeau, Bokum and
Gauthier, 1998; Pederson, 2002). Moreover, wet dental devices such as the evacuation system
(suctioning apparatus and saliva ejectors) are bases of cross-contamination among the patients
due to tubing backflow (Barbeau, Bokum and Gauthier, 1998). These dental instruments are
used to drain blood, saliva, tissue, and restoration debris that result from dental procedures
(Barbeau, Bokum and Gauthier, 1998). The evacuation system consists of a filter, plastic tubing,
and a mouth piece. Although the mouth piece is disposable, the filter and plastic tubing are not
and can be easily contaminated with pathogens. Since the evacuation system is not regularly
cleaned or disinfected, clearly not between consecutive patients, they can become a source of
cross-contamination among patients (Barbeau, Bokum and Gauthier, 1998). One other concern
from biofilm growth in dental settings is the interference with the mechanical functions of the
dental devices and the clogging of tubes and pipes. Based on the aforementioned biofilm
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growth control is a major concern for dental clinics hygiene and dental devices industry
(Barbeau et al., 1996).

Figure 1-1. Schematic for biofilm formation in dental unit water lines (DUWLs) and the use of
amalgam separators for the remove of amalgam from the wastewater.
Amalgam separators are a specialized type of filters used to recover amalgam waste from
the liquids removed from patient’s mouth during procedures involving amalgam containing
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fillings. Without these separators amalgam will travel through the DUWLs to the vacuum lines
and end of in the wastewater discharged to the municipal sewer system. The main problem
occurs from mercury that is being released from the amalgam. The amount of mercury in the
sludge of a wastewater treatment plant as well as the amount being discharge in wastewater
are regulated by Canadian Environmental Protection Act, 1999.
Germiphene developed a product for cleaning DUWLs known commercially as Gobble.
Gobble utilizes a beneficial biofilm formed from the non-pathogenic Bacillus Species to cover
the inner walls of the DUWLs. This beneficial biofilm is safe for human consumption and will
prevent the formation of pathogenic biofilm. It is useful to enhance the formation of such
beneficial biofilm especially with new commissioned DUWLs. However, some dental clinics have
been experiencing excessive shedding of biofilm. These biofilm aggregates that peel from the
inner walls of the DUWLs have been travelling through the DUWLs and accumulating in the
amalgam separator. This accumulation of biofilm aggregates in the amalgam separator requires
a more frequent replacement of the filter. These filters are expensive to replace. Also, the
proper disposal of the amalgam filter is expensive and must be contracted to a specialized
company that carries a certificate of approval to handle biohazard and hazardous wastes. The
ability to better control biofilm growth could therefore lead to developing an overall better
product.
It must be emphasised here that the aim of this research is not to kill the biofilm nor
completely remove it, but control its formation in the DUWLs. In this thesis, the term “control”,
as in control biofilm formation, implies the ability to either enhance, inhibit, or remove biofilm
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formation. There is abundant of previous knowledge that can be employed in this research to
find effective methods to control biofilm formation.

1.3 Research Objectives
1.3.1

General Research Objective

The general objective of this thesis is to thoroughly investigate the capability of different
suggested treatments for controlling biofilm formations. To be able to inhibit, enhance, and
most importantly eradicate biofilm formation.
The main problem faced from the presence of biofilm in DUWLs is the physical barrier
provided by the biofilm extracellular structure. This structure provides a diffusion barrier that
harbors different pathogens from chemical treatments, and it interferes with the physical
properties of the dental devices. The intention of this work is not to kill biofilms or the
microorganisms living within the biofilm community, as by doing so, the biofilm structure
“skeleton” remains intact and can facilitate the attachment of new microorganisms, and the
biofilm cycle continues building on the extracellular structure causing more problems.
1.3.2

Specific Research Objectives

1.3.2.1 Investigate Biofilm Control Using Norspermidine
There is current apparent controversy in the literature on the interaction of norspermidine
with biofilms. It has been reported that norspermidine is self-produced in mature biofilm
formed by Bacillus subtilis to trigger biofilm disassembly (Kolodkin-Gal et al., 2012). While other
researchers reported that norspermidine is not self-produced by Bacillus subtilis and when
added to biofilms it enhanced growth (Hobley et al., 2014). Moreover, to the best knowledge of
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the authors, present literature is lacking for quantitative studies that investigate the interaction
of norspermidine with biofilms. Therefore, it was deemed necessary to further investigate the
interaction between norspermidine and biofilms, and whether norspermidine can be used to
dismember biofilm formation or not.
1.3.2.2 Investigate Biofilm Control Using Amino Acids
Previous researchers have reported that four D-amino acids (D-tyrosine, D-tryptophan, Dmethionine, and D-leucine) are self-produced in late stages of biofilms formed by Bacillus
subtilis to trigger biofilm disassembly (Kolodkin-Gal et al., 2010). To the best knowledge of the
authors, no quantitative studies that investigated biofilm removal using D-amino acids exist
today. Hence, it was considered important to further investigate the removal of biofilms using
D-amino acids, and if any synergetic effects can be noticed for combined treatments that can
lead to optimization experiments.
1.3.2.3 Investigate Biofilm Control Using Enzymes
Enzymatic treatments are being suggested as relatively new method for biofilm removal
due to their environmentally friendly nature, high efficiency, and low cost (Cortés, Bonilla and
Sinisterra, 2011; Taraszkiewicz et al., 2013; Meireles et al., 2016). There exists today abundant
information in the literature on different types of enzymes that are being used in different
applications. To the best of the author's knowledge, current published work related to the use
of enzymes for biofilm removal lacks a comprehensive approach to the problem. Most of the
published studies deal with a specific type of microorganism, enzyme(s), and substratum
(Johansen and Falholt, 1997; Loiselle and Anderson, 2003; Molobela, Cloete and Beukes, 2010;
Marcato-Romain et al., 2012). The diversity in the biofilm-forming microorganisms is coupled
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with diversity in biofilms constituents (Branda et al., 2001; Morikawa et al., 2006; Molobela,
Cloete and Beukes, 2010), which should be accounted for in the selection of proper enzymatic
treatments (Molobela, Cloete and Beukes, 2010). Although biofilms are complex in their
composition, the two main constituents of biofilms reportedly are polysaccharides and proteins
(Branda et al., 2001; Morikawa et al., 2006; Molobela, Cloete and Beukes, 2010). Therefore, it
was considered important to further investigate the available enzymes that can target those
two constituents and degrade them. The published literature will be revisited for the selection
of specific enzymes that have been reported to degrade biofilms by targeting the
polysaccharides and proteins constituents (polysaccharide-degrading enzymes and proteases).
The selected enzymes will be further investigated to select the most effective in biofilm
removal.
1.3.2.4 Optimization of Biofilm Removal Using Enzymatic Treatments
The use of enzymatic treatments as anti-biofilm agents have proven to be successful
(Taraszkiewicz et al., 2013; Thallinger et al., 2013; Meireles et al., 2016). Enzymes present a
more green, efficient, and affordable alternative to chemical treatments used to eradicate
biofilms (Cordeiro, Hippius and Werner, 2011; Cortés, Bonilla and Sinisterra, 2011; Srey, Jahid
and Ha, 2013). To obtain a higher biofilm removal efficiency, previous researchers have
recommended the use of anti-biofilm enzymatic treatments consisting from mixtures of
different enzymes targeting different substrate types (Augustin, Ali-Vehmas and Atroshi, 2004;
Cordeiro, Hippius and Werner, 2011; Torres et al., 2011). To the best knowledge of the authors,
no such studies exist in the literature. Consequently, it was considered vital to conduct a “first
of its kind” optimization study for the use of proteases and polysaccharide-degrading enzymes
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for biofilm removal. The top two of each, proteases and polysaccharide-degrading enzymes,
that will show the highest biofilm removal efficiency in the preceding objective (Section 1.3.2.3)
will be further utilized in the optimization study.

1.4 Thesis Overview
This thesis contains four chapters. The first chapter is the introduction which presents the
research background, the problem description and motivation, research objectives (general and
specific), and the thesis overview. The second chapter is the literature review which will provide
the reader with the related background information on bacteria and biofilms, biofilm life cycle,
bacterial strains used (Bacillus species and Pseudomonas fluorescens), factors governing biofilm
formation, polyamines, amino acids, and enzymes. The third chapter is the experimental results
where the methodology used and results obtained are presented and discussed. The fourth
chapter is the summary and conclusions of the thesis.
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Figure 1-2. Overview of the procedure used for evaluating the efficiency of the different biofilm
control agents tested in this thesis. Fixed (killed) biofilm is treated with methanol to preserve
biofilm formation at a certain stage to be quantified at a later stage.
This thesis investigated different biofilm control agents. Each biofilm control agent
investigated in the subsections of chapter three had a specific preparation procedure and
application method and unique results. Nevertheless, the assessment of the effectiveness of
each different biofilm control agent tested was done following the flow chart presented in
Figure 1-2.

15

1.5 References
Atkinson, S. and Williams, P. (2009) ‘Quorum sensing and social networking in the microbial
world’, Journal Royal Soc. Interfaces, 6(August), pp. 959–978. doi: doi:10.1098/rsif.2009.0203.
Atlas, R. M. and Williams, J. F. (1995) ‘Legionella Contamination of Dental-Unit Waters’, Applied
and Environmental Microbiology, 61(4), pp. 1208–1213.
Augustin, M., Ali-Vehmas, T. and Atroshi, F. (2004) ‘Assessment of enzymatic cleaning agents
and disinfectants against bacterial biofilms’, Journal of Pharmacy and Pharmaceutical Sciences,
7(1), pp. 55–64.
Barbeau, J. et al. (1996) ‘Multiparametric Analysis of Waterline Contamination in Dental Units’,
Applied and environmental microbiology, 62(11), pp. 3954–3959.
Barbeau, J., Bokum, L. and Gauthier, C. (1998) ‘Cross-contamination potential ejectors used in
dentistry of saliva’, Journal of Hospital Infection, (40), pp. 303–311.
Bartram, J. et al. (2007) ‘Legionella and the prevention of legionellosis’, World Health
Organization.
Branda, S. S. et al. (2001) ‘Fruiting body formation by Bacillus subtilis.’, Proceedings of the
National Academy of Sciences of the United States of America, 98(20), pp. 11621–6. doi:
10.1073/pnas.191384198.
Cobb, C. et al. (2002) ‘Waterline Flushing Affect Planktonic Bacteria Levels?’, Journal of Dental
Education, 66(4), pp. 549–555.

16

Coleman, D. C. et al. (2009) ‘Biofilm problems in dental unit water systems and its practical
control.’, Journal of applied microbiology, 106(5), pp. 1424–37. doi: 10.1111/j.13652672.2008.04100.x.
Coleman, D. C. et al. (2010) ‘Microbial biofilm control within the dental clinic: reducing multiple
risks’, Journal of Infection Prevention, 11(6), pp. 192–198.
Cordeiro, A. L., Hippius, C. and Werner, C. (2011) ‘Immobilized enzymes affect biofilm
formation’, Biotechnology Letters, 33(9), pp. 1897–1904. doi: 10.1007/s10529-011-0643-3.
Cortés, M. E., Bonilla, J. C. and Sinisterra, R. D. (2011) ‘Biofilm formation, control and novel
strategies for eradication’, Science against microbial pathogens: communicating current
research and technological advances, pp. 896–905.
Depaola, L. et al. (2002) ‘A review of the science regarding dental unit waterlines’, The Journal
of the American Dental Association, 133, pp. 1199–1206.
Fiehn, N.-E. and Larsen, T. (2002) ‘The effect of drying dental unit waterline biofilms on the
bacterial load of dental unit water’, International Dental Journal, 52(4), pp. 251–254. doi:
10.1111/j.1875-595X.2002.tb00626.x.
Gilbert, P. and McBain, A. J. (2001) ‘Biofilms: Their impact on health and their recalcitrance
toward biocides’, American Journal of Infection Control, 29(4), pp. 252–255. doi:
10.1067/mic.2001.115673.

17

Griffith, D. E. et al. (2007) ‘An official ATS/IDSA statement: diagnosis, treatment, and prevention
of nontuberculous mycobacterial diseases.’, American journal of respiratory and critical care
medicine, 175(4), pp. 367–416. doi: 10.1164/rccm.200604-571ST.
Hobley, L. et al. (2014) ‘Norspermidine is not a self-produced trigger for biofilm disassembly.’,
Cell. The Authors, 156(4), pp. 844–54. doi: 10.1016/j.cell.2014.01.012.
Johansen, C. and Falholt, P. E. R. (1997) ‘Enzymatic Removal and Disinfection of Bacterial
Biofilms’, 63(9), pp. 3724–3728.
Kettering, J. et al. (2002) ‘Reducing Bacterial Counts in Dental Unit Waterlines : Tap Water vs .
Distilled Water’, The Journal of Contemporary Dental Practice, 3(3).
Kohn, W. et al. (2003) ‘Guidelines for Infection Control in Dental Health-Care Settings — 2003’,
Center for Dieseas Control, 52(RR-17).
Kolodkin-Gal, I. et al. (2010) ‘D-amino acids trigger biofilm disassembly.’, Science (New York,
N.Y.), 328(5978), pp. 627–9. doi: 10.1126/science.1188628.
Kolodkin-Gal, I. et al. (2012) ‘A self-produced trigger for biofilm disassembly that targets
exopolysaccharide.’, Cell, 149(3), pp. 684–92. doi: 10.1016/j.cell.2012.02.055.
Liu, W.-T. et al. (2010) ‘Imaging mass spectrometry of intraspecies metabolic exchange revealed
the cannibalistic factors of Bacillus subtilis.’, Proceedings of the National Academy of Sciences
of the United States of America, 107(37), pp. 16286–90. doi: 10.1073/pnas.1008368107.

18

Loiselle, M. and Anderson, K. W. (2003) ‘The use of cellulase in inhibiting biofilm formation
from organisms commonly found on medical implants’, Biofouling, 19(2), pp. 77–85. doi:
10.1080/0892701021000030142.
Marcato-Romain, C. E. et al. (2012) ‘Removal of microbial multi-species biofilms from the paper
industry by enzymatic treatments’, Biofouling, 28(3), pp. 305–314. doi:
10.1080/08927014.2012.673122.
Meireles, A. et al. (2016) ‘The current knowledge on the application of anti-biofilm enzymes in
the food industry’, Food Research International. Elsevier Ltd, 86, pp. 140–146. doi:
10.1016/j.foodres.2016.06.006.
Mills, S. (2000) ‘The Dental Unit Waterline Controversy: Defusing the Myth, Defining the
Sloutions.’, The Journal of the American Dental Association, 131, pp. 1427–1441.
Molobela, I. P., Cloete, T. E. and Beukes, M. (2010) ‘Protease and amylase enzymes for biofilm
removal and degradation of extracellular polymeric substances (EPS) produced by
Pseudomonas fluorescens bacteria’, African Journal of Microbiology Research, 4(14), pp. 1515–
1524. Available at: http://www.academicjournals.org/ajmr.
Morikawa, M. et al. (2006) ‘Biofilm formation by a Bacillus subtilis strain that produces Gamapolyglutamate’, Microbiology, 152(9), pp. 2801–2807. doi: 10.1099/mic.0.29060-0.
Pederson, E. (2002) ‘Waterline biofilm and the dental treatment facility: a review.’, General
Dentistry, 50, pp. 190–195.

19

Rowland, B. and Voorheesville, N. (2003) ‘Bacterial Contamination of Dental Unit Waterlines:
What is Your Dentist Spraying Into Your Mouth?’, Clinical Microbiology Newsletter, 25(10), pp.
73–77.
Shank, E. a. et al. (2011) ‘Interspecies interactions that result in Bacillus subtilis forming biofilms
are mediated mainly by members of its own genus’, Proceedings of the National Academy of
Sciences of the United States of America, 108(48), pp. E1236–E1243. doi:
10.1073/pnas.1103630108.
Shatokhin, A. (2010) ‘Problem of nosocomial infection with Hepatitis B, C viruses and HIV in
Russian dental institutes: review’, Retrovirology, 7(Suppl 1), p. P133. doi: 10.1186/1742-4690-7S1-P133.
Srey, S., Jahid, I. K. and Ha, S. Do (2013) ‘Biofilm formation in food industries: A food safety
concern’, Food Control. Elsevier Ltd, 31(2), pp. 572–585. doi: 10.1016/j.foodcont.2012.12.001.
Stoodley, P., Boyle, J. D. and Lappin-scott, H. M. (1999) ‘Influence of flow on the structure of
bacterial biofilms’, in The 8th International Symposium on Microbial Ecology.
Taraszkiewicz, A. et al. (2013) ‘Innovative strategies to overcome biofilm resistance’, BioMed
Research International, 2013. doi: 10.1155/2013/150653.
Thallinger, B. et al. (2013) ‘Antimicrobial enzymes: An emerging strategy to fight microbes and
microbial biofilms’, Biotechnology Journal, 8(1), pp. 97–109. doi: 10.1002/biot.201200313.

20

Torres, C. E. et al. (2011) ‘Enzymatic treatment for preventing biofilm formation in the paper
industry’, Applied Microbiology and Biotechnology, 92(1), pp. 95–103. doi: 10.1007/s00253011-3305-4.
Tuttlebee, C. M. et al. (2002) ‘Effective control of dental chair unit waterline biofilm and marked
reduction of bacterial contamination of output water using two peroxide-based disinfectants’,
Journal of Hospital Infection, 52(3), pp. 192–205. doi: 10.1053/jhin.2002.1282.
Vasickova, P. et al. (2010) ‘Issues Concerning Survival of Viruses on Surfaces’, Food and
Environmental Virology, 2(1), pp. 24–34. doi: 10.1007/s12560-010-9025-6.
Vlamakis, H. et al. (2013) ‘Sticking together: building a biofilm the Bacillus subtilis way.’, Nature
reviews. Microbiology. Nature Publishing Group, 11(3), pp. 157–68. doi: 10.1038/nrmicro2960.
Wirthlin, M. R. and Marshall, G. W. (2001) ‘Evaluation of Ultrasonic Scaling Unit Waterline
Contamination After Use of Chlorine Dioxide Mouthrinse Lavage’, (March), pp. 401–410.
Young, L. and Armstrong, D. (1972) ‘Pseudomonas aeruginosa’, CRC Critical Reviews, (26), pp.
291–347.

21

Chapter 2 - Literature Review
2.1 Preface
This thesis aims to investigate different potential biofilm control agents and their ability to
control biofilm formation. Therefore, a literature review was prepared to provide the reader
with the relevant background information on bacteria, biofilm, and biofilm control agents. The
literature review presented in this chapter is divided into seven subsections (subsections 2.22.7) reviewing the major related topics covered in this thesis. Section 2.2 will provide
information on bacteria and biofilms, Section 2.3 will provide information on biofilms life cycle,
Section 2.4 will provide information on the bacterial strains used in this research, Section 2.5
will provide information on the factors governing biofilm formation, Section 2.6 will provide
information on polyamines and the previous work that used them for biofilm control, Section
2.6 will provide information on amino acids and their related previous research as biofilm
control agents, and finally Section 2.8 will provide information on enzymes and their use as
biofilm control agents.

2.2 Bacteria and Biofilms
Bacterial microorganisms are single-celled living beings, also known as prokaryotes, which
have been considered to be “simple” when compared to other multicellular organisms.
Relatively recent studies have shown that these simple microorganisms can perform complex
processes and behaviors. Few examples of that can be the spore formation of Bacillus subtilis,
and bacterial biofilms which are both used by bacteria as survival mechanisms (Karatan and
Watnick, 2009). In the spore formation, vegetative cells will generate multiple internal and
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external signals to produce a new morphological shape that can adapt to harsh environments.
When free planktonic bacterial cells find them self in a favorable environment (i.e. abundant
nutrients, surface area) they tend to form biofilms, and once the surrounding environment
becomes less favorable they will disassemble their biofilms and return to their free planktonic
form and start a new quest to find another favorable location to start a new biofilm, and so on
the cycle continues (Karatan and Watnick, 2009; Romero and Kolter, 2011). While in the biofilm
formation bacterial cells aggregate and get attached together to form a protective layer that
shelters the cells underneath it, by doing that bacteria have evolved to tolerate low
concentrations of antibiotics and antimicrobials that they could not have survived in their free
individual cell form (O’Toole, Kaplan and Kolter, 2000; O’Toole and Stewart, 2005). Biofilms are
defined as complex multicellular communities that form by bacterial aggregation on abiotic and
biotic surfaces. Bacterial cells in a biofilm are connected together by an extracellular matrix,
which consists of exopolysaccharides and amyloid protein fibers, and sometimes DNA, with the
exopolysaccharides and proteins being the main constituent (Hall-Stoodley, Costerton and
Stoodley, 2004; Bryers, 2008; Coleman et al., 2010; Molobela, Cloete and Beukes, 2010). Biofilm
formation is part of the life cycle of bacteria and is vital for its survival, biofilms provide the
bacterial cells located underneath is with a protective shield from surfactants and antibiotics, in
addition to the optimum positioning of the bacteria to access nutrients (Costerton et al., 1987;
Cava et al., 2011). Biofilms have a complex architectural shape that contains channels for the
flow of food and nutrient within and throughout their community. Moreover, there is an
interdependent relationship among the biofilm members including communications between
different species through different signalling compound (Rowland and Voorheesville, 2003).
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Biofilms are complex and hard to characterise, in example, it was found that in dental units
water lines only 4% of bacterial cells within a biofilm community are cultivable with the rest
being non-cultivable or dead (Depaola et al., 2002).
In aquatic systems, bacteria tend to form biofilms at interfaces with abiotic and biotic
surfaces. Biofilms can adhere to solid surfaces in the liquid-solid interface, they can also form
floating biofilms called pellicles in the liquid-air interface of static cultures (Hall-Stoodley,
Costerton and Stoodley, 2004; Bryers, 2008; Cava et al., 2011; Kolodkin-Gal et al., 2012). Biofilm
formation starts after the initial layer of colonies are attached to the surface through the
reversible and weak van der Waals forces. More attachment sites will become available for the
free microorganisms on the initial biofilm layer and the attachment becomes more permanent
due to other cell attachment methods. Consequently, biofilm growth is promoted and the
protective extracellular matrix secretion is initiated (Coleman et al., 2010).

2.3 Biofilms Life Cycle
Biofilms go through different stages in their life cycle which can be summarised in: free
planktonic cells, Initial attachment, early biofilm, mature biofilm, biofilm disassembly, and
return into its original planktonic form (Palmer and White, 1997; O’Toole, Kaplan and Kolter,
2000). Environmental stress is the main reason for biofilms formation with the availability of
nutrients being the main driving force; some other environmental factors can trigger biofilm
initiation such as temperature, pH, iron, and oxygen with all these factors being microorganism
specific (O’Toole, Kaplan and Kolter, 2000). Planktonic cells are transferred from the liquid
media to the surface boundary by physical forces or by bacterial movement through their
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flagella. If the environmental condition promotes biofilm formation, planktonic cells will be
induced to attach to the surface and they will change from motile cells into non-motile. This
attachment is governed by different environmental factors such as surface structure,
temperature and pressure. When bacterial cells are attached to each other the term cohesion is
used, while the term adhesion is used when bacterial cells are attached to a surface (Garrett,
Bhakoo and Zhang, 2008). External physical forces affect the bacterial adhesion to surfaces.
These forces are: Electrostatic interactions, Van der Waals forces, steric interactions, all
together known as the DVLO (Derjaguin, Verwey, Landau and Overbek) (Coleman et al., 2010).
After initial adhesion of the bacteria to the surface some bacterial cells will become
permanently adsorbed to the surface and form the initial attached biofilm layer. The initially
attached cells will divide and facilitate the cohesion of additional free planktonic cells that will
get attached to the initial layer (Coleman et al., 2010). Consequently, new bacterial cells will
grow sideward and outward to form a mushroom like shape. Bacterial cells are connected
together and to the surface by the exopolysaccharides and protein fibers (O’Toole, Kaplan and
Kolter, 2000), forming the early biofilm which will grow and adapt to the surrounding
environment that will develop into a mature biofilm. Bacterial cells at this point are
characterised with and increased synthesis of exopolysaccharides, higher antimicrobial
resistance, UV light tolerance, and formation of bacterial spore cells (Habash and Reid, 1999;
O’Toole, Kaplan and Kolter, 2000; Rowland and Voorheesville, 2003; Garrett, Bhakoo and
Zhang, 2008; Coleman et al., 2010; Vlamakis et al., 2013). At late stages of the mature biofilm,
bacterial cells will start the secretion of small molecules such as polyamines and D-amino acids.
These small molecules will target the protein fibers and the exopolysaccharides that connect
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the bacterial cells in the biofilm, initiating the biofilm disassembly and the release of planktonic
cells and bacterial spores as a survival mechanism. Released planktonic cells and spores will
migrate to find another favorable location and initiate a new biofilm community (Kolodkin-Gal
et al., 2010, 2012).

Figure 2-1. Biofilm life cycle for Bacillus subtilis, modified from (Cava et al., 2011).

2.4 Bacterial Strains
2.4.1

Bacillus Species

The Bacillus species (sp.) strain used is known commercially as Unizyme 20X CSB 20 NF
SPORE, and it was obtained from the industrial partner (Germiphene Inc.). Many researchers
have employed Bacillus bacteria in different research studies, which made it a model
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microorganism for understanding biofilm development (K P Lemon et al., 2008). Bacillus sp. is a
rod-shaped, motile, gram-positive, spore-forming, biofilm forming, and non-pathogenic
bacteria that are well known for their ability to highly compete with other types of
microorganisms as a response to nutrients depletion and increased population densities.
Bacillus sp. are usually found in terrestrial (soil and vegetation) and aquatic environments, this
ability to adapt to a wide range of environments makes it clear why this bacterial species is
abundant in the environment. They grow in the mesophilic temperature range with an optimal
temperature of growth ranging between 25 to 37 oC (Grossman, 1995; Maglott et al., 2007;
Earl, Losick and Kolter, 2008).
The cell wall of Bacillus sp. bacteria has a rigid structure, made of a polymer composed of
sugars and amino acids known as peptidoglycan also known as murein in bacteria. Bacillus sp.
uses its flagella to swarm around. (Schaechter, Ingraham and Neidhardt, 2006). Bacillus cells
can produce toxins (enzymes) that kill different species they encounter in a mixed culture (Liu
et al., 2010).
It had been conceived previously that Bacillus sp. are strictly aerobic bacteria, which means
that oxygen is required for their growth. However, later studies have shown that they can grow
in anaerobic conditions. Nitrite and nitrates are used as electron acceptors in the absence of
oxygen during the cell respiration (Nakano and Zuber, 1994; Marino et al., 2001).
Bacillus sp. forms biofilms on the surface of plants roots (Earl, Losick and Kolter, 2008),
evidence exist that this is a favorable association for the plants and it promotes plant growth
due to the following reasons: (a) it activates the plant immune system making the plants ready
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to overcome other harmful pathogens; (b) their biofilms will overgrow and kill other potential
pathogens that can affect the plant health; (c) they make key nutrients to the plants
(phosphorus and nitrogen) more readily available to the plant (Cazorla et al., 2007; Nagórska,
Bikowski and Obuchowski, 2007; Earl, Losick and Kolter, 2008). In animals, Bacillus subtilis is
considered to have beneficial effects when ingested by maintaining a healthy bacterial
community in their gastrointestinal tract (Hong, Duc and Cutting, 2005). Several popular
fermented food products in Japan such as fermented soybeans contain Bacillus subtilis, these
types of food have been thought to carry many health benefits (Inatsu et al., 2006). Other
industrial uses of Bacillus subtilis in the manufacturing of many types of enzymes such as
xylanase, lipase, protease, amylase (Westers, Westers and Quax, 2004).
2.4.2

Pseudomonas Fluorescens

The Pseudomonas fluorescens strain used in this research was purchased from DSMZ in
Germany, it is known commercially as Pseudomonas fluorescens (Migula 1895) DSM no. 50090,
Type strain. Pseudomonas fluorescens is considered a model microorganism for studying
biofilms (Rossignol et al., 2008). Pseudomonas fluorescens is a gram-negative, rod-shaped, nonspore forming, motile (via flagella), biofilm forming, non-pathogenic bacteria (Rossignol et al.,
2008; Scales et al., 2014). They are considered obligate aerobes, but they can survive in
anaerobic conditions by using nitrate as an electron acceptor during cellular respiration. It
grows in mesophilic temperatures (Optimal temp. 25 to 30 oC) (Donnarumma et al., 2010), due
to its ability to resist a wide range of antibiotics and disinfectants and its high adaptation, this
bacterium is largely reported in many locations in the environment and in hospitals (Spiers,
Buckling and Rainey, 2000; Rossignol et al., 2008; Scales et al., 2014). Previous research has
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reported that Pseudomonas fluorescens biofilms are mainly composed of proteins (Molobela,
Cloete and Beukes, 2010). Previous researchers showed that when compared with biofilms
formed by other pathogenic gram-negative microorganisms (Staphylococcus aureus,
Pseudomonas aeruginosa, and Staphylococcus epidermidis), Pseudomonas fluorescens biofilms
has shown the highest resistance to treatments, which makes their biofilm the worst case
scenario for biofilm removal (Johansen and Falholt, 1997).

2.5 Factors Governing Biofilm Formation
2.5.1

The Effect of Nutrients

Bacteria require a source of energy and raw materials to grow. Bacterial cells that can
obtain energy from sunlight are called Autotrophs (self-feeding); while bacterial cells that
obtain energy from oxidizing inorganic and organic materials are called heterotrophs (otherfeeding). The heterotrophs are the most common types in humans and medical applications
(Todar, 2012). For a bacterial cell to generate energy and carry on biosynthesis the surrounding
environment must provide all the required substances. These substances that are utilized for
bacterial growth are usually referred to as nutrients. Bacterial cells grown in laboratories are
always grown in a culture media that provides them with all the essential nutrients for growth
and development (Todar, 2012). Major elements required for bacterial growth are the same
elements used in the composition of the bacterial cell itself and those are: C, H, N, O, P, S, Ca,
Mn, K, Mg, Fe and some trace concentrations of Mo, Co, Zn, Cu. These molecules have
structural or functional roles in the bacterial cells and are usually found in inorganic
compounds, water, and other molecules. Trace concentration of metals are required by certain
bacterial cells and their presence is not necessary in the culture medium, they work as co29

factors for enzymatic reactions in the cells (Todar, 2012). It must be stated that nutrients are
bacteria-specific and what one bacterial cell can utilize for energy another bacterial cell may not
be able to utilize, since some metabolizing enzymes may not be present or the fact that these
molecules cannot be transported through the cell wall membrane of that specific bacteria
(Todar, 2012).
Bacterial cells in a biofilm cannot utilize the available energy source in its surrounding
environment without being able to transport it into the biofilm cells. Usually, nutrients are
dissolved and must be able first to diffuse through the mass transfer boundary layer this is
known as the external mass transfer, following that the nutrients need to diffuse through the
biofilm matrix and this is known as the internal mass transfer to finally reach the bacterial cells.
The decrease in the thickness of the boundary layer is reversely correlated with the nutrients
diffusion rate (Characklis and Marshall, 1990; Ghannoum and O’Toole, 2004).
2.5.2

The Effect of Temperature

The ideal temperature for bacterial growth and development is related to the rate of
nutrients intake, a higher rate will result in a rapid biofilm formation (Stepanovic et al., 2003).
The metabolism of nutrients is dependent on the usage of enzymes, based on that the rate of
biofilm formation and development of biochemical and physiological systems depends on the
availability and reaction rates of enzymes (Garrett, Bhakoo and Zhang, 2008). Optimal growth
of bacterial cells and their biofilms requires ideal temperatures, and consequently when
temperatures deviate from the ideal temperature that reduces their growth efficiency. Due to
reduction in the reaction rates of the bacterial enzymes, and the change in the physical
properties in the surrounding environment to the cells (Garrett, Bhakoo and Zhang, 2008).
30

A study by Fletcher et al. (Fletcher, 1977) investigated how the attachment of cells in the
stationary phase is affected by temperature in the marine Pseudomonad, results showed that
temperature and cell adhesive properties are proportional to each other. That was related to
the reduction in the bacterial surface polymers and the reduction in surface area at lower
temperatures. On the other hand, a study by Herald et al. (Herald and Zottola, 1988) observed
that the bacterial cell flagella counts is temperature dependent, several flagellas were noticed
at 10 oC, whilst two or three flagellas were noticed at 21 oC, and only one flagella was observed
at 35 oC. Based on that, initial interactions between the bacterial cells and the attachment
surface will increase at lower temperature, which likely will increase the chances of initial
attachment of bacterial cells. Moreover, at lower temperatures there are more uniform
properties of the exopolysaccharides which in turn enhances the bacterial cells attachment. It
was also found that the use of high temperatures (80 to 90 oC) have negative effects on biofilm
removal due to the “baking effects”. Results showed that high temperatures are not effective
for biofilm removal; in fact, high temperatures increased the adherent nature of the biofilms to
the attachment surface (Marion-Ferey et al., 2003).
2.5.3

The Effect of pH

The manipulation of the pH is common for detergents and disinfectants used to kill bacteria
due to its direct effect on bacterial growth (Garrett, Bhakoo and Zhang, 2008). Bacterial cells
possess proton pumps in their membrane that are used to expel protons from the cytoplasm to
generate the proton motor force, which is used to regulate the cytoplasm pH (Rowland and
Voorheesville, 2003; Garrett, Bhakoo and Zhang, 2008). A sudden change in external pH can
cause influx of protons into the cytoplasm and that is problematic to the bacterial cells (Booth,
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1985). Large variations in the pH of the surrounding environment of a bacterial cell can have
fatal effects on it. Bacterial cells overcome the changes in pH by adjusting the synthesis and
activity of proteins in cellular processes (Olson, 1993). Researchers have shown that a gradual
decrease in pH will increase the bacterial cell survival when compared to a sudden drop in pH
(Li et al., 2001).
Although bacterial cells can adapt with gradual changes in pH, some cellular activities
cannot adapt with pH changes. An example on that will be the excretion of the
exopolysaccharides. An optimum pH value for exopolysaccharides secretion is species
dependent; usually for most bacteria it is in the neutral range (Oliveira et al., 1994).
2.5.4

The Effect of Flow Dynamics

The common testing methods used for biofilm control usually employ the use of microtiter
plates (6, 12, and 96 well) in static conditions (Kolodkin-Gal et al., 2010; Cava et al., 2011;
Brandenburg et al., 2013; Leiman et al., 2013), the use of microtiter plates has been evaluated
previously and found to be appropriate for testing biofilm control agents (Stiefel et al., 2016).
Biofilm forming in static conditions are different from biofilms forming in a dynamic fluid
system. One example on biofilm formation inside tubes and pipes is the biofilm formation
inside DUWLs. Flow inside DUWLs is described to be laminar, flow velocity near the inner
DUWLs wall approaches zero due to friction, which dramatically reduce the shear forces
exerted on the biofilm developing on the inner walls of the DUWLs. This in fact reduces the
chances of biofilm dislodging from the inner wall of DUWLs (Rowland and Voorheesville, 2003).
A higher flow velocity is usually associated with higher shear forces exerted on the biofilm
inside the DUWLs. Fluid dynamics has direct effects on biofilm formation; a biofilm will form in
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different shapes with specific characteristics depending on the fluid dynamics under which it
formed (Stoodley, Boyle and Lappin-scott, 1999; Buckingham-Meyer, Goeres and Hamilton,
2007). It had been reported that when flow was turned off biofilm thickness increased 38% in
comparison to biofilm grown at 1.5 m s-1 flow velocity (Stoodley, Boyle and Lappin-scott, 1999).
Biofilms forming under higher shear forces are denser, more strongly attached to the surface,
have lower profile thickness, and have lower internal diffusivity when compared with biofilms
formed in static conditions or under lower shear conditions (Vieira, Melo and Pinheiro, 1993;
Pereira et al., 2002).
When compared to municipal water network, DUWLs represent an ideal environment for
biofilm growth for many reasons other than the abundance of nutrients. Flow rates inside
DUWLs can be as low as 2 mL min-1 or as high as 100 mL min-1 and it turns into static conditions
over night and when the dental units are not in use (Rowland and Voorheesville, 2003). This
flow is considered to be very low when compared to flow rates of 5000 mL min -1 in usual
municipal water networks (Swift, 1999; Pederson, 2002). Another factor is the surface area to
volume ratio. Normally DUWLs have an inner diameter ranging between 1/16 and 1/8 inch. The
inner diameter of DUWLs has an inverse relationship with the area available for bacterial
attachment and growth, as the inner diameter of the DUWLs decrease the surface area to
volume ratio will increase dramatically (Pederson, 2002).
2.5.5

The Effect of Surface Type
Previous literature has presented the effect of surface physical and chemical

characteristics on bacterial adhesion to surfaces. Surface roughness is being used over a large
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scale of measurements. The surface patterns that have been reported to reduce biofilm
formation was in the scale of the bacterial cells (i.e. between 1 and 2 µm) (Graham et al., 2013).
In a previous study by Graham et al. 2013, the attachment of Escherichia coli (E. coli)
was evaluated on surfaces related to medical applications made from titanium, silicon and,
glass. The researchers reported that the attachment of E. coli on the different surfaces was
proportional to wettability of the surfaces quantified by measuring the surface contact angle
using deionized water droplets. Interestingly the researchers reported that the inherent surface
roughness did not correlate with the attachment of E. coli cells. The same researchers
evaluated the effect of engineered surface roughness on the attachment of E. coli. Different
topographical features were formed from silicon surfaces and tested at static and microfluidic
flow conditions for E. coli attachment, the highest attachment observed was on un-patterned
flat surfaces, while linear patterned surfaces showed less bacterial attachment. They also
reported that surfaces containing holes further reduced attachment of E. coli when compared
to surfaces with linear patterns. The authors concluded that the shape of the surface features,
spacing, size have high effect on the cell-surface interactions which should be considered in the
design of anti-biofilm surfaces (Graham et al., 2013).
Previous studies have shown that surfaces that are formed from repetitive microscale
patterns can reduce bacterial attachment to surfaces (Whitehead and Verran, 2006). A study by
Schumacher et al. 2007 suggested that the use of microscale biometric patterns that are similar
to ones on shark skin reduced bacterial attachment to surfaces significantly lower than similarly
sized different patterns. The same researchers reported that engineered surfaces with spacings
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that are equal to the size of the individual bacterial cells significantly enhanced the attachment
of bacterial cells to surfaces (Schumacher et al., 2007).
Other research focused on different coatings that can be used to reduce bacterial
attachment to surfaces such as immobilized enzymes (Cordeiro, Hippius and Werner, 2011),
this method was not seen effective for the use in dental treatments as enzymes can be
denatured due to different chemical treatment that can pass through DUWLs. Other research
focused on the use of active coatings that have bactericidal effects (such as copper) to prevent
biofilm formation on surfaces (Zeiger et al., 2014), these treatments have shown to be
ineffective in DUWLs applications due to physical degradation by debris released from dental
treatments passing through the DUWLs. More information can be found in the review by Tuson
et al. 2013 on surface modifications and the interactions between bacteria and surfaces (Tuson
and Weibel, 2013).
The research that focuses on modifying surfaces to reduce bacterial attachment can
produce very useful results that can be used by the different manufacturers of dental and
medical equipment. On the other hand, this method is not applicable for the removal of preexisting biofilm from surfaces.

2.6 Polyamines
Polyamines are organic compounds that have two or more amino groups. Polyamines are
found naturally in all types of bacteria and in most animal cells, they are considered to be
important growth factors in microorganisms. In microorganisms, they are made from
putrescene, while in mammals they are made from arginine (Lawrence, 2004). Polyamines are
important for the growth and development of cells; it is no surprise they occur in high
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concentrations in milk and other dairy products, they can also be found in other food products
such as: fish, meat, fruits, and nuts. In addition to the polyamines that exist in nature, there are
many other synthetic industrial polyamines (Lawrence, 2004). There is an increased interest in
polyamines due to their high distribution among most living cells and their high concentrations
especially in rapidly growing tissue (Tabor and Tabor, 1984).
The life span of biofilms formed by Bacillus subtilis is limited. After three days of incubation
in a biofilm growth medium at 22 oC the biofilm matures, and after eight days the biofilm
disassembles and start releasing the free planktonic cells (Kolodkin-Gal et al., 2010; Romero et
al., 2011). It was previously found by Kolodkin-Gal et al. (2010) that an eight day old bacillus
subtilis culture contained factors that inhibited the formation of pellicles when mixed with fresh
cultures, these factors were mixtures of D-amino acids (Kolodkin-Gal et al., 2010). Following the
same procedure, the same researchers announced the discovery of a new biofilm disassembly
factor that was found in the eight-day Bacillus subtilis biofilm growth medium, this factor is the
polyamine norspermidine, which was found at concentrations ranging between 50 and 80 µM
in the eight-day biofilm growth media culture which makes that the minimum required
concentration for pellicle formation inhibition. Furthermore, norspermidine was present in the
three day biofilm growth media culture only at a lower concentration of less than 1 µM and
that concentration had no inhibition effects on pellicle formation (Kolodkin-Gal et al., 2012).
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Figure 2-2. Specificity in structural activity of polyamines with exopolysaccharides, modified
from (Kolodkin-Gal et al., 2012).
There is evidence of direct interaction between norspermidine and the exopolysaccharides,
this interaction was specific to norspermidine that other similar polyamines such as spermidine
that only have one extra methylene group did not show any biofilm inhibiting activity at
concentration as high as 2 mM. Moreover, Bacillus subtilis mutant cells that could not produce
norspermidine and D-amino acids formed long living pellicles. In their research paper KolodkinGal et al. 2012 presented data showing extreme reduction in the average diameter of the
exopolysaccharides aggregates before and after the addition of norspermidine (570 nm and 85
nm respectively) similar results were obtained from norspermine. Using molecular modeling
(Figure 2-2) the researchers suggested that the amines in norspermidine and other polyamines
that are similar in structure and charge ("three methylene groups flanked by two positively
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charged amino groups") interacts with the negatively charged residues (i.e. uronic acid) or the
neutral sugars with polar groups (i.e. poly-N-acetyglucosamine) that exist in the secondary
structure of the exopolysaccharides. They hypothesised that norspermidine interacts directly
with the exopolysaccharides within the biofilm community. This interaction disrupts the biofilm
formation and diminishes the pre-existing biofilm and causes it to collapse in biofilms
communities from Bacillus subtilis, Staphylococcus aureus, and Escherichia coli (Kolodkin-Gal et
al., 2012).
A later study by Hobley et al. 2014, revisited the findings of Kolodkin-Gal et al. 2012. In
contrast, they found that norspermidine can not naturally exist in biofilms formed by Bacillus
subtilis, therefore norspermidine is not self-produced by Bacillus subtilis. They also found that
the gene responsible to produce norspermidine in V. cholera was missing in Bacillus subtilis
genome. The researchers suggested that norspermidine does not have a native role in the
physiology of Bacillus subtilis biofilms. Moreover, the researchers stated that spermidine has an
essential role in robust biofilm formation from Bacillus subtilis and norspermidine can
substitute spermidine efficiently for that role. Moreover, results showed that biofilm formation
from Bacillus subtilis wild type was inhibited by norspermidine at a minimum concentration in
the range of 250 to 300 µM. Pellicle formation was completely inhibited at a minimum
concentration of 500 µM. When norspermidine concentrations were lower than 250 µM,
biofilm formation was enhanced (Hobley et al., 2014).
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2.7 Amino Acids
The word chirality is used to describe objects when their mirror reflected image cannot be
superimposed on their original image. One good example on that is the human hand, which in
fact where the word was derived from in Greek. The term enantiomers have been used to refer
to the two mirror images of a chiral molecule. Although enantiomers share almost the same
physical properties (i.e. molecular weight, solubility…), they have different interactions when
they are subjected to plane-polarized light. The common basis of chirality in molecules is a
carbon atom that is bonded to four groups; this carbon atom is called the chiral center or
stereocenter (Cava et al., 2011). The arrangement of the atoms bonded to the chiral center in
three-dimension is used to describe the chirality of a molecule. For amino acids and sugars the
D or L are the nomenclature used to describe their chirality (Meierhenrich, 2008). The
structures of D- and L- enantiomers of Tyrosine are presented in Figure 2-3.

Figure 2-3. Chirality of Tyrosine.
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Unlike chemical synthesis that can usually produce both enantiomers, enzymes show
clear substrate selectivity, and based on that biochemical processes usually use and produce
particular enantiomers. One good example on that is the fact that L-amino acids are the
building blocks of proteins in the ribosomal synthesis, at the same time D-amino acids cannot
be utilized into proteins though ribosomal synthesis. Another example on that are the
enantiomers of alanine. While L-alanine is considered to be a germinant, and in the presence of
L-alanine and other nutrients bacterial spores can reactivate their metabolism and grow again,
it was discovered that D-alanine is a strong inhibitor of Bacillus spore germination (Hills, 1949).
Following that discovery researchers have shown that Bacillus bacteria uses D-alanine as an
auto inhibitor for spore germination at spore densities that are considered high when
compared to available nutrients. This is considered a survival mechanism in Bacillus bacteria to
prevent premature germination of bacterial spores in low nutrient environments and high
spore density which will lead to cell death due to rapid consumption of available nutrients
(Halvorson and Spiegelman, 1952; McKevitt et al., 2007).
Among the different enantiomers of amino acids, the L-amino acids are the most common and
naturally existing in nature and in many living organisms. L-amino acids are utilized for the
manufacture of D-amino acids. The process of changing the L- amino acid to its D-amino acid
enantiomer is called racemases; within racemases the stereochemistry of the chiral α-carbon
atom is changed (Tanner, 2002).
Bacteria show great resistance to chemical, biological, and physical assaults. Mostly, due to the
existence of the peptidoglycan cell wall, this is also known as the murein, which is located
outside of the cytoplasmic membrane of most bacteria (Park, 1996; Holtje, 1998; Nanninga,
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1998). The peptidoglycan cell wall is a flexible strong polymer that has a net-like shape, it is
composed of linear glycan strands formed from disaccharide chains and cross linked by short
polypeptides (Cava et al., 2011). The peptidoglycan cell wall provides the bacterial cell with
many benefits such as: protecting the contents of the bacterial cell, strength to hold its shape,
resists the osmotic pressure, provides a framework structure to anchor cell envelop
components (Holtje, 1998; Young, 2006; Dramsi et al., 2008; Vollmer, Blanot and de Pedro,
2008). One interesting feature of the peptidoglycan cell wall composition is the D-amino acids
that are present in the polypeptides (Nagata et al., 1998). These D-amino acids help in forming
the structure of the peptidoglycan cell wall and provide resilience to the known proteases (Cava
et al., 2011). The most common D-amino acids found in peptidoglycan cell wall are D-alanine
and D-glutamate. However, the peptidoglycan cell wall of other bacteria incorporate other Damino acids such as D-serine in Staphylococcus aureus (vancomysin-resistant bacteria), and Daspartate in Enterococcus and Lactococcus (Sieradzki and Tomasz, 1996; de Jonge, Gage, and
Xu, 2002; Reynolds and Courvalin, 2005; Bellais et al., 2006; Veiga et al., 2006). These
incorporations are thought to increase the bacterial resistance to antibacterial agents (de
Lencastre, Oliveira and Tomasz, 2007).
Previous researchers have concluded that D-amino acids are self-produced by Bacillus subtilis
to disassemble their biofilms in the stationary phase of their life cycle (Kolodkin-Gal et al.,
2010). This is triggered when nutrients are limited and the products of metabolic waste have
accumulated, which makes it more favorable to escape into the free planktonic cells form. In
specific, D-tyrosine, D-tryptophan, D-leucine, and D-methionine have shown capabilities in
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biofilm growth inhibition in both solid and liquid mediums (Lam et al., 2009; Kolodkin-Gal et al.,
2010; Leiman et al., 2013).
A study by Kolodkin-Gal et al. 2010 reported the existence of self-produced D-amino
acids in mature biofilm growth medium (6 to 8 days old). In their experiments, they showed
that a minimum concentration of 3µM, 5 mM, 8.5 mM, and 2 mM for D-tyrosine, D-tryptophan,
D-leucine, and D-methionine respectively must be used to inhibit biofilm formation by Bacillus
subtilis. Moreover, a mixture of the aforementioned D-amino acids with a concentration of 10
nM for each D-amino acid was potent and had synergetic results that dismembered the preexisting biofilms. They also suggested that amyloid protein TasA fibers that connects the
bacterial cells within the biofilm are anchored to the cell wall, when D-amino acids are
introduced to the biofilm they incorporate them self into the cell wall by replacing the preexisting D-alanine, and consequently the protein fibers are disengaged from their anchors
which causes the biofilm to disassemble (Kolodkin-Gal et al., 2010). They also stated that the
corresponding L-amino acids had no effects on Bacillus subtilis biofilm disassembly, and that the
presence of D-alanine will mitigate the inhibitory effects of the aforementioned D-amino acids.
They also found similar results when same treatments were tested on biofilms from
Pseudomonas aeruginosa (Kolodkin-Gal et al., 2010). However, the direct interaction between
the D-amino acids and the protein amyloid fibers is not the only mean by which biofilm
disassembly is promoted by D-amino acids. The same researchers stated that D-amino acids
dispersed biofilms from bacterial species that are not known to have amyloid protein fibers in
their biofilm matrix such as Staphylococcus aureus and Pseudomonas aeruginosa.
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Another study by Leiman et al. 2013 stated that D-tyrosine, D-tryptophan, D-leucine,
and D-methionine can inhibit Bacillus subtilis biofilms. They suggested that the major inhibitory
effect of the mentioned D-amino acids on biofilm growth arises from their interference with
protein synthesis by their misincorporation into the protein synthesis. They also stated that Dtyrosine in specific is a metabolic inhibitor for Bacillus subtilis. It was also proposed that the
presence of L-amino acids will mitigate the inhibitory effects of the D-amino acids on Bacillus
subtilis biofilm. They also said that a mixture of the four amino acids at a concentration of 10
nM each was not sufficient for Bacillus subtilis biofilm inhibition, and a higher concentration
(500 nM) is required for such inhibitory effects. They also suggested that the presence of Dalanine did not counter the effects of the four D-amino acids in contrast to the presence of Ltyrosine which countered the effects of the D-amino acids (Leiman et al., 2013). This contradicts
what was presented by Kolodkin-Gal et al. 2010.
Brandenburg et al. 2013 conducted a study that aimed to study the effects of amino
acids on biofilm formation and motility of Pseudomonas aeruginosa. Results obtained showed
that only D-tryptophan and D-tyrosine possessed inhibitory effects with D-tryptophan being
most effective, while D-methionine and D-leucine interestingly increased biofilm growth.
Moreover, at a concentration of 10 mM both tryptophan isoforms (D and L) were effective in
biofilm inhibition with the L-tryptophan being more effective than D-tryptophan (86% and 71%
at 24 hr respectively). A mixture with an equimolar ratio of both tryptophan isoforms (total
concentration of 10 mM tryptophan) resulted in higher inhibitory effects (93% at 24 hr). They
hypothesised that tryptophan enhances bacterial cell swimming motility (~40%) by increasing
the flagellar activity of bacterial cells, which results in biofilm growth inhibition and
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disassembly. Since bacterial cells that were under flagellar arrest before introducing tryptophan
will prefer to detach from the biofilm (Brandenburg et al., 2013). These results contradict what
was presented in the previously mentioned two studies.
In summary, D-amino acids can inhibit biofilm formation and disperse pre-existing biofilms
through different mechanisms which can be characterised by the following: (i) misincorporation
of D-amino acids into the cell wall by replacing the D-alanine in the polypeptide chains, and
consequently the amyloid protein fibers are disengaged from their anchors, (ii) D-amino acids
can interfere with protein synthesis by their misincorporation into the protein synthesis, (iii) Damino acids increase the flagellar activity of bacterial cells and promote free planktonic cells
form. The fact that D-amino acids can be used to control biofilm formation is significantly
promising due to the lack of toxicity and the favorable pharmacokinetic properties of D-amino
acids (Jayaraman and Wood, 2008).

2.8 Enzymes
Enzymes are biological catalyst made from amino acids strings, they accelerate chemical
reactions by lowering their activation energy, similar to other catalyst, enzymes do not get
consumed within the reactions they catalyze (Berg, Tymoczko and Stryer, 2002). Enzymes have
a limitless number of possible applications such as but not limited to cellular metabolism,
detergents, food industry, animal feed, textiles, drugs, pulp, personal care, baking, and paper
(Kirk, Borchert and Fuglsang, 2002). There is a current interest in enzymes to be used as antibiofilm agents, this was after their reported promising results in the removal of biofilm from
industrial surfaces (Taraszkiewicz et al., 2013; Thallinger et al., 2013; Meireles et al., 2016).
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Previous research have described enzymes as affordable, efficient, and echo-friendly
alternative to the chemicals that have been used in eradicating biofilms (Cordeiro, Hippius and
Werner, 2011; Cortés, Bonilla and Sinisterra, 2011; Srey, Jahid and Ha, 2013). Enzymes have
been approved by regulatory agencies, and there has been no side effects reported from using
enzymes for cleaning surfaces and in industry (Schmidt, 2012; Meireles et al., 2016).
Enzymes mitigate biofilm formation by breaking the extracellular matrix components and
weakening its structural integrity (Molobela, Cloete and Beukes, 2010). There are different
factors that affect enzymes efficiency such as the substrate type and concentration, enzyme
concentration, pH, temperature, cofactors or inhibitors, and presence or absence of activators
(Madhumathi, 2007; Meireles et al., 2016). The enzymes used to mitigate biofilm related
problems has been categorised into anti-quorum sensing, oxidative enzymes, polysaccharide
degrading enzymes, and proteolytic enzymes (Thallinger et al., 2013).
Quorum sensing is the intercellular communication system used by bacterial cells in
communities with high cell density (i.e. a Biofilm), it is used among bacterial cells to regulate
many of their physiological activities including biofilm formation(Pearson, Van Delden and
Iglewski, 1999; Meireles et al., 2016). This communication system operates through the release,
and detection of small self-produced molecules (autoinducers) used as signalling molecules
among different bacterial cells within the biofilm community (LaSarre and Federle, 2013). Antiquorum sensing enzymes such as lactonases and AHL acylase can prevent the signaling
molecules from binding to their target (transcriptional regulators), this is done by the
hydrolyses of the transcriptional regulators and/or the hydrolyses of the signalling molecule
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respectively, eventually preventing them from bonding (Thallinger et al., 2013). More
information about quorum sensing can be found in previous work (Kalia, 2015).
Oxidative enzymes such as xanthine oxidase, deoxyribonuclease, and lipoxygenases can
produce superoxide anions that are used to destroy invading pathogens, it can also disperse
biofilms by targeting the DNA in the extracellular matrix of the biofilm (Valko et al., 2007;
Thallinger et al., 2013; Okshevsky and Meyer, 2015a). This is similar to the defence system used
in the human body defence system against pathogens (Thallinger et al., 2013). Further
information can be found on oxidative enzymes in many previous valuable studies (HallStoodley et al., 2008; Thomas et al., 2008; Okshevsky and Meyer, 2015b).
Proteases (proteolytic enzymes) are enzymes that hydrolyse peptide bonds in proteins, they
contain a range of enzymes that vary in their mechanisms and targeted substrates (Hedstrom,
2002). There are two major groups of proteases, exopeptidases are proteases that hydrolyse
the peptide bond at the C-terminal and the N-terminal (i.e. Aminopeptidase and
Carboxypeptidase), and endopeptidases are proteases that hydrolyse the peptide bond at the
inner regions within the molecule (i.e. Savinase, Protamex, Subtilisin A, and Trypsin) (Obayashi
and Suzuki, 2005). Previous researchers have reported promising results on the use of Savinase
as an anti-biofilm agent (C Leroy et al., 2008; Molobela, Cloete and Beukes, 2010).
A study by Marcato-Romain et al. 2012 investigated the effectiveness of different enzymes in
reducing biofilm formation in paper industry. The extracellular matrix material (found to be
mainly composed from proteins) was extracted from six industrial biofilms and treated with
different enzymes (glycosidases, lipases, and proteases) at varying concentrations and contact
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time. Only proteases were found to be effective in biofilm reduction, in specific, Savinase was
found to be the most effective in biofilm reduction which exceeded 80% (Marcato-Romain et
al., 2012).
Protamex is an enzyme introduced first in fisheries for its ability to hydrolyse proteins
(Dumay et al., 2009; Nguyen et al., 2011; Minh, 2015). To this date, no previous studied could
be found on the use of Protamex as an anti-biofilm agent. Due to its wide use for protein
hydrolysis in the fish industry, It was considered in this work as a potential anti-biofilm removal
agent.
A study by Cordeiro et al. 2011 has investigated the effect of immobilized enzymes on
the initial attachment of Staphylococcus epidermidis and Pseudomonas aeruginosa on
poly(ethylene-alt-maleic) anhydride copolymer surfaces. The enzymes Subtilisin A and Cellulase
were immobilized by covalent bonding on the surfaces, and test control were prepared by using
heat-inactivated enzymes on the surfaces. The tested surfaces were submerged in a suspension
containing bacterial culture (106 CFU/mL) and incubated at 37oC for 24 hrs. The surfaces are
then washed and the remaining attached cells were plated in serial dilutions for viable cell
count quantification. The immobilized Subtilisin A reduced the attachment of P. aeruginosa by
44%, no effect on the attachment of S. epidermidis was noticed. The authors concluded that
different biomolecules are involved in the initial attachment step among different bacterial
strains which requires a wide spectrum of enzymes coatings to control biofilm attachment to
surfaces (Cordeiro, Hippius and Werner, 2011).
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Chaignon et al. 2007 investigated the use of the protease Trypsin for removing biofilms
from different bacterial species (S. epidermidis RP62A, S. epidermidis 444, S. epidermidis 5, S.
lugdunensis 47, S. aureus 383, S. lugdunensis 18a). The biofilms were grown in 96-well
microtiter plates and then treated with Trypsin (100 μL) at 1 mg mL −1 in 20 mM Tris buffer (pH
7.5) for 2 h. Biofilms were measured indirectly using safranin stain (5%) and quantified via
absorbance measurements at optical density of 492 nm. Their results showed that Trypsin was
able to remove more than 70% of biofilms formed by S. lugdunensis 47, S. epidermidis 444, S.
aureus 383, S. lugdunensis 18a. In contrary, Trypsin hand no effect on biofilm formed by S.
epidermidis 5 and S. epidermidis RP62A., the authors hypothesised that this was due to their
biofilm composition being rich in polysaccharides, which is not a suitable substrate for Trypsin.
The authors stated that the removal of the polysaccharide-rich biofilm formed by S. epidermidis
444 using Trypsin was a result of the interdependent roll of proteins and polysaccharides in the
structural integrity of biofilms formed by this strain of bacteria (Chaignon et al., 2007). In a
similar study by Rohde et al. 2007, 98% of pre-grown biofilms from Staphylococcus epidermidis
and Staphylococcus aureus were removed using Trypsin (100 µg/mL applied for 16 hrs at 37 oC)
(Rohde et al., 2007).
Polysaccharides and polysaccharide-degrading enzymes are naturally abundant, with
bacteria being the main source for polysaccharide-degrading enzymes, these enzymes are used
by bacteria to takedown host defences in nature (Jedrzejas, 2000). There are two main types
of polysaccharide-degrading enzymes lyases and hydrolases. Lyases enzymes degrade
polysaccharides using the β-elimination process that is based on the mechanism of proton
donation and acceptance, more information can be found in previous research (Jedrzejas and
48

Chantalat, 2000). Hydrolases enzymes degrade polysaccharides by the hydrolysis of the
glycosidic bonds between the building blocks of the sugar, some of the hydrolases enzymes use
the mechanism of direct-displacement where a water molecule replaces the leaving group from
the substrate (Jedrzejas, 2000). The polysaccharide-degrading enzyme Cellulase is vastly used as
an anti-biofilm enzyme for the removal and prevention o biofilms (Loiselle and Anderson, 2003;
Cordeiro, Hippius and Werner, 2011).
Cordeiro et al. 2011 reported that Cellulase was effective in reducing the attachment of
S. epidermidis by 67%, while it had no effect on biofilms formed by P. aeruginosa, the
researchers followed the same procedure explained previously for subtilisin A (Cordeiro,
Hippius and Werner, 2011).
A study by Loiselle et al. 2003 investigated the use of Cellulase for inhibiting biofilm
formed by P. aeruginosa. The biofilm was gown on a glass slide for four days inside a flow
chamber. Biofilm formation was quantified using viable cell counts (CFU) and by biomass areal
density (mg cm-2). The biofilm tested was grown in the presence of Cellulase at different
concentrations and pH values. Controls were prepared using deactivated Cellulase. The results
presented showed that Cellulase could partially inhibit biofilm. The highest biofilm areal density
removal achieved using Cellulase was 88% at concentration of 75.2 U mL-1 at pH 5. While viable
cell counts was reduced 60% at concentration of 9.4 U mL-1 and pH 5, no effect of
concentration increase was noticed for viable cell counts (Loiselle and Anderson, 2003).
Pectinases are heterogenous mixtures of enzymes that hydrolyse pectic substances,
they are abundant in plants and microorganisms (Jayani, Saxena and Gupta, 2005).
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Pectic compounds are polysaccharides that are negatively charged, acidic, macromolecules that
have high molecular weight, they are abundantly found in the plant kingdom (Jayani, Saxena
and Gupta, 2005).Pectinases have an important role in the plant kingdom in the degradation of
the plant cell wall (Ward and Moo-Young, 1989). They also have an important role at plant
maturation in softening the plant tissue (Sakai, 1992), they also have an ecological role in the
degradation and recycling of plant waste material (Lang and Dörnenburg, 2000).
A study by Johansen et al. 1997 investigated the use of Pectinex as an anti-biofilm agent
on biofilms formed by Staphylococcus aureus ATCC 25923, Pseudomonas fluorescens AH2, and
Pseudomonas aeruginosa ATCC 10148. Discs made from steel and polypropylene were vertically
immerged in growth medium and the biofilm was allowed to form on both sides of the discs
while stirring continuously at 200 rounds per minute for four days at 26oC. The loosely attached
cells were then removed by washing the discs using phosphate buffer (pH 7), following to that,
the discs were incubated in different concentrations of Pectinex prepared in phosphate buffer
for 15 min, static, at 20 oC. Control samples were prepared using phosphate buffer solution
containing no Pectinex. The biofilm removal was assessed using the total number of cells and
the number of respiring cells, which were quantified using fluorescence microscopy. The
presented results showed that Pectinex was successful in removing biofilms formed by all
tested bacterial strains. The cell number for P. aeruginosa and S. aureus were reduced by two
log reductions, while the cell number count for P. fluorescens was reduced one log reduction, at
a Pectinex concentration of 180 PSU mL-1 (Johansen and Falholt, 1997).
The first obstacle to overcome in biofilm removal is the extracellular matrix which
shields and covers the bacterial cells living within the biofilm community. Due to the abundance
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of available enzymes, the different biofilm composition among different bacterial strains, and
the substrate specificity of enzymes (Simões, Simões and Vieira, 2010), it is important to
investigate and compare the ability of different available enzymes to remove biofilms. Although
biofilms have a complex composition, they are composed mainly from polysaccharides and
proteins, which makes polysaccharide-degrading enzymes and proteases the most suitable
enzymes for their removal, this due to their substrate compatibility (Meyer, 2003). Hence,
polysaccharide-degrading enzymes and proteases will be investigated in this work.
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Chapter 3 - Experimental Work

3.1 Preface
The results of the experimental work conducted in this thesis are presented in Chapter
Chapter 3. The experimental work is presented in four subsections (subsections 3.2-3.5), each
subsection represents a separate contribution. Each subsection was directed toward one of the
four specific research objectives presented previously in Sections (1.3.2.1-1.3.2.4).
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3.2 Biofilm Control Using Norspermidine
Bilal Al-Bataina, Erin Johnson, and Lars Rehmann
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3.2.1. Preface
Section 3.2 presents the experimental work conducted to fulfill the specific objective
presented in Section 1.3.2.1. The work presented in this section provides a possible explanation
for the apparent contradiction in previous work presented by different researchers on the role
of norspermidine in removing biofilm. Based on the results presented in Section 3.2
norspermidine can remove nonactive biofilms, and enhance the growth of active biofilms. The
apparent controversy in previous published research was attributed to the different viable state
of the treated biofilm. Section 3.2 provides quantitative information on biofilm removal and
biofilm growth enhancement using norspermidine.
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3.2.2. Introduction
When free planktonic bacterial cells find a surface in a favorable environment they tend
to colonize it by forming biofilms (Henrici, 1933; Torres et al., 2012; Daniel et al., 2016). While
in biofilm formation, bacterial cells aggregate to form a protective layer that shelters the cells
underneath. In doing so, bacteria have evolved to tolerate low concentrations of antibiotics and
antimicrobials (O’Toole, Kaplan and Kolter, 2000; O’Toole and Stewart, 2005). Bacterial cells in a
biofilm are connected together by an extracellular matrix, which consists of polysaccharides,
protein fibers, and in some cases DNA, with the exopolysaccharides and proteins being the
main constituent (Donlan, 2002; Hall-Stoodley, Costerton and Stoodley, 2004; Molobela, Cloete
and Beukes, 2010; Daniel et al., 2016). Biofilm formation, a vital part of the bacteria life cycle,
in harsh environments, also positions the bacteria to access nutrients (Costerton et al., 1987;
DeBeer, Stoodley and Lewandowski, 1994). Biofilms have a complex architectural shape that
contains channels for the flow of nutrients within and throughout their community (DeBeer,
Stoodley and Lewandowski, 1994). Naturally occurring biofilms are difficult to fully characterize,
for example only 4% of the bacterial cells living in biofilm communities in dental units water
lines (DUWL) are cultivable, with the rest being non-cultivable or dead (Barbeau et al., 1996;
Barbeau, Bokum and Gauthier, 1998). Biofilms can adhere to solid surfaces at the liquid-solid
interface and can also form floating biofilms called pellicles in the liquid-air interface of static
cultures (Bryers, 2008; Cava et al., 2011; Kolodkin-Gal et al., 2012). Biofilm formation in medical
and industrial settings have been problematic, this is due to the adverse effects of the
pathogens they can potentially harbor on public health (Rowland and Voorheesville, 2003), and
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due to their negative interference with the mechanical functions of industrial settings (Torres et
al., 2012).
The typical ‘life cycle’ of a biofilm can be summarized in five main cyclical stages: free
planktonic cells, initial attachment, early biofilm, mature biofilm, biofilm disassembly. After
biofilm disassembly, many bacteria return to their original free planktonic form (Palmer and
White, 1997; O’Toole, Kaplan and Kolter, 2000). Environmental stress promotes biofilms
formation with the availability of nutrients being the main driving force; some other
environmental factors can affect biofilm formation such as temperature, pH, iron, and oxygen
with all these factors being microorganism specific (O’Toole, Kaplan and Kolter, 2000). At late
stages of the mature biofilm, bacterial cells have been reported to secrete small molecules such
as polyamines and D-amino acids. These molecules have been reported to target the
exopolysaccharides and protein fibers in the extracellular matrix that connect the bacterial cells
in the biofilm, initiating the biofilm disassembly and the release of planktonic cells and bacterial
spores as a survival mechanism. Released planktonic cells and spores will migrate to find
another favorable location and initiate a new biofilm community (Kolodkin-Gal et al., 2010,
2012).
Controlled studies are typically undertaken with single species biofilms. The timeline of
such lab experiment can differ substantially from natural biofilms (Jahid et al., 2015). The life
span of biofilms formed by Bacillus subtilis in lab studies is in the order of days (Kolodkin-Gal et
al., 2010, 2012; Hobley et al., 2014), while biofilms in natural environments can form over
longer durations (Jahid et al., 2015). In lab studies biofilms of B. subtilis can matures in three
days, and after eight days it disassembles and start releasing the free planktonic cells (Kolodkin71

Gal et al., 2010; Romero et al., 2011). Biofilms formed over longer durations exhibited some
variations from biofilms formed over short durations (i.e. higher tolerance to harsh
environments) (Jiang et al., 2017) .
Polyamines are believed to function as growth factors in microorganisms, thus they are found
naturally in all types of bacteria and in most animal cells (Tabor and Tabor, 1984). There has
been an increased interest in the recent years in polyamines due to their debated role in
biofilm formation (Hobley et al., 2014; Nesse, Berg and Vestby, 2015; Cardile et al., 2017).
There exists today some high-profile controversy among researchers on the interactions
between the polyamine norspermidine and biofilms formed by B. subtilis. It was initially
identified as an agent involved in biofilm disassembly in a highly-cited study, which was later
retracted (Kolodkin-Gal et al., 2012). While other researchers proposed norspermidine to play
an essential role in the formation of a robust biofilm of the same organism (Hobley et al., 2014).
There is a lack of quantitative studies on the interaction between norspermidine and biofilm
formation. It was therefore the objective of this study to clarify the effects of norspermidine on
Bacillus sp. biofilm formation by investigating its effect on biofilms of different viable states.
3.2.3. Experimental Procedures
3.2.3.1.

Materials

3.2.3.1.1 Macronutrients Concentrate
To prepare 100 mL macronutrients, 100 mL DI-Water, 1.9 g MgCl2, 1.03 g CaCl2.2H2O, 0.1 g
MnCl2.4H2O, 0.1 g FeCl2.4H2O, 0.0014 g ZnCl2, sterile filter.
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3.2.3.1.2 Amino Acids and Thiamine Concentrate
To prepare 100 mL, 100 mL DI-Water, 0.5 g L-tryptophan, 0.5 g L-phenylalanine, 0.5 g Lthreonine, 0.006 g Thiamine-HCL, sterile filter.
3.2.3.1.3 10X Tbase
To prepare 250 mL, 4.95 g (NH4)2SO4 (0.15M ammonium sulphate), 34.84 g K2HPO4 (0.8M
potassium phosphate dibasic), 14.97 g KH2PO4 (0.44M potassium phosphate monobasic), 2.5 g
Trisodium citrate (34 mM sodium citrate), add DI-Water to bring the total volume to 250 mL,
autoclaved for 20 min.
3.2.3.1.4 Biofilm Growth Media 1 (BGM1)
To prepare 1 L, 900 mL of DI-Water, 10 g tryptone, 10 g NaCl, 5 g yeast extract, 0.04 g Dglucose), 0.012 g MgSO4, and finally add 10 mL of 10X Tbase, autoclave for 20 min.
3.2.3.1.5 Biofilm Growth Media 2 (BGM2)
To prepare 1L, 0.871 g K2HPO4, 20.9 g MOPS free acid, 2 mL of 10M KOH, 5 g glycerol, 5 g
glutamic acid, bring volume to 1L using DI-Water, sterile filter the mixture, remove 1 mL from
the mixture and add 1 mL micronutrients concentrate, remove 1 mL from the mixture and add
1 mL amino acids and thiamine concentrate.
3.2.3.1.6 Wash Buffer (Sterile)
To prepare 1 L, 900 mL DI-Water, 1 ml of 1M MgSO4, 100 mL of the 10X Tbase solution,
autoclave for 20 min.
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3.2.3.1.7 Crystal Violet Stain
To prepare 1 L of 0.1 % (w/v) crystal violet stain, 1 gm of crystal violet powder, 1 L of wash
buffer. Stir the mix until the crystal violet dissolve completely.
3.2.3.1.8 Sodium Phosphate Buffer (SPB)
To prepare sodium phosphate buffer at pH 7.6, first prepare 60 mM of Na 2HPO4.7H2O solution
by dissolving 16.1 g in 1 L DI-Water, then prepare 60 mM of NaH2PO4.H2O solution by dissolving
8.28 g in 1L DI-Water. Mix the two solutions until the desired pH is obtained (the desired pH
was obtained by mixing 12.5 mL of 60 mM Na2HPO4.7H2O to 1 mL of 60 mM NaH2PO4.H2O).
3.2.3.2.

Methods

3.2.3.1.9 Bacterial Strain
The bacterium used in this research is a Bacillus sp. known commercially as Unizyme 20X CSB 20
NF SPORE, obtained from Germiphene Inc. Brantford, Ontario, Canada.
3.2.3.1.10 Seed Culture Preparation (sterile procedure)
Four milliliters of Bacillus sp. spore suspension are poured into a small vial. Using a pipette 1 mL
of the poured spore suspension is transferred into a sterile microcentrifuge vial, centrifuge at
10,000 rounds per minute for 60 seconds. At this point, bacterial spores should be visible to the
naked eye as a white precipitated powder in the bottom of the vial. The supernatant is
removed and 1 mL wash buffer is added. The vial is then mixed using a vortex until the bacterial
spores are completely dissolved, following that the sample is centrifuged again, pour off the
supernatant, another 1 mL of wash buffer is added, vortex again, centrifuge, pour off
supernatant. Now the spore suspension is washed two times using the wash buffer. One
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milliliter of biofilm growth media is added to the vial containing the washed Bacillus sp. spores
and the sample is mixed using a vortex until completely dissolved. Half a milliliter of the
Bacillus sp. washed spores and re-suspended in biofilm growth media is added into a sterile 125
mL flask with a cover that contains 20 mL of biofilm growth media and a stir bar. The mixture is
then placed on the magnetic stirrer at 300 rounds per minute inside a 37 oC humidified
incubator oven for 270 min until optical density at 600 nm is between 1 and 1.6 when Milli-Q
water is used as blank.
3.2.3.1.11 Inoculating the Microtiter Plates with Seed Culture (sterile procedure)
Biofilm was grown in microtiter plates, a common method used in biofilm related studies
(Kolodkin-Gal et al., 2012; Hobley et al., 2014; Liu et al., 2015). A 200-mL glass petri dish with a
flat bottom is filled with biofilm growth media (each plate requires 10 mL) and a stir bar. The
prepared Bacillus sp. seed culture is then diluted in a 1:100 ratio in biofilm growth media. The
petri dish is then placed on a magnetic stirrer at 300 rpm. It should be assured that no bubbles
are formed, if that happens the rpm should be lowered until no more bubbles are formed. A
multichannel pipette is then used to transfer 100 µL from the petri dish while stirring into wells
in the microplates. Also, 100 µL of sterile biofilm growth media are transferred into control
wells. Each plate is then covered with a sterile thin film (25 µm) to seal it and reduce
evaporation, one hole is poked in the center of each well using a 22-gauge sterile needle.
Separate needles should be used for each of the inoculated wells and control wells to ensure no
cross contamination will occur. The microplates are then incubated at 37 oC humidified oven in
static conditions for 32 h. Following that, plates are washed with wash buffer.
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3.2.3.1.12 Washing Microtiter Plates with Buffer Solution
The thin film placed on the microplate is removed and then the microplate is placed in the
Tecan Hydroflex Plate Washer. Each well in the plate is filled with 100 µL of wash buffer
solution using the drip mode and then wash buffer is aspirated. This will remove the remaining
media and free cells (Stepanović et al., 2000). The device must be calibrated not to touch the
sides or the bottom of the wells. Following that 150 µL of wash buffer solution is dispensed and
aspirated same as the previous step, the process is repeated for a total of three times. Finally,
the microtiter plate is gently flicked and the face of the microtiter plate is turned facing down
on a paper towel to release any excess liquid.
3.2.3.1.13 Fixing Biofilm Growth
This step in performed to fix initial biofilm growth that will be compared with the biofilm
remaining in other wells after applying treatment to them. Fixed biofilms are assumed to be
nonactive or dead. This process is repeated at the end of the treatment duration to treated
wells and prior to biofilm quantification. Using a multichannel micropipette, the volume of 200
µL of methanol (99%) are dispensed into desired wells. The microtiter plate is then covered
with aluminum foil to prevent evaporation. After 20 min, the methanol is removed using the
multichannel micropipette. Plates are then left to air dry at room temperature (Stepanović et
al., 2000; Kwasny and Opperman, 2010).
3.2.3.1.14 Applying Treatments
After the thin film is removed and the wells are washed with the buffer solution. Treatment is
applied by dispensing 125 µL of treatment solution into desired wells using the multichannel
micropipette. The microtiter plates are then covered with thin film and holes are poked in the
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center of each well using the 22-gauge sterile needle as described previously. The microtiter
plates are then incubated in a humidified oven with the temperature set at 37 oC for the
decided treatment duration.
3.2.3.1.15 Total Biofilm Quantification Using Crystal Violet Stain
Crystal violet binding assay has been used in abundant by researchers to quantify biofilms
formation from gram-positive bacteria such as Bacillus Subtilis (O’Toole, Kaplan and Kolter,
2000; Kolodkin-Gal et al., 2010, 2012; Brandenburg et al., 2013). This method was initially
described by Christensen et al. 1985, which was followed with many improvements to increase
its accuracy and to allow biofilm quantification in the microtiter plate wells (Stepanović et al.,
2000).Crystal violet is a basic dye that binds to the exopolysaccharides and negatively charged
surface molecules and stains them with a violet color, following that crystal violet can be easily
resolubilized using an acetic acid solution(Li, Yan and Xu, 2003; Negri et al., 2010). Due to the
fact that crystal violet binds to both dead and alive cells in addition to the extracellular matrix,
this method remains not suitable for evaluating the ability to kill biofilm cells or to measure
disinfectants efficiencies on biofilms (Li, Yan and Xu, 2003).
To quantify biofilm formation in the microtiter plates, 150 µL of 0.1 % (W/V) crystal violet is
dispensed into each well using the multichannel micropipette. The microtiter plate is covered
to prevent evaporation and incubated at room temperature for 60 min (Stepanović et al., 2000;
Kwasny and Opperman, 2010). Microtiter plates are washed 4 times by dispensing 200 µL DIwater in drip mode and aspirating using the Tecan Hydroflex plate washer (washing the plates 4
times have proven to produce a washing waste liquid that is free of stain). Microtiter plates are
then left to air dry at room temperature. The crystal violet is then resolubilized by dispensing
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200 µl 30% acetic acid into each well using the multichannel micropipette (Stepanović et al.,
2000). The microtiter plates are then covered and incubated without shaking at room
temperature for 20 min. Using the multichannel pipette, transfer 100 µL from each well to new
hard polystyrene plate with the clear flat bottom for quantification. Absorbance at OD 570 nm
is measured using a TECAN infinite M200 Pro plate reader (Stepanović et al., 2000). The mean
OD 570 nm value for the media only controls is subtracted from the OD 570 nm of the treated
wells, this represents the environmental noise in the measurements.
3.2.3.1.16 Biofilm Viability Using Fluorescein Diacetate
Biofilm viability following treatment will be measured using the fluorescein diacetate (FDA)
method. The FDA method has been used by several researchers for viability measurements
(Clarke et al., 2001; Wanandy et al., 2005; Armour, Powell and Boyce, 2008). A stock solution
of FDA is prepared with a concentration of 10 mg mL-1 FDA in acetone. FDA Stock solution
samples are then stored in the freezer at -80 oC.
The prepared FDA stock solution samples are taken out from the -80 oC freezer. The FDA stock
solution is then diluted (1:50) using sodium phosphate buffer (60 mM, pH 7.6), this will result in
a 0.2 mg mL-1 FDA concentration. Using a multichannel pipette, 100 μL of the sodium
phosphate buffer (60 mM, pH 7.6) is dispensed into each tested well. The diluted FDA stock
solution is vortexed and then 100 μL is dispensed into each tested well (FDA concentration in
each well is now 0.1 mg mL-1). Microplates are covered with thin film and a single hole is poked
at the center of each tested well. The microplates are then covered with foil for darkness and
incubate at 37 oC for 1 h with shaking at 150 rpm. Transfer 100 μL from each well to a rigid flat
bottom black fluorescent plate for reading. All fluorescence measurements were quantified
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using M1000 Plate Reader (λ excitation = 405 nm, λ emission = 520 nm, top mode, optimal gain, and
no lid). The response of the assay is enhanced by norspermidine addition; hence a washing step
was introduced prior to the addition of FDA. The effectiveness of the washing was verified
experimentally (data not shown).
3.2.3.1.17 HPLC analysis
The supernatant in the microtiter plates was collected following the formation of biofilms
amended with different concentrations of norspermidine. Samples collected and prepared
standards were benzoylated using the procedure explained in Morgan (1998) (Morgan, 1998).
In the benzoylation process, a benzene ring is attached to the polyamine to be able to detect it
using the HPLC system. The HPLC analysis utilized an Agilent 1260 Infinity instrument equipped
with an autosampler and an Agilent 1260 Infinity Diode Array Detector (DAD) for UV-detection
set at 229 nm. The column used was a ZORBAX 300SB-C18 (4.6 x 250mm, 5µm). The sample run
duration was 10 min, isocratic with 45% acetonitrile in water, sample injection volume of 40 µL,
flow rate of 0.8 mL/min, and the column temperature was 25 oC.
3.2.4. Results
3.2.4.1.

Biofilm Formations in Different Microtiter Plates are Comparable
All biofilm studies were conducted by cultivating Bacillus sp. in microtiter plates based

on a modified method (Stepanović et al., 2000; Branda et al., 2001; Kwasny and Opperman,
2010). Reproducibility of biofilm growth and removal within the envisioned parameter space is
crucial. It was therefore evaluated first, in order to validate comparisons between different
wells within the same microtiter plate and between different microplates prepared from the
same batch. Biofilm growth was quantified in 80 wells per plate in three separate plates
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following a 32 h incubation time. A one-way ANOVA test was performed for inter-plate
comparison of biofilm formation after 32 h incubation time. The results showed no significant
difference (p-value = 0.34) among the three plates. The average biofilm formations in the three
plates (based on 80 wells/plate) with a 95-per-cent confidence interval were 1.66 ±0.041, 1.69
±0.037, and 1.71 ±0.043 Absorbance Units (based on crystal violet staining assay), respectively.
The standard deviation between the three different plates’ averages was found to be 0.022.
3.2.4.2.

Biofilm Formation Increased for Active Biofilms in the Presence of Norspermidine,

Crystal Violet Staining.

Figure 3-1. Biofilm Formation Increased Following the Addition of Norspermidine to Active
Biofilm.
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To investigate the effects of norspermidine on active biofilm, microtiter plates were
inoculated with Bacillus sp. and the biofilm was grown for 32 h at 37oC. Following that, the
plates were washed to remove existing media and one column (8 wells) was inactivated and
fixed using methanol (the fixed column represent initial biofilm growth) (Stepanović et al.,
2000). The remaining wells in the microtiter plates were then filled with 150 µL fresh media
(BGM2, only promoting slow biofilm formation compared to BGM1) and different
concentrations of norspermidine and incubated at 37oC for an additional 24 hrs. At the end of
the treatment time, the amount of biofilm was quantified.
The results of the quantification (crystal violet staining analysis, Figure 3-1) show that additional
biofilm formation occurred (denoted with 0 mM norspermidine in Figure 3-1) when compared
to the biofilm that was fixated after 32 h. The amount of biofilm increased with increasing the
amount of norspermidine in the medium, up to 73% at 1 mM norspermidine.
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3.2.4.3.

Biofilm Formation Decreased for Nonactive Biofilms in the Presence of

Norspermidine, Crystal Violet Staining.

Figure 3-2. Biofilm Formation Decreased Following the Addition of Norspermidine to Fixed
Biofilm.
The effects of norspermidine on non-active biofilm was investigated in a similar way as
described above, only that all wells were inactivated with methanol. Quantification of the
biofilm after incubation in the presence of norspermidine (crystal violet staining) is shown in
Figure 3-2. Under the employed conditions, a slight decrease was observed in the amount of
quantifiable biofilm for the control wells without norspermidine, while this effect was
substantially increased with increasing concentrations of norspermidine. Up to 39% removal
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was achieved for the norspermidine concentration of 1 mM on fixed, non-active biofilm (Figure
3-2).
3.2.4.4.

Norspermidine in Growth Media was Consumed When Added to Active Biofilms

Figure 3-3. Norspermidine Concentration following 24 h Norspermidine Treatment Decreased
with Active Biofilm, But Not for Nonactive Biofilm. Error bars represent 95% confidence interval
(n=12).
In order to understand the nature of the interaction between norspermidine and the
biofilm, the supernatant remaining in the microtiter plates following the 24 h treatment was
collected and analyzed for remaining norspermidine via HPLC (Morgan, 1998). It can be seen
from Figure 3-3 that the amount of supplemented norspermidine was reduced in the active
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biofilm samples. Residual norspermidine could be detected, however, the more biofilm was
formed (Figure 3-1), the more norspermidine was reduced (Figure 3-3). This effect was not
observed in the presence of inactive biofilm (fixed), where the norspermidine concentration
after incubation is similar to the initially available amount.
3.2.4.5.

Verification of Previous Results with Secondary Activity Assay (FDA testing)
The biofilm quantification via crystal violet staining, does not discriminate between

living or dead cells. The observed increase in biofilm formation in the presence of
norspermidine was therefore further investigated through the fluorescein diacetate (FDA)
viability assay.

Figure 3-4. Norspermidine Addition Enhanced Biofilm Viability.
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The intra-plate reproducibility of the FDA testing was evaluated to validate the
comparison between the different treatments within the same microtiter plate. Biofilm grown
within the same microtiter plate under the same conditions was tested using the FDA method.
A one-way ANOVA test was performed for intra-plate comparison of biofilm viability. The
results showed no significant difference (p-value = 0.19) among the ten-tested columns (each
column contain 8 wells) within the same microtiter plate (data not shown).
Following the growth of biofilms for 32 h, norspermidine treatment was applied with different
concentrations for 24 h. The biofilm grown in the microtiter plates was washed five times using
sodium phosphate buffer saline, this was to assure that norspermidine was not left behind,
interfering with the FDA test results. Following that, the enzymatic activity of the biofilm was
measured using the FDA viability test and the results are presented in Figure 3-4. Biofilm
treated with higher concentration of norspermidine showed higher enzymatic activity with a
significant difference between concentrations of 0 and 1 mM norspermidine. The data follows
the same trend as the data generated through total biomass quantification via crystal violet
staining (Figure 3-1), hence verifying via a different detection mechanism.
3.2.5. Discussion
The effect of increased norspermidine concentrations on active biofilm was associated
with an increase in biofilm formation (Figure 3-1). No inhibitory effects were detected for
norspermidine concentrations on biofilm formation, up to 1 mM. These results appear to be in
contradiction with findings reported by Kolodkin-Gal et al. (2012), showing that an inhibitory
effect of norspermidine on biofilm formation at concentrations as low as 0.05-0.08 mM. While
the results of this study partially agreed with Hobley et al. (2014) whom found that the addition
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of norspermidine at concentrations 0.01- 0.025 mM resulted in more robust biofilm formation,
they also reported inhibitory effects on biofilm formation at concentrations higher than 0.250.30 mM, which was not observed here. The results obtained in Figure 3-1 suggests that
norspermidine addition can be beneficial in situations where rapid biofilm growth is favored.
Norspermidine can also be utilized in other applications were biofilm formation is beneficial
(i.e. plant biocontrol agents, inhibitor of mild steel corrosion, bioreactor, and bioremediation)
(Morikawa, 2006), for more information please refer to Morikawa (2006).
Naturally occurring polyamines, such as, spermidine and spermine, are reported in higher
concentrations in fast growing tissues and are involved in the process that controls cellular
growth in prokaryotic cells such as bacteria (Tabor and Tabor, 1984; Rodriguez-Garay, Phillips
and Kuehn, 1989). Polyamines modulate membrane fusion and protect the functionality and
structural integrity of the bacterial organisms (Meers et al., 1986; Marton and Morris, 1987).
Since the shorter polyamine, norspermidine can replace the essential role of spermidine in the
formation of robust biofilms (Burrell et al., 2010; Hobley et al., 2014), this provides a possible
explanation for the increase in biofilm formation associated with the increase of norspermidine
concentration (Figure 3-1). The biological utilization of norspermidine in different cellular
processes offers a possible explanation for the increase in biofilm formation, which was
associated with the depletion of norspermidine concertation in the supernatant extracted from
the microtiter plate wells containing actively growing biofilms (Figure 3-3), and an increase in
viability of the biofilm (Figure 3-4).
Previous researchers have referred to norspermidine as a biofilm disassembly agent that
prevents biofilm formation and disassembles pre-existing biofilm (Kolodkin-Gal et al., 2012;
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Böttcher et al., 2013; Oppenheimer-Shaanan, Steinberg and Kolodkin-Gal, 2013). This apparent
contradiction can likely be contributed to the different vital stages of the biofilms in question.
This study clearly shows that norspermidine accelerates biofilm dissolution when its biological
activities were artificially stopped by fixing the biofilm using methanol. The results of the
interactions between norspermidine and the pre-existing nonactive biofilm are the direct
opposite of the results found with the active biofilm. Since the biofilm was no longer actively
growing, the interaction between the added norspermidine concentrations and the nonactive
(fixed) biofilm was of a pure chemical nature and it is assumed that no biological process take
place. When the concentration of added norspermidine increased, the pre-existing nonactive
(fixed) biofilm removal increased (Figure 3-2). It is reported that norspermidine targets the
exopolysaccharides component in the biofilm. Norspermidine binds to the negatively charged
groups (i.e. uronic acid) or to the neutral sugars with polar groups (i.e. poly-Nacetylglucosamine) in the secondary structure of the exopolysaccharides through Coulombic
attraction and hydrogen bonding (Kolodkin-Gal et al., 2012; Oppenheimer-Shaanan, Steinberg
and Kolodkin-Gal, 2013). These interactions between polyamines and biofilms are structure and
charge specific; only polyamines with three methylene groups and flanked by two amino groups
that are positively charged were successful in dismembering the biofilms (i.e. norspermidine,
norspermine, …etc) (Kolodkin-Gal et al., 2012). The aforementioned mechanism provides a
possible explanation for the removal of the pre-existing nonactive (fixed) biofilm noticed in
Figure 3-2 following the addition of norspermidine.
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3.2.6. Conclusions
Based on these results, with regards to biofilm formation and disassembly, it could be
concluded that norspermidine can serve two functions. When norspermidine was added to an
active biofilm, the biofilm formation increased due to the biological utilization of
norspermidine, with no inhibition of biofilm formation at concentrations as high as 1 mM. On
the other hand, when norspermidine was added to a pre-existing nonactive (fixed or dead)
biofilm, biofilm formation was disassembled due to chemical interactions between
norspermidine and the exopolysaccharides part of the biofilm. The results obtained in this
research emphasizes that when it comes to investigating and testing of biofilm removal agents,
the biological activity of the biofilm must be carefully considered. The interaction between the
biofilm and norspermidine was dependent on its biological activity. When added to an active
biofilm, biological process dominated the chemical interaction between norspermidine and the
exopolysaccharides, which resulted in the increase of biofilm formation (Figure 3-1). The
chemical interaction between the exopolysaccharides and norspermidine were likely not
significant until the biological processes had ceased (after fixing the biofilm with methanol) and
this resulted in the disassembly of the pre-existing nonactive biofilm (Figure 3-2) due to the
interactions between norspermidine and the exopolysaccharides in the pre-existing biofilm. The
fluorescein diacetate testing results also supported these findings.
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3.3 Biofilm Control Using Amino Acids
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3.3.1. Preface
Section 3.3 presents the experimental work performed to fulfill the specific objective
presented in Section 1.3.2.2. The presented results in Section 3.3 provided a quantitative
evaluation of biofilm removal using D-amino acids. The results obtained in Section 3.3 suggests
that D-amino acids have limited biofilm removal capabilities, while they were found to be more
suitable for inhibiting biofilm growth. No clear synergetic effects were noticed from the
combined treatment.
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3.3.2. Introduction
Biofilms are multicellular communities formed by bacterial aggregation on surfaces. The
bacterial cells within the biofilm are connected together by an extracellular matrix consisting of
exopolysaccharides, protein fibers, and DNA (Costerton, Stewart and Greenberg, 1999; Donlan,
2002; Hall-Stoodley, Costerton and Stoodley, 2004). The formation of biofilms is vital for
bacterial survival and a natural part of their life cycle, they protect the bacterial cells living
within from harsh environments, they also provide optimal positioning for the bacterial cells
living within to access nutrients (DeBeer, Stoodley and Lewandowski, 1994; Costerton, Stewart
and Greenberg, 1999). Bacterial cells in aquatic systems can form biofilms on both biotic and
abiotic surfaces. They can adhere to solid surfaces at the liquid-solid interface, and they can
form floating biofilms known as pellicles at the liquid-air interface (Hall-Stoodley, Costerton and
Stoodley, 2004; Bryers, 2008; Cava et al., 2011). The main driving force for biofilm formation is
the availability of nutrients. Environmental stress promotes biofilm formation, factors such as
temperature, pH, iron, and oxygen affects biofilm formation, although they are microorganism
specific (O’Toole, Kaplan and Kolter, 2000). The architectural shape of biofilms is complex, it
contains channels for the flow of nutrients within and through their community (DeBeer,
Stoodley and Lewandowski, 1994). In addition to connecting the bacterial cells together, the
extracellular matrix connects the bacterial cells to the surface, this will form the initial biofilm
which will grow to a mature biofilm and adapt to its surrounding environment. The bacterial
cells within the biofilm at this point are characterised by an increase synthesis of
exopolysaccharides, UV light tolerance, higher antimicrobial resistance, and formation of
bacterial spores (Habash and Reid, 1999; O’Toole, Kaplan and Kolter, 2000; Hall-Stoodley and
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Stoodley, 2002; Rowland and Voorheesville, 2003; Garrett, Bhakoo and Zhang, 2008; Coleman
et al., 2010; Vlamakis et al., 2013).
One example of problematic biofilms is the potential pathogenic biofilm that form in dental
settings. Several researchers have reported the formation of pathogenic biofilms in dental
settings. Biofilms can form in sinks, tanks, suction hoses, tubing, pipes, handpieces, air and
water syringes, and ultrasonic scalers (Barbeau, Bokum and Gauthier, 1998; Coleman et al.,
2009, 2010). Different pathogenic microorganisms (viruses, bacteria, algae, and fugai) can be
found inside biofilms (Coleman et al., 2010; Vasickova et al., 2010). Pathogenic biofilms are
responsible for high contamination levels in water used for invasive procedures in dental clincs
(Barbeau et al., 1996; Barbeau, Bokum and Gauthier, 1998). In dental clinics, crosscontamination among different patients with pathogens released from biofilms can occur
through aerosols from dental tools, and from tubing backflow in wet dental devices such as the
evacuation system. These dental tools are used to drain blood, tissue, saliva, and other debris
from dental procedures (Barbeau, Bokum and Gauthier, 1998). Biofilm growth inside dental
settings can have adverse effects on dental equipment by interfering with their mechanical
functions, and clogging tubes and pipes. Based on the aforementioned, it is a major concern to
control biofilm formation in dental clinics to protect both the patients and the dental settings
(Barbeau et al., 1996).
When the biofilm is mature, bacterial cells will secrete small molecules such as amino acids
and polyamines. These small molecules will target the exopolysaccharides and protein fibers in
the extracellular matrix, which initiates the biofilm disassembly and the release of bacterial
spores and free planktonic cells (Kolodkin-Gal et al., 2010, 2012). Biofilms formed from Bacillus
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subtilis mature after three days incubation in biofilm growth medium at 22 oC, and after eight
days the biofilm disassembles and release free planktonic cells (Kolodkin-Gal et al., 2010;
Romero et al., 2011).
Bacteria has high resistance to physical, biological, and chemical assaults, this is due to their
peptidoglycan call wall (also known as the murein), in most bacteria it is located outside the
cytoplasmic membrane (Park, 1996; Holtje, 1998; Nanninga, 1998). The peptidoglycan cell wall
is a strong and flexible polymer with a net-like shape, composed from short polypeptides
(proteins) that cross link linear glycan strands (formed from disaccharide chains) (Cava et al.,
2011). The peptidoglycan cell wall has many benefits such as protecting the contents of the
bacterial cell, resists osmotic pressure, holds the bacterial cell shape, and provides a framework
to anchor the components of the cell envelop (Holtje, 1998; Young, 2006; Dramsi et al., 2008;
Vollmer, Blanot and de Pedro, 2008). One interesting fact about the polypeptides in the
peptidoglycan cell wall is that they contain D-amino acids (Nagata et al., 1998). These D-amino
acids help forming the structure of peptidoglycan cell wall and provide it with resilience to
different proteases (Cava et al., 2011). The two most common D-amino acids found in the
peptidoglycan cell wall are D-alanine and D-glutamate, other D-amino acids have been reported
also such as D-serine and D-asp (Sieradzki and Tomasz, 1996; Reynolds and Courvalin, 2005;
Bellais et al., 2006; Veiga et al., 2006). Their incorporation into the peptidoglycan cell wall is
believed to increase its resistance to antibacterial agents (de Lencastre, Oliveira and Tomasz,
2007).
Previous researchers presented evidence that D-amino acids are produced by Bacillus
subtilis to dismember their own biofilms at a late stage of the biofilm life cycle (Kolodkin-Gal et
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al., 2010). The release of D-amino acids is triggered by the accumulation of metabolic waste
and the low concentration of nutrients, at this point it is more favourable for the bacteria to
dismember its biofilm, and release free planktonic cells that will migrate to a new favorable
location to establish a new biofilm (Karatan and Watnick, 2009). The D-amino acids D-tyrosine,
D-leucine, D-tryptophan, and D-methionine have shown promising results in biofilm growth
inhibition (Lam et al., 2009; Kolodkin-Gal et al., 2010; Leiman et al., 2013). The probability that
D-amino acids can be used to control biofilm formation is significantly promising due to the lack
of toxicity and the favorable pharmacokinetic properties of D-amino acids (Jayaraman and
Wood, 2008).
Kolodkin-Gal et al. 2010, have reported self produced D-amino acids in the growth medium
of mature biofilms. The results of their study showed that to inhibit biofilm formation by
Bacillus subtilis a minimum concentration of 2 mM, 8.5 mM, 5 mM, and 3 µM is required for Dmethionine, D-leucine, D-tryptophan, and D-tyrosine respectively. Their results also showed
that a mixture of the four mentioned D-amino acids was potent to biofilm growth and can
dismember pre-existing biofilms. The researchers suggested that the D-amino acids will be
miss-incorporated into the cell wall and disengage the biofilm. They reported that the
corresponding L-amino acids did not have any effect on Bacillus subtilis biofilm disassembly. It
was also reported that D-alanine did mitigate the inhibitory effects of the four mentioned Damino acids. Similar results were obtained, by the same researchers, when the treatments were
tested on biofilms of Pseudomonas aeruginosa. The researchers also suggested that the
interaction between the D-amino acids and the protein amyloid fibers is not the only way by
which D-amino acids disassemble biofilms. As they found that D-amino acids were successful in
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dispersing biofilms from bacterial species that are not known to have amyloid protein fibers
such as Pseudomonas aeruginosa (Kolodkin-Gal et al., 2010).
Another study by Leiman et al. 2013 stated that D-leucine, D-tryptophan, D-tyrosine, and Dmethionine can inhibit biofilms formed by Bacillus subtilis. The minimum reported
concentrations required to inhibit biofilm formation for D-leucine, D-tryptophan, and Dtyrosine were 8.5 mM, 5 mM, and 6 µM respectively, while no information was provided for Dmethionine. The researchers suggested that the four mentioned D-amino acids interfere with
protein synthesis by their misincorporation into the process, which results in the inhibition of
the biofilm growth. The researchers stated that D-tyrosine is a metabolic inhibitor for Bacillus
subtilis. It was also suggested that the inhibitory effects of the D-amino acids on Bacillus subtilis
biofilm can be mitigated in the presence of L-amino acids. They also reported that a mixture of
the four D-amino acids at a concentration higher than that obtained by Kolodkin-Gal et al. 2010
was required to inhibit biofilm formation. The results they obtained also showed that the
inhibitory effects of the four D-amino acids on biofilm formation were not countered in the
presence of D-alanine. Moreover, they found that the presence of L-tyrosine did counter the
inhibitory effects of the four D-amino acids (Leiman et al., 2013). These results contradict the
findings of Kolodkin-Gal et al. 2010.
Brandenburg et al. 2013, investigated the effects of amino acids on the formation and motility
of biofilms produced by Pseudomonas aeruginosa. The results obtained in their study showed
that only D-tyrosine and D-tryptophan had inhibitory effects at concentrations of 2.5 mM for
each, with the latter being most effective. The biofilm growth was enhanced with the addition
of D-methionine with concentrations between 2.5 and 10 mM. The addition of D-leucine with
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concentrations between 2.5 and 10 mM had no significant effect on biofilm formation.
Moreover, at a concentration of 10 mM, both D-tryptophan and L-tryptophan were found to be
effective in inhibiting biofilm growth, with L-tryptophan being more effective than Dtryptophan in inhibiting biofilm formation (86% and 71% respectively). A mixture containing an
equimolar ratio of both tryptophan isoforms with a total concentration of 10 mM tryptophan
had higher inhibitory effects (93% at 24 hr), which contradicts what was reported by the two
previously mentioned studies. The researchers hypothesised that tryptophan enhances the
swimming motility (~40%) of bacterial cells by enhancing the flagellar activity of the bacterial
cells which will prefer to detach from the biofilm and swim freely, consequently resulting in the
inhibition of biofilm growth and promoting biofilm disassembly (Brandenburg et al., 2013).
Even though previous research has provided abundant information on the interactions
between D-amino acids and biofilms, there is a lack of quantitative studies on the ability of Damino acids to remove pre-exiting biofilms. In this research, the effects of D-amino acids on
biofilm formation and the dispersion of pre-existing biofilm will be further investigated.
3.3.3. Experimental Procedures
3.3.3.1. Materials
3.3.3.1.1.

Amino Acids and Thiamine Concentrate

200 mL DI-Water, 0.012 g Thiamine-HCL, 1 g L-tryptophan, 1 g L-threonine, 1 g L-phenylalanine,
the mixture was sterile filtered.
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3.3.3.1.2.

Macronutrients Concentrate

200 mL DI-Water, 0.2 g MnCl2.4H2O, 0.2 g FeCl2.4H2O, 0.0028 g ZnCl2, 3.8 g MgCl2, 2.06 g
CaCl2.2H2O, the mixture was sterile filtered.
3.3.3.1.3.

10X Tbase

116 mL of DI-Water, 1.25 g Trisodium citrate (34 mM sodium citrate), 2.48 g (NH4)2SO4 (0.15M
ammonium sulphate), 7.49 g KH2PO4 (0.44M potassium phosphate monobasic), 17.42 g K2HPO4
(0.8M potassium phosphate dibasic), the mixture was autoclaved for 20 min.
3.3.3.1.4.

Biofilm Growth Media 1 (BGM1)

225 mL of DI-Water, 2.5 mL of 10X Tbase, 2.5 g tryptone, 0.01 g D-glucose, 2.5 g NaCl, 1.25 g
yeast extract, 0.003 g MgSO4, the mixture was autoclaved for 20 min.
3.3.3.1.5.

Biofilm Growth Media 2 (BGM2)

1 mL of 10M KOH, 0.44 g K2HPO4, 10.45 g MOPS free acid, 2.5 g glycerol, 2.5 g glutamic acid, 0.5
mL amino acids and thiamine concentrate, 0.5 mL micronutrients concentrate, brought to a
volume of 500 mL using DI-Water, the mixture is sterile filtered.
3.3.3.1.6.

Wash Buffer (Sterile)

225 mL DI-Water, 25 mL of 10X Tbase, 0.25 ml of 1M MgSO4, the mixture was autoclaved for 20
min.
3.3.3.1.7.

Treatments Preparation

Treatments containing different concentrations of D-amino acids were prepared by dissolving
appropriate amounts of the different D-amino acids in BGM2.
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3.3.3.2.
3.3.3.2.1.

Methods
Bacterial Strain

The Bacillus sp. mixture used in this research is known commercially as Unizyme 20X CSB 20 NF
SPORE, and it was provided by Germiphene Inc.
3.3.3.2.2.

Washing Bacillus sp. Spores

Bacillus sp. spore suspension was washed three times. The washing procedure was performed
by centrifugation at 10,000 rounds per minute for 1 min, the supernatant was removed and the
spore concentrate was resuspended in 1 mL wash buffer using a vortex, this process was
repeated twice, in the third time the resuspension was in 1 mL BGM1. This results in 1 mL
washed Bacillus sp. spores.
3.3.3.2.3.

Seed Culture Preparation

A glass flask (150 mL) containing 20mL BGM1 was then inoculated with 0.5 mL of the washed
Bacillus sp. spores. The glass flask was then incubated at 37oC, stirring at 300 rounds per
minute, inside a humidified incubator for approximately 270 min until the optical density
measured at 600 nm was between 1 and 1.6.
3.3.3.2.4.

Inoculating the Microtiter Plates

The Bacillus sp. seed culture was diluted in BGM1 (1:100), while stirring, 100 µL were
transferred into each well in the microtiter plates. Controls were prepared by transferring 100
µL of sterile BGM1 into the designated control wells. To reduce evaporation from wells,
microtiter plates were covered with a sterile thin film, a single hole was poked in the thin film at
the center of each well using a sterile needle (22-gage) for aeration. The microtiter plates were

104

incubated in static conditions inside a humidified oven at 37 oC for 32 hrs. At the end of the
incubation time, the microtiter plates are washed three times with the wash buffer using the
Tecan Hydroflex Plate Washer.
3.3.3.2.5.

Fixing Biofilm Growth

Fixed biofilms are presumed to be dead or nonactive. This procedure is performed at two
stages, first to the designated wells for initial growth to quantify the initial biofilm growth
following the 32 hrs incubation, second to the designated treated wells in the microtiter plates
to be able to quantify biofilm formation following the 24 hrs application of treatments
(explained below). The BGM1 was removed using the Tecan Hydroflex Plate Washer, and each
well was incubated with 200µL methanol for 20 min. Microtiter plates are then placed on the
bench top to air dry completely at room temperature (Stepanović et al., 2000; Kwasny and
Opperman, 2010).
3.3.3.2.6.

Applying Treatments

After the initial biofilm growth, the microtiter plates are washed and treatments were applied
to the designated wells by dispensing 125 µL of treatment solutions into wells. The microtiter
plates were then incubated for 24 hrs in the humidified oven with the same conditions
described above.
3.3.3.2.7.

Total Biofilm Quantification Using Crystal Violet Stain

The crystal violet binding assay is a method commonly used to quantify biofilms (O’Toole,
Kaplan and Kolter, 2000; Kolodkin-Gal et al., 2010, 2012; Brandenburg et al., 2013; Zhang and
Hu, 2013). To quantify the biofilm, 150 µL of 0.1 % (W/V) crystal violet was transferred into
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each well in the microtiter plates, plates are covered using aluminum foil and incubated on
bench top for 1 hr (Stepanović et al., 2000; Kwasny and Opperman, 2010). Subsequently, the
microtiter plates were washed 4 times using the Tecan Hydroflex plate washer by dispensing
200 µL DI-Water in drip mode and aspirating, previous work showed that 4 times was sufficient
for removing all excess (nonbinding) crystal violet stain. The microtiter plates are then left on
bench top to air dry completely. The biofilm-binding crystal violet was then resolubilized by
transferring 200 µL of 30% acetic acid into each well (Stepanović et al., 2000), the microtier
plates are then covered with aluminum foil on bench top for 20 min at room temperature.
Subsequently,100 µL from each well were transferred to clear flat bottom polystyrene plates
for absorbance quantification at OD 570 nm using the plate reader (TECAN infinite M200 Pro).
3.3.4. Results
All treatments in this section were delivered to the biofilm in a solution that contained
BGM2. When the treatment was only containing BGM2 without any D-amino acids, it was
termed as zero concentration. Following the 32-hr incubation time, the designated wells for
initial biofilm growth were treated with methanol, and it is termed as Fixed. Methanol
treatment was done to kill the biofilm and preserve its initial growth to be used as a benchmark
to compare it later with the treated biofilm and to be further used for biofilm removal
calculations. This will allow to evaluate the effectiveness of the D-amino acid treatments in
biofilm removal.
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Figure 3-5.The effect of D-tyrosine on Bacillus sp. biofilm formation.
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Figure 3-6. The effect of D-tryptophan on Bacillus sp. biofilm formation.
It can be seen from Figure 3-5 and Figure 3-6 that D-tyrosine and D-tryptophan at
concentrations of 5 mM and higher inhibited biofilm formation. The pre-existing biofilm was
dispersed at concentrations of 10 mM and higher for both D-tyrosine and D-tryptophan. The
increase in the concentration of both D-tyrosine and D-tryptophan was proportional with the
amount of biofilm dispersion. For D-tyrosine and D-tryptophan, a concentration less than 5 mM
did not show any significant inhibitory effects on biofilm formation. The maximum biofilm
removal using D-tyrosine at 20 µM and D-tryptophan at 15 mM was 31% and 28% respectively.
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Figure 3-7. The effect of D-methionine on Bacillus sp. biofilm formation.
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Figure 3-8. The effect of D-leucine on Bacillus sp. biofilm formation.
D-methionine and D-leucine were successful in inhibiting biofilm formation (Figure 3-7
and Figure 3-8, respectively) at concentrations of 5 mM and higher. However, no significant
reduction in the pre-existing biofilm was noticed. Moreover, the increase in their concentration
did not seem to have any significant effect on biofilm control. No significant effects on biofilm
formation were noticed for concentrations of 1 mM for both D-methionine and D-leucine.
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Figure 3-9. The effect of D-amino acids mixture on Bacillus sp. biofilm formation. D-tyrosine
concentration is in the units of µM while the remaining D-amino acids are in the units of mM.
The results of D-amino acid mixture are presented in Figure 3-9. Results show that the
D-amino acid mixture was successful in inhibiting biofilm formation for minimum
concentrations of 5. Significant reduction in the pre-existing biofilm was noticed for
concentrations of 10 mM and higher of each. Moreover, the increase in the mixture
concentration had a significant effect on biofilm control. Apparently, the D-amino acids mixture
was the most effective treatment for biofilm control, the highest biofilm removal was 39% at
concentrations of 20. No significant effect was noticed on the biofilm removal for
concentrations less than 5.
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3.3.5. Discussion
Biofilm control do not require the development of treatments that can only kill biofilms
without removing them. The desired treatments for biofilm control will have the ability to
enhance, inhibit, or disperse biofilm formation. The results obtained (Figure 3-5) showed that
D-tyrosine could inhibit biofilm formation at a concentration of 5 µM. The other three D-amino
acids (D-tryptophan, D-methionine, and D-leucine) were also all successful in inhibiting biofilm
formation, only at a higher concentration of 5 mM for each (Figure 3-6, Figure 3-7, and Figure
3-8, respectively). Lower concentrations did not show any inhibitory effects on biofilm
formation. This inhibition in biofilm formation was obtained through different mechanisms.
Bacterial cells are connected within the biofilm by the amyloid protein fibers that anchor to the
D-alanine in the peptidoglycan cell wall of the bacterial cell, when D-amino acids are present
they can incorporate themselves into the cell wall by replacing the pre-existing D-alanine. This
incorporation disengages the protein fibers from the cell wall and consequently causing the
inhibition of biofilm formation and the pre-existing biofilm to disperse (Kolodkin-Gal et al.,
2010). The D-amino acids tested can also be miss-incorporated into the protein synthesis, which
results in the inhibition of the biofilm formation (Leiman et al., 2013). Although all four D-amino
acids investigated in this research showed inhibitory effects on biofilm formation, only Dtyrosine and D-tryptophan showed the ability to remove pre-existing biofilms.
It is hypothesised that D-tyrosine inhibits biofilm formation and disperses the preexisting biofilm by two mechanisms; first by the miss-incorporation of D-tyrosine into the cell
wall by replacing the D-alanine in the cell wall, and its consequent disengagement of attached
cells and preventing new cells to attach, due to lack of attachment sites. Second due to
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metabolic inhibition associated with D-tyrosine (Champney and Jensen, 1969), which inhibit
biofilm formation due to lack of access to nutrients, and disperse the pre-existing biofilm due to
the unfavorable environment surrounding it, as cells prefer to return to its free planktonic form
(Karatan and Watnick, 2009).
D-tryptophan also showed inhibition of biofilm formation and dispersed pre-existing
biofilms. One mechanism was the miss-incorporation of D-tryptophan into the cell wall as
explained previously. The other mechanism is the significant increase in swimming motility, Dtryptophan has been reported to significantly increase the swimming motility of bacterial cells
(Brandenburg et al., 2013), and cells may favor the detachment from the biofilm (Boles,
Thoendel and Singh, 2005), consequently dispersing pre-existing biofilm. Since flagellar arrest is
important for biofilm formation an increase in flagellar activity will inhibit biofilm formation,
and disperse pre-existing biofilms (O’Toole and Kolter, 1998; Brandenburg et al., 2013). The
results obtained for D-tryptophan was agreeing with the results obtained by Kolodkin-Gal et al.
2010 and Leiman et al. 2013.
The minimum concentration of D-leucine required to inhibit biofilm formation (5 mM)
was lower than that obtained by Kolodkin-Gal et al. 2010 and Leiman et al. 2013 (8.5 mM for
both previous studies). While the minimum concentration of D-tyrosine required to inhibit
biofilm formation (5 µM) was higher than that obtained by Kolodkin-Gal et al. 2010 (3 µM) and
less than that obtained by Leiman et al. 2013 (6 µM). Although some differences existed in the
minimum concentration required for the inhibition of biofilm formation, these differences
remain limited. The minimum concentration of D-methionine to inhibit biofilm formation was 5
mM, this concentration was higher than that reported by Kolodkin-Gal et al. 2010 (2 mM).
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The results for the combined treatment (Figure 3-9) suggests that for complete
inhibition of biofilm formation a minimum concentration of 5 µM of D-tyrosine and 5 mM each
for the other three D-amino acids was required to inhibit biofilm formation. The treatment with
a lower concentration of 1 µM of D-tyrosine and 1 mM of the three other D-amino acids
showed limited biofilm inhibition, this can be seen when compared with both the treatment
containing no D-amino acids (0) and the fixed biofilm. The removal of the pre-existing biofilm
was not noticed for combined treatments with concentrations less than 5 µM for D-tyrosine
and 5 mM for each of the other three D-amino acids. The amount of biofilm dispersed was
proportional to the concentration of the D-amino acids until it levels at concentrations between
15 and 20 mM.
The minimum concentration required for biofilm inhibition and dispersal obtained in
this research was higher than that reported by previous researchers. Kolodkin-Gal et al. 2010
reported that a mixture of the four mentioned D-amino acids with a concentration of 10 nM of
each D-amino acid was potent to the biofilm growth, and it was successful in dismembering
part of the pre-existing biofilms. Following that, Leiman et al. 2013 also reported that a mixture
of the four D-amino acids at a concentration of 10 nM of each was not able to inhibit biofilm
formation, but rather a higher concentration of 500 nM was required to achieve inhibitory
effects.
By comparing the results obtained in Figure 3-5 and Figure 3-6 for D-tyrosine and Dtryptophan respectively, with the results obtained from the D-amino acids mixture presented in
Figure 3-9 , no clear synergetic effects can be seen from combining D-amino acids in a mixed
treatments. The mixed treatment was more effective in removing pre-existing biofilm (39%)
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when compared with the biofilm removal achieved by D-tyrosine (31%) and D-tryptophan
(28%), this is hypothesised to be a result of combining the effects of D-tyrosine and Dtryptophan in the mixed treatment containing the four different D-amino acids.
3.3.6. Conclusions
The results obtained suggests that the D-amino acids investigated in this research can
be utilized to inhibit growth of pre-existing Bacillus sp. biofilm. The use of D-tyrosine and Dtryptophan did result to some extent in partial removal of pre-exiting Bacillus sp. biofilm. The Damino acid mixture although removed pre-existing Bacillus sp. biofilm, it did not show clear
synergetic effects from combining the amino acids into a mixed treatment. Therefore, the use
of D-amino acids can be seen beneficial for inhibiting Bacillus sp. biofilm formation, but showed
limited abilities in removing Bacillus sp. pre-existing biofilms. Since no clear synergetic effects
were detected for the combined treatments, it is not recommended to conduct any
optimization studies on biofilm removal using D-amino acids.
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3.4.1. Preface
Section 3.4 presents the experimental work conducted to fulfill the specific objective
presented in Section 1.3.2.3. A comprehensive approach was used in the selection of relevant
enzymes and evaluate their ability to remove biofilms of different compositions. The results
presented in Section 3.4 suggests that the protease Savinase and the polysaccharide-degrading
enzyme Pectinex had the highest biofilm removal capabilities among the different tested
enzymes. The results obtained in Section 3.4 along with previous recommendations from other
researchers suggests promising results from the optimization of biofilm removal using an
enzymatic treatment containing proteases and polysaccharide-degrading enzymes.
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3.4.2. Introduction
Biofilms are multicellular heterogenous communities formed by the aggregation of
bacteria on surfaces. Cells within a biofilm community are encased and connected together by
an extracellular matrix that consists mainly from exopolysaccharides and protein fibers
(Costerton, Stewart and Greenberg, 1999; Donlan, 2002; Hall-Stoodley, Costerton and Stoodley,
2004). The extracellular matrix encases the biofilm community, it connects the bacterial cells
together and to the surface. Bacterial cells living in a biofilm are characterised by an increased
synthesis of extracellular matrix, UV light tolerance, the formation of free planktonic cells, the
formation of bacterial spores, and higher antibacterial resistance, (Habash and Reid, 1999;
O’Toole, Kaplan and Kolter, 2000; Hall-Stoodley and Stoodley, 2002; Garrett, Bhakoo and
Zhang, 2008; Vlamakis et al., 2013).
Removal of biofilms using chemical treatments was found to be a challenging process
(Ntsama-Essomba et al., 1997; Vickery, Pajkos and Cossart, 2004). Chemical treatments cannot
penetrate the biofilm due to the reaction-diffusion barrier it forms between the chemicals and
the bacterial cells living within the biofilm (Gilbert and McBain, 2001). This fact makes biofilm
communities highly resistant to disinfectants, antibiotics, and biocides. Bacteria living in a
biofilm formation was found to be between 100 and 1000-fold more resistant to chemical
treatments than bacteria living in free planktonic form (Gilbert and McBain, 2001).
Depending on the bacterial strain and other extrinsic factors (gaseous levels, nutrients
fluctuations, and fluid shear) the extracellular matrix composition can vary (Simões, Simões and
Vieira, 2010). The composition of the biofilm can contain all or some of the following:
phospholipids, carbohydrates, glycoproteins, lipids, nucleic acids, polysaccharides, and amyloid
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proteins (Branda et al., 2005; Flemming and Wingender, 2010; Hobley et al., 2015). Regardless
of the different biofilm components, the main two components are the polysaccharides and
proteins (Sutherland, 2001; Marvasi, Visscher and Casillas Martinez, 2010; Molobela, Cloete and
Beukes, 2010).
Bacillus sp. is considered a model microorganism for biofilm related studies and it was
employed by different researchers in their studies (K. P. Lemon et al., 2008). Bacillus sp. is a
gram-positive, biofilm forming, and non-pathogenic bacteria. Bacillus sp. can adapt in a wide
range of conditions and is usually found in terrestrial and aquatic environments (Grossman,
1995; Maglott et al., 2007; Earl, Losick and Kolter, 2008). The major component of the
extracellular structural matrix in biofilms formed by Bacillus sp. is the polysaccharides (Branda
et al., 2001; Morikawa et al., 2006). Another model bacterium for biofilm related studies is the
gram-negative, biofilm forming, and non-pathogenic Pseudomonas fluorescens (Rossignol et al.,
2008). Due to its high adaptation and its ability to resist a wide range of disinfectants and
antibiotics this bacterium is ubiquitous in the environment and hospitals (Spiers, Buckling and
Rainey, 2000; Rossignol et al., 2008). It has been reported that biofilms formed by
Pseudomonas fluorescens are mainly composed of proteins (Molobela, Cloete and Beukes,
2010). Currently, there is an increased interest in the use of enzymes as anti-biofilm agents, this
came following their successful use in removing biofilms from industrial surfaces (Taraszkiewicz
et al., 2013; Thallinger et al., 2013; Meireles et al., 2016). Enzymes have been described as
efficient, affordable, and greener alternative than the harmful and ineffective chemicals used in
diminishing problems associated with biofilm formation (Cordeiro, Hippius and Werner, 2011;
Cortés, Bonilla and Sinisterra, 2011; Srey, Jahid and Ha, 2013). There is no evidence of any side
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effects from using enzymes in the industry and the use of enzymes for cleaning surfaces was
approved by regulatory agencies (Schmidt, 2012; Meireles et al., 2016). Biofilms can be
degraded by enzymes through different routes, enzymes can degrade the extracellular matrix
encasing the biofilm, degrade the components of the biofilm, interfere with quorum sensing,
cause cells lysis, and catalyse the production of antimicrobials (Donlan, 2002; Augustin, AliVehmas and Atroshi, 2004; Simões, Simões and Vieira, 2010; Werner, 2011; Thallinger et al.,
2013). Enzymes weaken the structural integrity of the biofilm by breaking the components of
the extracellular matrix (Molobela, Cloete and Beukes, 2010). Regardless of the different modes
of action, for an enzyme to degrade a biofilm the first line of defence it will face is the
extracellular matrix that covers and shields the bacterial cells in biofilm community. Enzymes
used to remove biofilms are divided into four groups and those are oxidative enzymes, antiquorum sensing, proteolytic enzymes such as proteases, and polysaccharide-degrading
enzymes (Thallinger et al., 2013).
Proteases are a class of proteolytic enzymes that can hydrolyse proteins. This class of
enzymes contain a wide range of enzymes that are different in their target substrates and
mechanisms (Hedstrom, 2002).
Previous research has shown that proteases have been successful in degrading proteins
in pipelines (Augustin, Ali-Vehmas and Atroshi, 2004). Different researchers reported that
Savinase was successful in preventing and removing biofilm formations (C Leroy et al., 2008;
Molobela, Cloete and Beukes, 2010). Leroy et al. 2008 compared the efficiency of different
commercial enzymes (seven polysaccharide-degrading, four proteases, and one lipase) to
eradicate biofilms formed by the marine bacterial strain Pseudoalteromonas sp. D41. The
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biofilm was grown in a 96-well microtiter plate for 24 h using sterile seawater at 20 oC. The
biofilm biomass was quantified by using fluorescent dye DAPI (4[prime]6-diamidino-2phenylindole). The results presented suggested that Savinase was the most efficient enzyme in
removing and preventing biofilms (50% reduction of pre-existing biofilms after a 24 hrs
treatment at a concentration of 1.7 mg mL-1, and up to 100% reduction in bacterial adhesion).
The authors concluded that depending on the type of enzyme and the used concentrations
enzymes might remove biofilms or inversely enhance their formation (C Leroy et al., 2008).
Protamex was used by previous researchers for the hydrolyses of peptide bonds from
different sources such as Yellowfin Tuna, Sardine heads, and Soybean (Dumay et al., 2009;
Nguyen et al., 2011; Minh, 2015). Cordeiro et al. 2011 investigated the effect of immobilized
subtilisin A on the initial attachment of Pseudomonas aeruginosa and Staphylococcus
epidermidis. The tested enzymes (Subtilisin A and Cellulase) were immobilized on a
poly(ethylene-alt-maleic) anhydride copolymer films by covalent binding. Test controls were
prepared using heat to inactivate enzymes. Test slides and controls were submerged in
bacterial suspension (106 CFU/mL) and incubated in sterile conditions for 24 hrs at 37 oC. After
incubation, the test samples were washed to remove loosely attached bacteria by immersion
into a saline solution, the cells that remained attached after the wash step were plated in serial
dilutions for quantification of viable cell count. By comparing the active and inactive surfaces,
the immobilized subtilisin A had no effect on the attachment of S. epidermidis but reduced the
attachment of P. aeruginosa by 44%. The authors concluded that the initial steps of attachment
for different bacteria involves different biomolecules, which requires a broad spectrum of
enzymatic coatings to control biofilm(Cordeiro, Hippius and Werner, 2011). A study by Tasso et
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al. 2009 investigated the control of biofilm by targeting the adhesives used by microorganisms
to attach to surfaces. The researchers used the protease Subtilisin A by covalently attaching it
to tested surfaces at different concentrations. The immobilized enzymatic coating was tested
for its effect on the adhesion strength and settlement of two major species (green alga Ulva
linza, and the diatom Navicula perminuta). The researchers reported that the immobilized
Subtilisin A was effective in reducing the adhesion strength and settlement of the tested
microorganisms (Tasso et al., 2009).
The protease Trypsin is substrate-specific for the peptide bonds of arginine and lysine
(Chaignon et al., 2007). A study by Chaignon et al. 2007 evaluated the ability of trypsin to
remove biofilms formed by S. epidermidis RP62A, S. epidermidis 5, S. epidermidis 444, S.
lugdunensis 47, S. lugdunensis 18a, S. aureus 383 in 96-well microtiter plates. The pre-grown
biofilms of the different bacterial species were treated with 100 μL of trypsin at 1 mg mL −1 in 20
mM Tris buffer, and pH 7.5 for 2 h. Biofilms were stained using 5% safranin and quantified by
measuring absorbance at 492 nm. Results obtained showed that Trypsin treatment removed
more than 70% of biofilm formed by S. epidermidis 444, S. lugdunensis 47, S. lugdunensis 18a, S.
aureus 383. While no effect of trypsin was noticed for biofilm formed by S. epidermidis RP62A,
S. epidermidis 5. The authors stated that Trypsin had no effect on biofilms formed by S.
epidermidis RP62A and S. epidermidis 5 due to their polysaccharide-rich composition. The
authors also hypothesised that the removal of biofilms formed by S. epidermidis 444
(polysaccharide rich biofilm) by Trypsin was due to the important role of proteins and
polysaccharide as well in the stability of the biofilm formed by this bacterial strain (Chaignon et
al., 2007). In a study by Rohde et al. 2007, Trypsin was used to remove pre-grown biofilm from
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Staphylococcus epidermidis and Staphylococcus aureus. Biofilm was cultivated in 96-well
microtiter plates, and a treatment containing Trypsin (100 µg/mL) was applied for 16 hrs at
37oC. The Trypsin treatment removed more than 98% of the biofilm formed in the microtiter
plates from both tested bacterial species (Rohde et al., 2007).
Polysaccharides molecules and their degrading enzymes are abundant in nature, with
many of these polysaccharide-degrading enzymes produced by bacteria, which in turn utilizes
these enzymes in their invasions to bypass host defences (Jedrzejas, 2000). The polysaccharide
degrading enzyme Cellulase arises among the different enzymes used as a common choice of
enzymatic treatments for prevention and removal of bacterial biofilms (Cordeiro, Hippius and
Werner, 2011). Following the same procedure discussed previously for Subtilisin A, and by
comparing results for active and inactive layers of enzymes, Cordeiro et al. 2011, reported that
Cellulase, in contrary to Subtilisin A, did not affect the attachment of P. aeruginosa and reduced
the attachment of S. epidermidis by 67%. (Cordeiro, Hippius and Werner, 2011). Loiselle et al.
2003 conducted a study to investigate the ability of Cellulase to inhibit biofilm formation by
Pseudomonas aeruginosa. Biofilm was formed on glass slides in a flow chamber for 4 days.
Biofilm formation was assessed by quantifying the biomass areal density (mg cm -2) and by
viable cell count (CFU). Biofilm was grown in the presence of different Cellulase concentrations
at pH 7 and 5. The test controls were prepared using deactivated Cellulase. The results reported
suggests that Cellulase was successful in partially inhibiting CFU formation and biomass by P.
aeruginosa. Areal densities were reduced by 36% and 58% for Cellulase concentrations of 9.4
and 37.6 Unit mL-1 at pH 7. While areal density was decreased by 60% and 88% for Cellulase
concentrations of 9.4 and 75.2 Unit mL-1 at pH 5. Viable cell counts decreased by 60% and 57%
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at pH 5 and 7 for Cellulase concentration of 9.4 Unit mL-1. The increase of Cellulase
concentration did not have any effect of viable cell counts (CFU) at the tested pH values
(Loiselle and Anderson, 2003).
Pectinases (pectinolytic enzymes) are heterogeneous mixtures of enzymes that are
abundant in plants and microorganisms for their ability to hydrolyze pectic substances (Jayani,
Saxena and Gupta, 2005). Pectic compounds are polysaccharides that are negatively charged,
acidic, high molecular weight macromolecules that are abundant in the plant kingdom (Jayani,
Saxena and Gupta, 2005). Pectinases play an important role in the plant kingdom as they
contribute in the plant cell wall degradation (Ward and Moo-Young, 1989). They also contribute
in softening plant tissue at maturation and storage (Sakai, 1992), and have an important
ecological role in the decomposition and recycle of plant waste materials (Lang and
Dörnenburg, 2000).
Pectinases have shown promising results as an anti-biofilm enzyme (Johansen and Falholt,
1997). In their study, Johansen et al. 1997, evaluated the use of Pectinex on biofilms formed
from Staphylococcus aureus ATCC 25923, Pseudomonas aeruginosa ATCC 10148, and
Pseudomonas fluorescens AH2. Sterile discs made from steel and polypropylene were
immerged vertically in a steel tank containing growth medium and biofilm was allowed to
develop on both sides of the discs at 26 oC for 4 days with stirring (200 rpm). The discs were
then rinsed to remove loosely attached cells using phosphate buffer (pH 7) prior to incubating
them with Pectinex in phosphate buffer for 15 min at 20 oC static. Phosphate buffer solution
(sterile) was used as a control. The total and respiring number of bacterial cells in the biofilm
was determined using fluorescence microscopy. From the results presented Pectinex was
129

effective in removing biofilms formed by all tested species. Almost two log reductions in the cell
number for S. aureus and P. aeruginosa, and one log reduction in the cell number for P.
fluorescens was achieved with Pectinex concentration of 180 PSU mL-1 (Johansen and Falholt,
1997).
Due to the complexity of the different biofilm compositions among different bacterial
species, and the abundant available enzymes in the market coupled with the enzymatic
substrate specificity (Simões, Simões and Vieira, 2010), it is of vital importance to evaluate and
compare the available related enzymes for their ability to remove biofilms. Although different
biofilms compositions are described as complex, the to main components of biofilms are
polysaccharides and proteins, hence, the most related enzymatic treatments recommended for
degrading different biofilms are the proteases and the polysaccharide-degrading enzymes
(Meyer, 2003). Far to the authors knowledge, the efficiency of the industrial enzymatic
mixtures CellicCTec2, CellicHTec2, and Protamex have never been evaluated for biofilm
removal.
In this research, the efficiency of commercially available polysaccharide-degrading
enzymes (Carezyme, CellicCTec2, CellicHTec2, and Pectinex) and proteolytic enzymes (Savinase,
Protamex, Trypsin, and Subtilisin A) in the removal of pre-grown biofilms of different
compositions formed by Bacillus sp. and Pseudomonas fluorescens will be evaluated and
compared.
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3.4.3. Experimental Procedures
3.4.3.1. Materials
3.4.3.1.1.

10X Tbase

To 232 mL DI-Water, add 2.5 g Trisodium citrate (34 mM sodium citrate), 4.95 g (NH4)2SO4
(0.15M ammonium sulphate), 14.97 g KH2PO4 (0.44M potassium phosphate monobasic), 34.84
g K2HPO4 (0.8M potassium phosphate dibasic), autoclave for 20 min.
3.4.3.1.2.

Biofilm Growth Media for Bacillus species.

To 900 mL of DI-Water, add 10 g tryptone, 5 g yeast extract, 10 g NaCl, 0.04 g D-glucose),
10 mL of 10X Tbase, 0.012 g MgSO4, autoclave for 20 min.
3.4.3.1.3.

Biofilm Growth Media for Pseudomonas fluorescens.

To 1000 mL of DI-Water, add 20 g peptone, 1.5 g K2HPO4, 1.5 g MgSO4.7H2O, 10 gm glycerol,
autoclave for 20 min.
3.4.3.1.4.

Wash Buffer (Sterile)

900 mL DI-Water, 1 ml of 1M MgSO4, 100 mL of the 10X Tbase solutions, autoclaved for 20
min.
3.4.3.1.5.

Sodium Acetate Buffer for Polysaccharide-degrading enzymes (pH 4)

410 mL of 0.2 M acetic acid solution, 2.45 g sodium acetate trihydrate, bring final volume to
1 L using DI-Water, autoclave for 20 min.
3.4.3.1.6.

Sodium Phosphate Buffer for Proteases (pH 8)

To 1000 mL of DI-Water, add 0.74 g Sodium Phosphate monobasic monohydrate, 25.23 g
sodium phosphate dibasic heptahydrate, autoclave 20 min.
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3.4.3.2. Methods
3.4.3.2.1.

Bacterial Strains

The Bacillus species strain used in this research was obtained from Germiphene Inc. It is
known commercially as Unizyme 20X CSB 20 NF SPORE. The Pseudomonas fluorescens strain
used in this research is known as Pseudomonas fluorescens Migula 1895 (DSM No. 50090, type
strain), and was obtained from DSMZ in Germany.
3.4.3.2.2.

Seed Culture Preparation

For Bacillus sp., one mL of the spore suspension was washed via centrifuge at 10,000
rounds per minute for 60 seconds and then re-suspended in 1 mL wash buffer (repeated three
times), this was followed by resuspension in 1 mL biofilm growth medium. A 150mL glass flask
containing 20mL medium was then inoculated with 0.5 mL of the resuspended cells at 300
rounds per minute inside a 37 oC humidified incubator oven for approximately 270 min until the
optical density at 600 nm was between 1 and 1.6 (using DI-Water as blank).
For P. fluorescens strain, the culture was revived in growth media and samples of 1 mL
size were sampled and preserved with 20% glycerol in -80oC freezer. Prior to each experiment
the frozen samples were revived in growth media until optical density measured at 600 nm was
between 1 and 1.6 (using DI-Water as blank).
3.4.3.2.3.

Inoculating the Microtiter Plates and Biofilm Growth

The prepared seed culture for each of the two strains was diluted in a 1:100 ratio in the
designated biofilm growth media, and each well in the microtiter plates was filled with 100 µL
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of the diluted seed culture. Control wells were prepared by filling wells in the microtiter plates
with 100 µL of sterile biofilm growth media. Each plate was covered with a sterile thin film to
reduce evaporation, a single hole was added for aeration in the center of each well using a 22gauge sterile needle. The microtiter plates containing Bacillus sp. were incubated at 37 oC in a
humidified oven in static conditions for 32 h. While the microtiter plates containing P.
fluorescens were incubated in a sterile chamber at 21 oC for 72 h and media was replenished
every 24 h. Subsequently the plates are washed (Tecan Hydroflex Plate Washer) gently three
times using wash buffer.
3.4.3.2.4.

Fixing Biofilm Growth

This step is done to fix initial biofilm growth to be compared with the biofilm remaining in
other wells following treatment. It is assumed that fixed biofilms are nonactive or dead. At the
end of the treatment duration this process is repeated to treated wells and prior to biofilm
quantification. Growth medium was removed, and each well was filled with 200µL methanol for
20 min. Microtiter plates are then left to air dry completely at room temperature (Stepanović et
al., 2000; Kwasny and Opperman, 2010).
3.4.3.2.5.

Enzymatic Treatments Preparation

The protease treatments (Savinase, Protamex, Subtilisin A, and Trypsin) were prepared in
sodium phosphate buffer (pH 8) at five concentrations (1, 5, 10, 15, and 30 U/mL), while the
polysaccharide-degrading enzymes (Pectinex, Carezyme, Cellic-CTec2, Cellic-HTec2) were
prepared in sodium acetate buffer (pH 4) at five concentrations 1, 5, 10, 15, and 30 U/mL for
Carezyme, Cellic-Ctec2, and Cellic-HTec and 5, 15, 25, 50, and 75 U/mL for Pectinex.
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The enzymatic activity of the different proteases was quantified before and after
conducting the experiments using casein as substrate (Folin and Ciocalteu, 1927; Anson, 1938),
no change was noticed in the enzymatic activity of the proteases (data not shown). The
protease activity unit (U) is defined as the amount of enzyme required to hydrolyse casein in
one minute, pH 7.5, 37oC, to produce color (Folin & Ciocalteau’s reagent) equivalent to 1 µmole
of tyrosine (Folin and Ciocalteu, 1927; Anson, 1938).
The activity of the polysaccharide degrading enzymes (Carezyme, Cellic-CTec2, and
Cellic-HTec2) were quantified before and after conducting the experiments using cellulose as a
substrate (Worthington, 1988), no change was noticed in the enzymatic activity of the tested
enzymes (results not shown). The enzymes activity unit (U) is defined as the amount of the
enzyme required at pH 5 and 37 oC, to liberate 1 µmole of glucose from cellulase in 1 h
(Worthington, 1988). The list of enzymes used in this work are presented in Table 3–1. The
activity unit (U) for Pectinex is defined as the amount of enzyme required to liberate 1 µmole of
galacturonic acid from poly-galacturonic acid in 1 h at pH 4 and 25 oC.
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Table 3–1. List of enzymes used and their optimum activity conditions.

Enzyme

Optimum Activity
Range
Temp.
pH
(Co)

Source

Name

Type

Protamex®

Protease

7.5 - 9.5

40 - 60

Sigma-Adrich Inc., Saint Louis, Mo, USA

Subtilisin A

Protease

7.5 - 10

50 - 65

Sigma-Adrich Inc., Saint Louis, Mo, USA

Trypsin

Protease

6.5 - 10

30 - 44

Sigma-Adrich Inc., Saint Louis, Mo, USA

Savinase

Protease

8.0 - 11

55 - 75

Sigma-Adrich Inc., Saint Louis, Mo, USA

Carezyme

Polysaccharide-degrading

4.0 - 5.5

35 - 60

Sigma-Adrich Inc., Saint Louis, Mo, USA

Pectinex Ultra

Polysaccharide-degrading

3.5 - 6.0

30 - 60

Sigma-Adrich Inc., Saint Louis, Mo, USA

Cellic CTec2

Polysaccharide-degrading

4.0 - 6.5

40 - 60

Novozymes A/S, Bagsværd, Denmark

Cellic HTec2

Polysaccharide-degrading

4.0 - 6.0

60 - 75

Novozymes A/S, Bagsværd, Denmark

3.4.3.2.6.

Applying Treatments

After washing the microtiter plates with the buffer solution, the designated treatment was
applied by dispensing 125 µL of enzymatic treatment solution into desired wells, that was
followed by incubation at 21 oC for 24 h.
3.4.3.2.7.

Total Biofilm Quantification Using Crystal Violet Stain

Biofilm formation was quantified using the crystal violet binding assay method. This method is
commonly used to quantify biofilms (O’Toole, Kaplan and Kolter, 2000; Kolodkin-Gal et al.,
2010, 2012; Brandenburg et al., 2013; Zhang and Hu, 2013). To quantify biofilm formation in
the microtiter plates, using a multichannel pipette, 150 µL of 0.1 % (W/V) crystal violet stain
was dispensed into each well, this was followed by 60 min incubation (Stepanović et al., 2000;
Kwasny and Opperman, 2010). The microtiter plate was washed 4 times by dispensing 200 µL
DI-Water in drip mode and then aspirating using the Tecan Hydroflex plate washer without
touching the bottom of the wells (previous testing proved that washing the plates 4 times
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produce a washing waste liquid that is stain free). Microtiter plates were then air dried
completely at room temperature. The crystal violet was then resolubilized by manually
dispensing 200 µl 30% acetic acid using a multichannel pipet into each well (Stepanović et al.,
2000), the microtitet plate is then incubated static at room temperature for 20 min. Using a
multichannel pipet, 100 µL from each well were transferred to clear polystyrene plates with the
flat bottom for to be quantified via measuring absorbance at OD 570 nm (TECAN infinite M200
Pro Plate reader).
3.4.4. Results
3.4.4.1. Reproducibility of Biofilm Formation in Different Microtiter Plates
Reproducibility of biofilm growth in the microtiter plates was evaluated first to validate
comparisons between different treatments within the same microtiter plate (intra-plate) and
between different microplates (inter-plate) prepared from the same batch. Biofilm growth for
P. fluorescens was quantified in 96 wells per plate in three separate plats following the
designated incubation time. A one-way ANOVA test was performed for inter-plate comparison
of biofilm formation. The results showed no significant difference (p-value = 0.63) among the
three plates. Reproducibility of P. fluorescens biofilm within the same plate was also assessed
using one-way ANOVA, the results obtained showed no significant difference (p-value = 0.73)
among the twelve columns (8 wells/column) within the same microtiter plate. Reproducibility
testing for Bacillus sp. showed no significant difference for both inter-plate and intra-plate
comparisons, for details please see Section 3.2.4.1 .
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3.4.4.2. Biofilm Removal Using Proteases

Figure 3-10. Bacillus sp. viable biofilm removal using proteases. Each enzyme was tested at 5
concentrations ranging between 1 and 30 U/mL. For each enzyme tested, only the enzyme
concentration resulting in the highest biofilm removal is plotted for comparison with other
tested enzymes. Each column is an average of 8 replicates. Error bars represent 95% confidence
intervals.
The effect of enzyme concentration on biofilm removal was evaluated for four different
enzymes. Savinase was the most effective protease in removing Bacillus sp. biofilms, as shown
in Figure 3-10. That was followed by Protamex, Subtilisin A, and Trypsin respectively. The
highest Bacillus sp. biofilms removal (68%) using proteases was achieved by Savinase (Figure
3-10).
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Figure 3-11. Pseudomonas fluorescens viable biofilm removal using proteases. Each enzyme was
tested at 5 concentrations ranging between 1 and 30 U/mL. For each enzyme tested, only the
enzyme concentration resulting in the highest biofilm removal is plotted for comparison with
other tested enzymes. Each column is an average of 8 replicates. Error bars represent 95%
confidence intervals.
Savinase was the most effective protease in P. fluorescens biofilm removal presented in
Figure 3-11, this was closely followed by Protamex, and then Subtilisin A, and Trypsin
respectively. The highest P. fluorescens biofilm removal (84%) by proteases was achieved by
Savinase (Figure 3-11).
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3.4.4.3. Biofilm Removal Using Polysaccharides-degrading Enzymes

Figure 3-12. Bacillus Sp. viable biofilm removal using polysaccharide-degrading enzymes. Each
enzyme was tested at 5 concentrations ranging between 1 and 75 U/mL. For each enzyme
tested, only the enzyme concentration resulting in the highest biofilm removal is plotted for
comparison with other tested enzymes. Each column is an average of 8 replicates. Error bars
represent 95% confidence intervals.
The polysaccharide-degrading enzyme Pectinex was the most effective enzyme in
removing biofilms formed by Bacillus sp. as presented in Figure 3-12
, this was followed by Cellic-CTec2, Carezyme, and Cellic-HTec2 respectively (Figure 3-12). The
highest Bacillus sp. biofilm removal (74%) using polysaccharide-degrading enzymes was
achieved by Pectinex (Figure 3-12).
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Figure 3-13. Pseudomonas fluoresces viable biofilm removal using polysaccharide-degrading
enzymes. Each enzyme was tested at 5 concentrations ranging between 1 and 75 U/mL. For
each enzyme tested, only the enzyme concentration resulting in the highest biofilm removal is
plotted for comparison with other tested enzymes. Each column is an average of 8 replicates.
Error bars represent 95% confidence intervals.
Pectinex was the most effective polysaccharide degrading enzyme in removing P.
fluorescens biofilms as presented in Figure 3-13, this was followed closely by Cellic-CTec2, and
then Cellic-HTec2, and Carezyme. The highest biofilm removal (55%) of P. fluorescens biofilms
using polysaccharide degrading enzymes was achieved by Pectinex (Figure 3-13).
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3.4.5. Discussion
The ability of different enzymatic treatments to remove biofilms formed by two
different bacterial strains has been evaluated. The bacterial strains tested in this research are
the gram-positive bacteria Bacillus sp. and the gram-negative bacteria P. fluorescens. Biofilms
formed by Bacillus sp. are well characterised, which made it a model microorganism for biofilm
studies (K. P. Lemon et al., 2008; Dervaux, Magniez and Libchaber, 2014). Biofilms formed by
Bacillus sp. has been reported to be mainly composed of polysaccharides (Branda et al., 2001;
Morikawa et al., 2006), while proteins are reported to be the main component of P. fluorescens
biofilms (Molobela, Cloete and Beukes, 2010), this variation in their biofilms composition
provides more different scenarios for testing the different enzymatic treatments. In addition, it
has been reported previously that when compared with the biofilms formed by other disease
causing gram-negative microorganisms (Pseudomonas aeruginosa, Staphylococcus aureus, and
Staphylococcus epidermidis), biofilms formed by P. fluorescens has shown the highest
resistance to enzymatic treatments (Johansen and Falholt, 1997).
Biofilms formed by Bacillus sp. and P. fluorescens were effectively removed by both
proteases and polysaccharide-degrading enzymes (Figure 3-10, Figure 3-11, Figure 3-12, and
Figure 3-13) only at different removal efficiencies. In general, proteases were more effective in
removing biofilms formed by P. fluorescens (84%) than biofilms formed by Bacillus sp. (68%)
this can be seen by comparing Figure 3-10 and Figure 3-11, while polysaccharide-degrading
enzymes were more effective in removing biofilms formed by Bacillus sp. (74 %) than biofilms
formed by P. fluorescens (55%), this can be seen by comparing Figure 3-12 and Figure 3-13. A
possible reason for this is the difference in the specific compositions of the biofilms formed by
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the two species. Biofilms formed by P. fluorescens are mainly composed from proteins
(Molobela, Cloete and Beukes, 2010), which makes it a more suitable substrate for proteases
and hence more vulnerable to degradations by proteases, while biofilms formed by Bacillus sp.
are mainly composed of polysaccharides (Branda et al., 2001; Morikawa et al., 2006), which is a
more suitable substrate for the polysaccharide-degrading enzymes, and therefor biofilms
formed by Bacillus sp. were more effectively removed by polysaccharide-degrading enzymes.
Among the proteases tested in this research, results obtained indicate that Savinase and
Protamex have the highest biofilm removals for biofilms formed by both Bacillus sp. (Figure
3-10) and P. fluorescens (Figure 3-11), this was followed by Subtilisin A and Trypsin respectively.
Possible reasons for that is the variation in the protein composition of the tested biofilms which
made them less resistant to Savinase and Protamex (Augustin, Ali-Vehmas and Atroshi, 2004;
Chaignon et al., 2007; Lequette et al., 2010; Molobela, Cloete and Beukes, 2010; Cordeiro,
Hippius and Werner, 2011). In addition, unlike Subtilisin A and Trypsin, Protamex contains
different enzymatic mixtures (bacillolysin, subtilisin, neutral proteases), which might give it an
advantage facing the variations in the biofilm protein components (Garcia-Mora et al., 2014;
Fernandes, 2016). Previous research has shown that Subtilisin A was effective at inhibiting
initial biofilm attachment, and not as much effective at dismembering pre-existing biofilms (C.
Leroy et al., 2008). The results obtained for Subtilisin A biofilm removal efficiency was similar to
previous research findings by others (Vickery, Pajkos and Cossart, 2004; Cordeiro, Hippius and
Werner, 2011). Previous research has also found Trypsin inefficient in removing biofilms formed
by Staphylococcus epidermidis biofilms, in contrary, they found it efficient in removing biofilms
formed by Staphylococcus aureus, this variation in efficiency was attributed to the difference in
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the protein composition between the two bacterial strains (Chaignon et al., 2007). The results
obtained here suggests that Savinase was the most effective protease in removing biofilms
formed by both species Bacillus sp. (68%) and P. fluorescenes (84%), this can be attributed to
the broad substrate specificity and the superior stability that Savinase posses when compared
to other proteases (Betzel et al., 1992; Georgieva et al., 2001; Marcato-Romain et al., 2012;
Garcia-Mora et al., 2014). Moreover, Savinase has been reported to possess bactericidal effects
(Smith, Green and Mason, 2003), and it was suggested that Savinase targets proteins involved
in bacterial adhesion in biofilm formation (C Leroy et al., 2008). Previous researchers have also
reported Savinase to be the most effective enzyme in biofilm removal (C Leroy et al., 2008;
Molobela, Cloete and Beukes, 2010; Marcato-Romain et al., 2012).
The results obtained for the polysaccharide degrading enzymes (Figure 3-12 and Figure
3-13) showed that Pectinex and Cellic-CTec2 had the highest removal efficiency for biofilm
formed by Bacillus sp. and P. fluorescens. For Bacillus sp. (Figure 3-12) this was followed by
Carezyme and Cellic-HTec2 respectively, while for P. fluorescens (Figure 3-13) this was followed
by Cellic-HTec2 and Carezyme respectively. The higher biofilm removal results obtained for
Pectinex and CellicCTec2 can be a results of specific substrate compatibility which made the
polysaccharides in biofilms formed by Bacillus sp. and P. fluorescens more suitable substrates
for enzymatic degradation by Pectinex and CellicCTec2 (Augustin, Ali-Vehmas and Atroshi,
2004; Chaignon et al., 2007; Lequette et al., 2010; Molobela, Cloete and Beukes, 2010).
Previous research reported that Cellulase (the main active enzyme in Carezyme, CellicCTec2
and CellicHTec2) was successful in reducing initial attachment of biofilms formed by S.
epidermidis, contrary results were obtained for Cellulase on biofilms formed by P. aeruginosa
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(Cordeiro, Hippius and Werner, 2011). Another research reported that Cellulases obtained from
two different sources partially inhibited biofilm by P. aeruginosa (Loiselle and Anderson, 2003).
Results obtained (Figure 3-12 and Figure 3-13) shows that for the exopolysaccharide-degrading
enzymes investigated in this research, Pectinex achieved the highest biofilm removal efficiency
for biofilms formed by both Bacillus sp. (74%) and P. fluorescens (55%). The superiority of
Pectinex removal efficiency over the other polysaccharide-degrading enzymes tested can be
due the fact that Pectinex is a multicomponent enzymatic mixture that contains different
enzymes including proteases (Protease, Pectinase, Arabanse, Cellulase, Hemicellulase, βglucanase, and Xylanase) (Johansen and Falholt, 1997; Olwoch et al., 2014), this wide diversity
in its enzymatic components gives it a broad substrate specificity that in addition to the broad
polysaccharide-degradation activity includes proteins degradation. Similar results for Pectinex
were obtained by previous researchers (Johansen and Falholt, 1997).
3.4.6. Conclusions
It could be concluded from the results presented here that the use of proteases and
polysaccharide degrading enzymes was successful in the removal of pre-existing biofilms
formed by Bacillus sp. and P. fluorescens. The proteases Savinase and Protamex, and the
polysaccharide-degrading enzymes Pectinex and CellicCTec2, have shown the highest removal
efficiency for pre-existing biofilm formed by Bacillus sp. and P. fluorescens. Proteases were
more effective in removing biofilm formed by P. fluorescens, while polysaccharide-degrading
enzymes were more effective in removing Bacillus sp. biofilm. Interestingly, the results
obtained emphasise the complexity of the structural stability of the biofilm. The ability of
polysaccharide degrading enzymes to remove a substantial amount of P. fluorescens biofilm
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(which is mainly composed of proteins), and the ability of proteases to remove a substantial
amount of Bacillus sp. biofilm (which is mainly composed from polysaccharides), reflects the
complex interdependent relationship between polysaccharides and proteins in maintaining the
stability and structural integrity of the biofilm formation. Future work should be directed
toward optimizing biofilm removal using enzymatic treatments to achieve the highest efficiency
in biofilm removal treatments that target a broader spectrum of biofilms.
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3.5 Optimization of Biofilm Removal Using Enzymatic Treatments
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3.5.1. Preface
Section 3.5 presents the experimental work done to fulfill the specific objective
previously presented in Section 1.3.2.4. Based on the results obtained in Section 3.5 the
proteases Savinase and Protamex and the polysaccharide-degrading enzymes Pectinex and
Cellic-Ctec2 showed the highest biofilm removal among the tested enzymes. Section 3.5 builds
on the results previously obtained in Section 3.4 and further optimize biofilm removal using
enzymatic treatments. The results of the optimization experiments showed that a treatment
containing Savinase and Pectinex had the highest biofilm removal efficiency. The models
developed were successful in predicting biofilm removal.
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3.5.2. Introduction
Biofilms are multicellular communities formed by bacterial aggregation on surfaces,
bacterial cells within a biofilm are connected together and to the surface by an extracellular
matrix consisting mainly from polysaccharides and proteins (Costerton et al., 1987; Donlan,
2002; Hall-Stoodley; Kolodkin-Gal et al., 2012). Distinctive characteristic of bacterial cells living
in a biofilm community can be summarised by higher antibacterial resistance, the formation of
free planktonic cells, UV light tolerance, the formation of bacterial spores, and an increased
synthesis of extracellular matrix (Habash and Reid, 1999; O’Toole, Kaplan and Kolter, 2000; HallStoodley and Stoodley, 2002; Rowland and Voorheesville, 2003; Garrett, Bhakoo and Zhang,
2008; Coleman et al., 2010; Vlamakis et al., 2013). Biofilm formation can be problimatic for the
healthcare and industrial sectors (Barbeau et al., 1996; Barbeau, Bokum and Gauthier, 1998).
Biofilm communities can harbour different undesirable pathogens, biofilm formation can cause
clogging of pipes and tubes, in addition, biofilms can interfere with the mechanical properties
of dental devices (Barbeau et al., 1996; Coleman et al., 2010; Vasickova et al., 2010).
The use of chemical treatments to remove biofilms was found to be challenging
(Ntsama-Essomba et al., 1997; Vickery, Pajkos and Cossart, 2004). Due to the physical barrier
between the chemical treatments and the bacterial cells living within the biofilm, chemical
treatments cannot access the bacterial cells (Gilbert and McBain, 2001). Lower diffusivity of
chemical treatments through biofilms makes them highly resistant to disinfectants, biocides,
and antibiotics. When compared to its free planktonic form, bacteria living in a biofilm
formation was reported to be up to 1000-fold more resistant to chemical treatments (Gilbert
and McBain, 2001). The composition of the extracellular matrix can vary depending on the
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bacterial strain and other external factors ( such as gaseous levels, and nutrients) (Simões,
Simões and Vieira, 2010). Biofilms composition includes carbohydrates, polysaccharides,
glycoproteins, nucleic acids, amyloid proteins, phospholipids, lipids, nucleic acids (Branda et al.,
2005; Flemming and Wingender, 2010; Hobley et al., 2014)
Enzymatic treatments have been recently suggested as anti-biofilm treatments, previous
research has shown their ability in removing biofilm from industrial surfaces (Taraszkiewicz et
al., 2013; Thallinger et al., 2013; Meireles et al., 2016). Enzymatic treatments have been
described as more affordable, efficient, and eco-friendly alternative than the chemical
treatments used in removing biofilms (Cordeiro, Hippius and Werner, 2011; Cortés, Bonilla and
Sinisterra, 2011; Srey, Jahid and Ha, 2013). The use of enzymes in industry and for cleaning
surfaces has been approved by regulatory agencies and no evidence of side effects has been
reported (Schmidt, 2012; Meireles et al., 2016).
Due to the substrate-specific nature of enzymes, it is vital to identify the components of
the extracellular matrix prior to the selection of the enzymatic treatment (Molobela, Cloete and
Beukes, 2010). Although there is variation in the constituents of biofilms the major two
components remains to be proteins and polysaccharides (Stewart and William Costerton, 2001;
Sutherland, 2001; Molobela, Cloete and Beukes, 2010), the specific enzymes that degrade these
two major components of biofilm are proteases and polysaccharide-degrading enzymes,
respectively (Jedrzejas, 2000; Jayani, Saxena and Gupta, 2005; C. Leroy et al., 2008). The ability
of proteases and polysaccharide-degrading enzymes in removing biofilm have been
investigated previously, the proteases Savinase and Protamex, and the polysaccharidedegrading enzymes Pectinex and Cellic-CTec2, have shown the highest efficiency in removing
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biofilms formed by Bacillus sp. and P. fluorescens, for more details please refer to Sections
3.4.4.2 and 3.4.4.3.
Bacillus species (Bacillus sp.) and Pseudomonas fluorescens (P. fluorescens) are
considered model microorganisms for biofilm related studies (K. P. Lemon et al., 2008;
Rossignol et al., 2008). Bacillus sp. is a non-pathogenic, gram-positive, biofilm forming bacteria,
they can be found in abundance in both terrestrial and aquatic environments due to their
ability to adapt to different environments (Grossman, 1995; Maglott et al., 2007; Earl, Losick
and Kolter, 2008). It has been reported that the major structural component of biofilms formed
by Bacillus sp. is polysaccharides (Branda et al., 2001; Morikawa et al., 2006). Pseudomonas
fluorescens is a gram-negative, non-pathogenic, biofilm forming bacteria (Rossignol et al.,
2008). This bacterium is ubiquitous in the environment and in hospitals, it is characterised with
high adaptation to different environments and its ability to resist a wide range of antibiotics
and disinfectants (Spiers, Buckling and Rainey, 2000; Rossignol et al., 2008). Previous research
reported that P. fluorescens produces biofilms that are mainly composed of proteins (Molobela,
Cloete and Beukes, 2010).
Taking into consideration the heterogeneity of biofilms compositions, and the substratespecific characteristic of enzymes makes it vital to use enzymatic mixtures to achieve a broader
spectrum and higher efficiency of biofilm removal (Augustin, Ali-Vehmas and Atroshi, 2004;
Torres et al., 2011). The use of enzymatic mixtures containing proteases and polysaccharidedegrading enzymes is expected to achieve higher biofilm removal efficiency (Thallinger et al.,
2013). Previous researchers expected promising results from using enzymatic mixtures
containing proteases and polysaccharide-degrading enzymes for biofilm removal in different
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applications (Orgaz et al., 2006; Torres et al., 2011; Zanaroli et al., 2011). To the best knowledge
of the authors, this is the first-of-kind optimization study on the use of proteases and
polysaccharide-degrading enzymes mixtures for biofilm removal.
Response surface methodology (RSM) is an effective mathematical and statistical tool
used for analysis, modeling, and optimization of a complicated process that include several
independent variables (factors) affecting a dependent variable (response) (Montgomery,
Runger and Hubele, 2001; Mason, Gunst and Hess, 2003; Montgomery, 2008). The advantage of
using this method is the reduction in the number of experiments required to optimize the
desired response, this method have been utilized by many researchers for optimization studies
in different fields (Sarchami and Rehmann, 2015; Barwal and Chaudhary, 2016; Sarchami,
Johnson and Rehmann, 2016).
The objective of this research is to optimize biofilm removal efficiency of pre-existing
biofilms formed by Bacillus sp. and P. fluorescens by using enzymatic mixtures consisting of the
proteases Savinase and Protamex, and the polysaccharide-degrading enzymes Pectinex and
Cellic-CTec2.
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3.5.3. Experimental Procedures

3.5.3.1.

Materials

3.5.3.1.1.

10X Tbase

928 mL DI-Water,10 g Trisodium citrate (34 mM sodium citrate), 19.8 g (NH4)2SO4 (0.15M
ammonium sulphate), 139.36 g K2HPO4 (0.8M potassium phosphate dibasic), 59.88 g KH2PO4
(0.44M potassium phosphate monobasic), autoclaved for 20 min.
3.5.3.1.2.

Biofilm Growth Media for Pseudomonas fluorescens

500 mL of DI-Water, 10 g peptone, 5 gm glycerol, 0.75 g K2HPO4, 0.75 g MgSO4.7H2O,
autoclaved for 20 min.
3.5.3.1.3.

Biofilm Growth Media for Bacillus species

450 mL of DI-Water, 50 mL of 10X Tbase, 5 g tryptone, 2.5 g yeast extract, 5 g NaCl, 0.02 g Dglucose), 0.006 g MgSO4, autoclaved for 20 min.
3.5.3.1.4.

Wash Buffer

450 mL DI-Water, 50 mL of the 10X Tbase solution, 0.5 mL of 1M MgSO4, autoclaved for 20 min.
3.5.3.1.5.

Sodium Phosphate Buffer for Proteases (pH 8)

500 mL of DI-Water, 12.7 g sodium phosphate dibasic heptahydrate, 0.37 g sodium phosphate
monobasic monohydrate, autoclaved 20 min.
3.5.3.1.6.

Sodium Phosphate Buffer for Mixed Enzymes Treatments (pH 6)

500 mL of DI-Water, 1.65 g sodium phosphate dibasic heptahydrate, 6.10 g sodium phosphate
monobasic monohydrate, autoclaved for 20 min.
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3.5.3.1.7.

Sodium Acetate Buffer for Polysaccharide-degrading enzymes (pH 4)

2.45 g sodium acetate trihydrate, 410 mL of 0.2 M acetic acid solution, bring final volume to 1 L,
autoclaved for 20 min.
3.5.3.1.8.

Bacterial Strains

The Bacillus species strain used is known commercially as Unizyme 20X CSB 20 NF SPORE
was provided by Germiphene Inc. The Pseudomonas fluorescens strain used was obtained from
DSMZ in Germany. It is known as Pseudomonas fluorescens Migula 1895 (DSM No. 50090, type
strain).
3.5.3.2.

Methods

3.5.3.2.1.

Seed Culture Preparation

3.5.3.2.1.1.

Bacillus species

One milliliter of the Bacillus sp. spore suspension was washed three times. The wash
procedure was carried on via centrifuge at 10,000 rounds per minute for 1 min and then
resuspended in 1 mL wash buffer using a vortex, the washed spores are then concentrated
using the centrifuge (10,000 rpm, 1 minute) and then resuspended in 1 mL biofilm growth
medium, half a milliliter of the washed resuspended spores were used to inoculate 20 mL of the
growth medium using a 150 mL glass flask inside a 37 oC humidified incubator oven at 300
rounds per min until optical density was between 1 and 1.6 at 600 nm (using DI-Water as
blank).
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3.5.3.2.1.2.

Pseudomonas fluorescens

The received P. fluorescens culture was revived in growth media until optical density was
1.2 at 600 nm. Samples of 1 mL size were taken and preserved with 20% glycerol in -80oC
freezer. At the start of each experiment, the frozen culture samples were revived in growth
media, by adding 0.5 mL of thawed culture to 20 mL fresh growth media, at 21 oC and 300
rounds per minute, until optical density measured was between 1 and 1.6 at 600 nm (using DIWater as blank).
3.5.3.2.2.

Inoculating the Microtiter Plates and Biofilm Growth

For each of the two bacterial strains, the prepared seed culture was diluted in a 1:100 ratio
in the appropriate growth media. The wells in the microtiter plates were filled with 100 µL of
the diluted seed culture. The control wells were prepared using 100 µL of sterile growth media.
The plates were covered with a thin sterile film to reduce evaporation, a hole was poked in the
center of the wells for aeration using a sterile 22-gauge needle. The Bacillus sp. microtiter
plates were then incubated in a humidified oven at 37 oC in static conditions for 38 h. The P.
fluorescens microtiter plates were incubated at 21 oC for 96 h, the growth media was
replenished every 24 h. Subsequently at the end of the incubation time the plates were washed
gently three times using wash buffer (Tecan Hydroflex Plate Washer).
3.5.3.2.3.

Fixing Biofilm Growth

Fixed biofilms are assumed to be dead or nonviable. This procedure is done to preserve the
biofilm that formed at a certain stage to be quantified later. This procedure is repeated twice
during the experiment. First time is after initial biofilm growth and just before applying the
enzymatic treatments, this is done to specific wells (8 wells) to be able to quantify initial biofilm
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growth prior to the application of treatments. The second time is done after the end of the
enzymatic treatment duration to the wells containing the enzymatic treatments and prior to
final biofilm quantification. The procedure was done by washing the microtiter plates to
remove growth medium, and filling each well with 200 µL methanol for 20 minutes at room
temperature. The methanol is then removed using the Tecan Hydroflex Plate Washer and
microtiter plates are left to air dry at room temperature (Stepanović et al., 2000; Kwasny and
Opperman, 2010).
3.5.3.2.4.

Enzymatic Treatments Preparation

The protease treatment containing Savinase and Protamex was prepared in sodium
phosphate buffer (pH 8), while the polysaccharide-degrading enzymes treatment containing
Pectinex and Cellic-CTec2 was prepared in sodium acetate buffer (pH 4). The mixed enzymatic
treatment containing Savinase and Pectinex was prepared in three different buffers, sodium
phosphate buffer (pH 8), sodium phosphate buffer (pH 6), and sodium acetate buffer (pH 4) as
previously explained.
The activities of the enzymes used were quantified before and after conducting the
experiments (data not shown), no change was noticed in the enzymatic activity, for more
details please refer to Section (3.4.3.2.5). The activity unit (U) of proteases (Savinase and
Protamex) is defined as the required amount of enzyme to hydrolyse casein at pH 7.5, 37 oC, in
1 minute, to produce color equivalent to 1 µmole of tyrosine (Folin and Ciocalteu, 1927; Anson,
1938). The activity unit (U) for Pectinex is defined as the amount of enzyme required to liberate
1 µmole of galacturonic acid from poly-galacturonic acid in 1 h at pH 4 and 25 oC. The activity
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unit (U) for Cellic-CTec2 is defined as the amount of Cellic-CTec2 required at 37oC, and pH 5 to
liberate 1 µmole of glucose from cellulase in 1 h (Worthington, 1988).
3.5.3.2.5.

Applying Treatments

At the end of initial biofilm growth, the microtiter plates are washed with the wash buffer
using Tecan Hydroflex Plate Washer. One column (8 wells) of each plate is fixed with methanol
as explained previously. The designated enzymatic treatments were applied by dispensing 125
µL of each enzymatic treatment into their designated wells. The microtiter plates for both
bacterial strains were then incubated at 21 oC in a sterile chamber for 24 h.
3.5.3.2.6.

Total Biofilm Quantification Using Crystal Violet Stain

Crystal violet binding assay is a widely used method for biofilm quantification (O’Toole,
Kaplan and Kolter, 2000; Kolodkin-Gal et al., 2010, 2012; Brandenburg et al., 2013; Zhang and
Hu, 2013). At the end of the treatment duration, microtiter plates are washed and fixed, and
left to air dry completely, now the microtiter plates are ready for biofilm quantification. By
using a manual multichannel pipette, each well was filled with 150 µL of 0.1 % (W/V) crystal
violet stain, the plates are then incubated at the bench top and room temperature for 60
minutes (Stepanović et al., 2000; Kwasny and Opperman, 2010). The non-binding crystal violet
stain in the wells is then washed 4 times using Tecan Hydroflex plate washer by dispensing 200
µL DI-Water in drip mode and aspirating without touching the bottom of the wells. The
microtiter plates were left to air dry on the bench top at room temperature. The biofilmbinding crystal violet was resolubilized by dispensing 200 µl of 30% acetic acid using a manual
multichannel pipettor into each well (Stepanović et al., 2000), the microtiter plates are then
incubated on bench top at room temperature for 20 min. Using a manual multichannel pipet, a
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volume of 100 µL from each well was transferred to polystyrene plates with the flat clear
bottom and absorbance is measured at 570 nm optical density using TECAN infinite M200 Pro
Plate reader.
3.5.3.2.7.

Optimization of Biofilm Removal

3.5.3.2.7.1 Biofilm Removal
Biofilm removal experiments were conducted on pre-grown biofilms in 96-well
microtiter plates using the different enzymatic treatments. Biofilm removal was calculated
using Equation (1) below:

(1)

Where the initial biofilm is the biofilm formed in the wells before the treatments were
applied, and the final biofilm is the biofilm remaining in the wells after the enzymatic
treatment.
3.5.3.2.7.2 Central Composite Design and Statistical Analysis
A two-factor central composite design (CCD) was developed to find the optimal
combination of enzymes concentrations for maximizing the biofilm removal efficiency using
enzymatic treatments. This method has been widely used by researchers in optimization
experiments in different fields of research (Kumari and Sarkar, 2014; Sarchami and Rehmann,
2015; Barwal and Chaudhary, 2016; Sarchami, Johnson and Rehmann, 2016). The five un-coded
values used for the different concentrations of each enzyme were as follows [high star point,
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high central point, center point, low central point, low star point]: Savinase, Protamex, and
Cellic concentrations (U/mL) [30.27, 28, 16, 4, 1.73]: Pectinex concentrations (U/mL) [97.1, 90,
52.5, 15, 7.9].
For the optimization of the protease enzyme Savinase and the polysaccharide-degrading
enzyme Pectinex, the pH, and microorganism type were both set as a categoric factors, the
enzymatic combinations were tested at three pH values (4, 6, and 8), and two microorganisms
(Bacillus sp. and P. fluorescens), these conditions result in a total of 6 blocks. The optimization
of the two proteases Savinase and Protamex was performed at a single pH value of 8 (optimal
pH for proteases), and microorganism type (Bacillus sp. and P. fluorescens) was set as categoric
factor, these conditions result in a total of 2 blocks. The optimization of the polysaccharidedegrading enzymes Pectinex and Cellic were performed at a single pH value of 4 (optimal pH for
polysaccharide-degrading enzymes), and microorganism type (Bacillus sp. and P. fluorescens)
was set as categoric factor, these conditions result in a total of 2 blocks. These conditions
combined for all the different tested conditions result in a total number of 10 blocks.
The software Design Expert 9.0.6.2 was used to develop the experimental central
composite design. Each non-centre point (total of 8 points) was tested in 4 replicates, while
centre points (total of 1 point) were tested in 9 replicates, a total of 41 runs for each block. All
locations of testing conditions were randomized on the microtiter plate.
Following the application of the different treatment combinations, the biofilm removal
was calculated for the different treatments using Equation (1). The treatment conditions (block)
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that resulted in the highest biofilm removal for each of Bacillus sp. and P. fluorescens was
chosen for model fitting and analysis (total of 2 models one for each microorganism).
The selection of the fitted model was determined using sequential model probability (pvalue), Lack-of-Fit probability (p-value), adjusted R2, and predicted R2. The second order model
presented in Equation (2) was selected and fitted to the experimental data using linear
regression analysis.

(2)

Where: Y is the dependent variable (biofilm removal), C is a constant representing the
regression coefficient, X is the independent variables (enzymes concentrations), and Ɛ is the
unobserved random error.
Design expert software 9.0.6.2 was used to analyse the experimental data obtained.
Analysis of variance (ANOVA) was used to verify the significance of the models selected and the
significance of each model term. The F-test with an alpha value of 0.05 was used to evaluate
the significance. The adequacy of the models was verified using model adequate precision and
predicted versus actual plots. Normal probability plots were used to evaluate the normal
distribution of errors for the fitted models (normally distributed, and insignificant).
Design Expert 9.0.6.2 was used for numerical optimization to find the optimal enzymes
concentrations required to achieve the highest biofilm removal efficiency. The developed
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model and enzymes optimization results were then validated by conducting experiments with
values near the predicted optimal points.
3.5.4. Results

3.5.4.1.

Central Composite Design (CCD)

The enzymes used in this research are industrial mixtures that have shown high
efficiency in biofilm removal for biofilms formed by Bacillus sp. and P. fluorescens (please see
Sections 3.4.4.2 and 3.4.4.3). The optimal conditions for these enzymes as specified by the
manufacturer are listed in Table 3–2.
Table 3–2. List of Enzymes and Their Reported Optimum Conditions.

Enzymes

Optimum Activity Range

Source

pH

Temp. (oC)

7.5 - 9.5

40 - 60

Sigma-Aldrich Inc., USA

Protease

8.0 - 11

55 - 75

Sigma-Aldrich Inc., USA

Polysaccharide-degrading

3.5 - 6.0

30 - 60

Sigma-Aldrich Inc., USA

Polysaccharide-degrading

4.0 - 6.5

40 - 60

Novozymes A/S, Denmark

Name

Type

Protamex

Protease

Savinase
Pectinex
Cellic

Synergistic effects are expected when using mixtures of the enzymes presented in Table
3–2, however conditions suitable for both proteases and polysaccharide-degrading can be
outside of the optimum conditions of the individual enzymes, hence an overall optimization
using mixtures of two enzymes in each tested block were conducted via a central composite
design. The pH value and the microbial strain were treated as categoric factors, and the
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enzymes concentrations were optimized, leading to 10 independent CCDs (blocks) as shown in
Table 3–3.
Table 3–3. List of Optimization Factors Used in CCDs.
Optimized factors
Enzymes (U/mL)

Categoric Factors
Bacterial Strain

Number
of Blocks

pH

Savinase & Pectinex

4, 6, 8

Bacillus sp.

P. fluorescens

6

Pectinex & Cellic

4

Bacillus sp.

P. fluorescens

2

Savinase & Protamex

8

Bacillus sp.

P. fluorescens

2

Total Blocks

10

After applying the different treatments for 24 hrs, biofilm removal was calculated using
Equation (1). The data of the block that resulted in the highest biofilm removal for each of the
two microbial strains (Bacillus sp. and P. fluorescens) are presented in Table 3–4 (similar data
was collected for the 8 other blocks). It can be seen from the experimental results presented in
Table 3–4 that the enzymatic treatment mixture containing Savinase and Pectinex resulted in
the highest biofilm removal for both bacterial strains, only at two different pH values (6 and 8
for Bacillus sp. and P. fluorescens, respectively). The use of Savinase and Pectinex was
successful in removing biofilms formed by Bacillus sp. and P. fluorescens within the range of
tested input variables. When compared with biofilms formed by Bacillus sp., results obtained in
Table 3–4 show that a higher biofilm removal was achieved for biofilms formed by P.
fluorescens.
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Table 3–4. Biofilm Removal Corresponding to Conditions (two blocks, one for each microbial
strain) That Resulted in The Maximum Biofilm Removal for Bacillus sp. and P. fluorescens
Determined for CCDs. Error values represent 95% confidence intervals.
Savinase Pectinex
U/mL
U/mL
1.7
4
4
16.0
16.0
16.0
28.0
28.0
30.3

52.5
15
90
7.9
52.5
97.1
15.0
90.0
52.5

Number of
replicates
4
4
4
4
9
4
4
4
4

pH
Bacillus sp.
P. fluorescens
6
6
6
6
6
6
6
6
6

8
8
8
8
8
8
8
8
8

Biofilm Removal (%)
Bacillus sp. P. fluorescens
48.7 ± 1.7
47.0 ± 3.4
53.0 ± 3.5
61.6 ± 1.3
66.2 ± 1.1
65.4 ± 2.0
63.4 ± 2.2
67.5 ± 1.0
65.2 ± 2.5

56.9 ± 4.1
61.0 ± 3.5
48.4 ± 4.1
76.8 ± 5.1
81.5 ± 2.9
65.5 ± 4.4
76.3 ± 2.5
77.9 ± 4.5
81.8 ± 2.5

The two treatment conditions (two blocks) presented in Table 3–4 were further used for model
selection and optimization (for all the following work presented in this research).
3.5.4.2.

Models Selection, Fitting, and Statistical Analysis
The data presented in Table 3–4 was fitted with the quadratic model presented in

Equation (2), the fit summary of the tested models are presented in Table 3–5. Based on the
results obtained for the sequential model sum of squares, the lack of fit test, adjusted R2 and
predicted R2 for the fitted models, a quadratic model was found to best fit the data and was
chosen for both Bacillus sp. and P. fluorescens (the data was also tested with linear and cubic
models, it was found to best fit the quadratic model presented in Equation (2), data not shown
for linear and quadratic models).
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Table 3–5. Fitted Model Selection Summary
Microbial
Strain

Model
Order

Sequential
p-value

Lack of Fit
p-value

Adjusted
R2

Predicted
R2

Bacillus sp.

Quadratic

< 0.0001

0.6159

0.9186

0.8993

P. fluorescens

Quadratic

< 0.0001

0.6266

0.8861

0.8642

The results obtained from the ANOVA test for the response surface of the fitted
quadratic models for Bacillus sp. and P. fluorescens are presented in Table 3–6 and Table 3–7,
respectively. The results presented in Table 3–6 shows all the significant model parameters. The
p-value obtained for the model suggests that it is highly significant, while the p-value for the
Lack-of-Fit test suggest that it was insignificant, which is desired. Similar results were obtained
in Table 3–7 for P. fluorescens. The results obtained for R2, Adjusted R2, and predicted R2 are
presented in Table 3–6 and Table 3–7, R2 and Adjusted R2 values are close to 1.0 which
indicates a high correlation between predicted and observed values, this shows that the models
are excellent in explaining the relationship between response (biofilm removal) and the
independent variables (enzymes concentrations) (Myers, Raymond H; Montgomery, Douglas C;
Anderson-Cook, 2009). From the results presented in Table 3–6 and Table 3–7 it can be seen
that Savinase was the parameter with the highest influence on the biofilm removal for both
microorganisms tested, the results showed that the interaction term (AB) was significant for the
removal of biofilm formed by P. fluorescens and not significant for Bacillus sp. The results show
that an optimal biofilm removal exist at a concentration that if exceeded the biofilm removal
will be negatively affected.
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Table 3–6. Analysis of variance table for response surface fitted quadratic model for Bacillus sp.
viable biofilm removal.
Source

Model
A(Savinase)
B(Pectinex)
A^2
B^2
Residual
Lack of Fit
Pure Error
Cor Total

Sum of
Squares
2207.58
1498.70
124.71
573.78
48.89
173.20
12.73
160.47
2380.78

R2
Adjusted R2
Predicted R2
Adequate Precision

Degree of
Freedom

Mean
Square

F
Value

p-value
Prob > F

Significant

4
1
1
1
1
36
4
32
40

551.89
1498.70
124.71
573.78
48.89
4.81
3.18
5.01

91.27
309.30
25.74
118.42
10.09

< 0.0001
< 0.0001
< 0.0001
< 0.0001
0.0031

Yes
Yes
Yes
Yes
Yes

0.6416

No

0.63

0.93
0.92
0.91
25.0

Final Equation in Terms of Actual Factors:
𝐵𝑖𝑜𝑓𝑖𝑙𝑚 𝑅𝑒𝑚𝑜𝑣𝑎𝑙 (%) = 37.954 + 2.068𝐴 + 0.199𝐵 − 0.045𝐴2 − 0.001𝐵2

The goodness of fit was statistically tested for the models and their associated
parameters using the F-test for ANOVA, the results obtained are presented in Table 3–6 and
Table 3–7. The models fitted to the biofilm removal of Bacillus sp. and P. fluorescens have an Fvalue of 91.27 and 63.21, the probability of an F-value this large to occur due to noise is 0.01%.
This indicates that the models are highly significant for the prediction of biofilm removal. The pvalues presented in Table 3–6 and Table 3–7 were used to evaluate the significance of the
models’ parameters. A p-value less than 0.05% is required for a model parameter to be
considered significant (Berthouex and Brown, 1994). From the results presented in Table 3–6
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and Table 3–7, it can be seen that all models’ parameters were found to be highly significant.
An adequate precision value of 4 is required for the model to be considered adequate. The
results obtained for adequate precision for the models in Table 3–6 and Table 3–7 are 22.67
and 22.29, which indicates that both models are highly adequate. The results presented in
Table 3–6 and Table 3–7 indicates that the models selected are suitable for prediction of biofilm
removal within the central composite design range.
Table 3–7. Analysis of variance table for response surface fitted quadratic model for P.
fluorescens viable biofilm removal.
Source

Sum of
Squares

Degree of
Freedom

Mean
Square

F
Value

p-value
Prob > F

Significant

Model
A(Savinase)
B(Pectinex)
AB
A2
B2
Residual
Lack of Fit
Pure Error
Cor Total

5224.25
3243.76
347.87
203.36
959.45
693.12
578.51
30.28
548.23
5802.76

5
1
1
1
1
1
35
3
32
40

1044.85
3243.76
347.87
203.36
959.45
693.12
16.53
10.09
17.13

63.21
196.25
21.05
12.30
58.05
41.93

< 0.0001
< 0.0001
< 0.0001
0.0013
< 0.0001
< 0.0001

Yes
Yes
Yes
Yes
Yes
Yes

0.59

0.63

No

R2
Adjusted R2
Predicted R2
Adequate Precision

0.90
0.89
0.86
22.29

Final Equation in Terms of Actual Factors:
𝐵𝑖𝑜𝑓𝑖𝑙𝑚 𝑅𝑒𝑚𝑜𝑣𝑎𝑙 (%) = 49.479 + 2.369𝐴 + 0.314𝐵 + 0.008𝐴𝐵 − 0.059𝐴2 − 0.005𝐵2
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The numerical relationship between the independent variables (enzymes
concentrations) and the dependent variable (biofilm removal) was described using a secondorder polynomial quadratic equation. The quadratic equations developed in terms of actual
factors (enzymes concentrations) for the response (biofilm removal) are presented Table 3–6
and Table 3–7 for Bacillus sp. and P. fluorescens, respectively.

Figure 3-14. Normal % Probability Versus Externally Studentized Residuals for Bacillus sp. (1.A)
and P. fluorescens (2.A) and The Model Predicted Values Versus Actual Experimental Values for
Bacillus sp. (1.B) and P. fluorescens (2.B).
The results of the normal (%) probability plots of the external studentized residuals for
the suggested models are presented in Figure 3-14 (1.A and 2.A, for Bacillus sp. and P.
fluorescens respectively), It can be seen from the plots that the errors were generally
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insignificant and normally distributed, which is desired. Residual analysis assures that the
analytical data fits the statistical assumptions. The results of the predicted versus actual plots
presented in Figure 3-14 (1.B and 2.B, for Bacillus sp. and P. fluorescens respectively) shows
that the models were satisfactory in predicting real conditions. Good agreement can be seen
between predicted and actual and no obvious dispersal can be noticed. Results obtained for
predicted versus actual (Figure 3-14) suggests that the models were adequate in predicting real
conditions. The diagnostic plots presented in Figure 3-14 can be used to evaluate how
satisfactory are the models developed, which was found to be highly satisfactory.

3.5.4.3.

Response Surface Analysis and Numerical Optimization
Response surface plots provide a better visualization of the effect of each of the tested

factors (enzymes concentration) on the measured response (Biofilm Removal) within the range
of the tested factors.
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Figure 3-15. Optimal Biofilm Removal for Bacillus sp. (A), and P. fluorescens (B).
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The response surface plots of biofilm removal for Bacillus sp. and P. fluorescens are
presented in Figure 3-15. It can be clearly seen from the plots that an optimum biofilm removal
exists within the observed design space with respect to enzymes concentration for both Bacillus
sp. and P. fluorescens. Increasing the enzymes concentrations close to midranges results in an
increase in biofilm removal for both Bacillus sp. and P. fluorescens. While increasing the
concentration of the enzyme beyond midrange results in a decrease in biofilm removal for both
Bacillus sp. and P. fluorescens.
Numerical optimization was conducted on the models developed for Biofilm removal for
each bacterial strain. The results of the numerical optimization for the different treatment
conditions tested (all 10 blocks) are presented in Table 3–8. The highest biofilm removal for
Bacillus sp. (68.7%) was achieved by Savinase (22.6 U/mL) and Pectinex (70.9 U/mL) at a pH of
6. The highest biofilm removal for P. fluorescens (84.5%) was achieved by Savinase (23.7 U/mL)
and Pectinex (48.8 U/mL) at a pH value of 8. The results presented in Table 3–8 suggest that, for
both microorganisms tested in this research, generally a higher biofilm removal can be achieved
at higher pH values, and when compared with Bacillus sp., a higher biofilm removal was
achieved by most treatments for biofilms formed by P. fluorescens.
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Table 3–8. Numerical Optimization Results of All Initial Treatment Conditions (10 blocks) for
Biofilm Removal for Bacillus sp. and P. fluorescens.
Bacterial
Species

pH

Enzymes
Name
1

2

Conc.* (U/mL)
1
2

Optimal
Biofilm
Removal (%)

Bacillus sp.
P. fluorescens

4
4

Savinase
Savinase

Pectinex
Pectinex

18.3
18.1

76.9
65.2

52.8
82

Bacillus sp.
P. fluorescens

6
6

Savinase
Savinase

Pectinex
Pectinex

19.6
14.1

63.8
57.3

68.1H
79.3

Bacillus sp.
P. fluorescens

8
8

Savinase
Savinase

Pectinex
Pectinex

23.3
23.7

62
48.8

50.6
84.5H

Bacillus sp.
P. fluorescens
Bacillus sp.
P. fluorescens

4
4
8
8

Pectinex
Pectinex
Savinase
Savinase

Cellic-CTec2
Cellic-CTec2
Protamex
Protamex

59.1
57.6
19.7
20.8

19
14.2
13.3
10.3

67.3
55.8
38.7
75.2

H

represents the highest biofilm removal obtained for the specified bacterial strain
* represents the enzyme concentration corresponding to the optimal biofilm removal

The results presented in Table 3–8 shows the numerical optimization of all treatment
conditions (10 blocks) tested at the beginning of this work. The results of the numerical
optimization of all treatment conditions (10 blocks) reassures the proper selection of the
treatment conditions (blocks) that resulted in the highest biofilm removal for each bacterial
strain (presented in Table 3–4). The results of the treatment conditions containing both
Savinase and Pectinex (6 blocks) presented in Table 3–8 showed that the pH value appears to
be proportional to the optimal concentration of Savinase and inversely related to the optimal
concentration of Pectinex.
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3.5.4.4.

Verification of Response Surface Models and Optimal Conditions
The actual and predicted values of Bacillus sp. and P. fluorescens near optimal biofilm

removal is presented in Table 3–9. The results of predicted and actual biofilm removal
presented in Table 3–9 for Bacillus sp. and P. fluorescens was compared using the statistical Ttest at 95% confidence interval and no significant difference was found (data not shown). The
results presented in Table 3–9 shows that the response surface models were successful in
predicting optimal biofilm removal.
Table 3–9. Models and Optimal Conditions Verification. Errors for biofilm removal represent 95%
confidence intervals.
Microorganism
Bacillus sp.
P. fluorescens

Factor 1
Savinase
16
16

Factor 2
Pectinex
52.5
52.5

Factor 3
pH
6
8

Biofilm Removal (%)
Predicted
Actual
66.17±1.42
67.27±1.29
81.44±2.62
80.09±3.25

3.5.5. Discussion
Treatments tested in this research were applied to pre-existing biofilms of both Bacillus
sp. and P. fluorescens at room temperature (21oC) for 24 h to mimic actual conditions in
treatment application. The enzymes used in this research are presented in Table 3–2, these
enzymes were chosen due to their reported efficiency in the removal of biofilms formed by
Bacillus sp. and P. fluorescens (please see Sections 3.4.4.2 and 3.4.4.3). The two microorganisms
used to produce biofilms, Bacillus sp. and P. fluorescens, are chosen due to their different
biofilm composition (please see Section 3.5.2); to represent more scenarios that might be
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encountered in real conditions. The intention of this study is not to discuss the mechanism of
biofilm removal using enzymes as this was covered in previous work (please see Section 3.4).
Although researchers have previously recommended the use of different enzymatic mixtures
for biofilm treatment ( Cordeiro, Hippius and Werner, 2011; Torres et al., 2011), to the best
knowledge of the authors, this is the first attempt to optimize the use of proteases and
polysaccharide-degrading enzymes in a mixed enzymatic treatment containing both enzymes
types for biofilm removal.
The experimental conditions and biofilm removal results presented in Table 3–4 are the
actual values of the independent variables (concentrations of enzymes used, pH, and bacterial
strain) and their measured responses (biofilm removal). All experimental conditions presented
in Table 3–4 were chosen based on a central composite design. The aim of the central
composite design was to present a simple empirical correlation between the concentrations of
the two different enzymes used (two independent variables) and biofilm removal (the
measured response). As can be seen from Table 3–4 and Table 3–8 all tested enzymatic
treatments were successful in removing biofilms formed by Bacillus sp. and P. fluorescens
within the ranges of tested input values. This was expected as previous work conducted
indicated that optimal biofilm removal existed within these ranges (please see Section 3.4.4).
The experimental conditions (enzyme 1, enzyme 2, pH, and bacterial strain) presented in Table
3–4 (and later confirmed in Table 3–8) that resulted in the highest biofilm removal for Bacillus
sp. and P. fluorescens were selected for further analysis.
The generated actual datasets for the treatment condition that resulted in the highest
biofilm removal (presented in Table 3–4) went through further analysis for model selection,
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using the sequential model sum of squares, lack-of-fit test, predicted R2, adjusted R2 presented
in Table 3–5 and were found to best fit the quadratic model presented in Equation (2). The pvalue under the sequential term in Table 3–5 represents the probability that the order terms
are modelling the noise rather than the trend in the response (biofilm removal). The p-values
obtained for the quadratic models of Bacillus sp. and P. fluorescens were less than 0.0001 for
both bacterial strains, the probability that the order terms are modelling the noise rather than
the trend in the response is less than 0.01%, which is highly desirable. The p-values obtained for
the lack-of-fit test for Bacillus sp. and P. fluorescens were 0.62 and 0.63, the best model should
have an insignificant lack-of-fit with the desired p-value higher than 0.10, the probability that
this large lack of fit could occur due to noise is 61.59% and 62.66%, respectively. The obtained
p-values for the lack-of-fit test shows that the selected models have highly insignificant lack-offit, which is highly desirable. The selected quadratic models for Bacillus sp. and P. fluorescens
have high R2 and adjusted R2 values (presented in Table 3–5), which is highly desirable. Based
on the results presented in Table 3–5, a quadratic model was selected for both Bacillus sp. and
P. fluorescens. The response surface representing the selected models is presented in Figure
3-15 for Bacillus sp. and P. fluorescens.
The selected quadratic models and their associated parameters for Bacillus sp. and P.
fluorescens were analysed for their significance using their F-value and the results are
presented in Table 3–6 and Table 3–7, respectively. The models F-value for Bacillus sp. and P.
fluorescens were found to be 91.27 and 63.21, there is less than 0.01% chance that F-values this
large could be due to noise. The associated model p-value is the probability that the data used
produced false effects, this value is desired to be less than 0.05 for the model to be significant,
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results of model p-value obtained for Bacillus sp. and P. fluorescens were less than 0.0001 for
both bacterial strains, which indicates that both models are highly significant. The significance
of models’ parameters was determined using their associated p-values, a p-value less than 0.05
is required for a model parameter to be considered significant, as can be seen from p-values
presented in Table 3–6 and Table 3–7, all models parameters were found to be highly
significant with p-values less than 0.0001. The results presented in Table 3–6 and Table 3–7 also
suggest that all tested factors have a great effect on biofilm removal.
The points presented in Figure 3-14 (1.A and 2.A) for the normal (%) probability of the
external studentized residuals lay close to the straight line and between -2.0 and 2, which
indicates that errors were insignificant and normally distributed (Mason, Gunst and Hess,
2003). This assures that the analytical data presented fits the statistical assumptions made.
Another important part of the model statistical analysis is the model adequacy check. Models
adequacy was evaluated using actual versus predicted plots presented in Figure 3-14 (1.B and
2.B), it can be seen that there is good agreement between actual and predicted values with no
obvious dispersal, this indicates that the models are adequate. These results confirm the
adequate precision results presented in Table 3–6 and Table 3–7.
Bacillus sp. optimal biofilm removal was found to be 68.7% at pH of 6, and
concentrations of 22.6 U/mL and 70.9 U/mL for Savinase and Pectinex respectively. Optimal
biofilm removal for P. fluorescens was found to be 84.5% at pH of 8, and concentrations of 22.6
U/mL and 70.9 U/mL for Savinase and Pectinex respectively. The response surface plots
presented in Figure 3-15 shows that Savinase and Pectinase were effective in removing preexisting biofilms formed by Bacillus sp. and P. fluorescens. Generally, the enzymatic treatments
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tested showed less biofilm removal (%) for Bacillus sp. and higher biofilm removal (%) for
biofilms formed by P. fluorescens, possible explanation for that is the different composition of
the biofilms formed by the two different bacterial strains (Morikawa et al., 2006; Molobela,
Cloete and Beukes, 2010), moreover, biofilms formed by Bacillus sp. were more robust (thicker)
when compared to biofilms formed by P. fluorescens (biofilm formation was measured
indirectly using crystal violet stain).
Previous studies that have separately used Pectinex and Savinase reported them to be
successful in removing biofilms (Johansen and Falholt, 1997; C. Leroy et al., 2008; Molobela,
Cloete and Beukes, 2010). Studies on optimization of enzymatic treatments for biofilm removal
are very limited, to the best knowledge of the authors, this is the first study that optimizes the
combined treatment of proteases and polysaccharide-degrading enzymes for removal of
biofilms. Only one enzymatic optimization study was found by Johansen and Falholt 1997, the
authors used two polysaccharide-degrading enzymes, Mutanase and Dextranase, for the
removal of plaque. In their study, a plaque was formed on hydroxyapatite discs and the
removal of the plaque was measured in terms of log reductions in colony forming units per disc
(CFU/disc). The authors reported additive effect (log reduction from 108 to 106 CFU/disc) from
combining both enzymes in one treatment rather than using them separately in treatments
(Johansen and Falholt, 1997). The authors also reported that Pectinex alone was able to reduce
the cell count for biofilm formed by P. fluorescens one log reduction (2.5x10-7 to 2.4x10-6) using
a concentration of 180 PSU mL-1 for 15 min at pH 7. A study by Leroy et al. 2008 investigated
and compared the efficiency of different enzymes (four proteases, seven polysaccharidedegrading, and one lipase) used as anti-biofilm agents against biofilms formed by marine
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bacterial strain Pseudoalteromonas sp. D41. The biofilm was grown for 24 hrs in a 96-well
microtiter plate using sterile seawater at 20 oC. Biofilm was quantified using fluorescent dye
DAPI (4[prime]6-diamidino-2-phenylindole). Results obtained showed that Savinase had the
highest efficiency in preventing and removing biofilms (up to 100% reduction in bacterial
adhesion and 50% reduction of pre-existing biofilms after a 24 hrs treatment at a concentration
of 1.7 mg mL-1). From their results, the authors concluded that depending on the enzymes used
and their concentrations, enzymes could remove biofilms or inversely increase their formation
(C Leroy et al., 2008).
The validation of the response surface models and optimal conditions was done by
performing and independent confirming experiment around the estimated optimal conditions,
the results of the predicted and actual values of biofilm removal are presented in Table 3–9.
The actual and predicted values presented in Table 3–9 were compared using the statistical Ttest at 95% confidence interval and no significant difference was found between them. This
indicates that the proposed models can be used for the prediction of biofilm removal using
Savinase and Pectinex.
3.5.6. Conclusions
In conclusion, synergetic effects can be noticed by combining the protease Savinase and
the polysaccharide-degrading enzyme Pectinex. The enzymatic mixtures containing these two
enzymes were more effective than treatments containing two enzymes from the same type
(the proteases Savinase and Protamex, and the Polysaccharide-degrading Pectinex and Cellic).
Identifying the optimal concentrations of enzymes for biofilm removal is vital not only from an
economical point, the results presented suggests that increasing the enzyme concentration
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beyond the optimal resulted in adverse effects on biofilm removal, this is hypothesised to be a
result of the elevated amounts of sugars that are associated in the enzymatic mixtures
preparations during their manufacturing process. The results suggest that the pH can have a
high influence on the biofilm removal process, this is due to its influence on both the efficiency
of the enzymes and its direct effect on biofilm formation. The use of a mixed (protease and
polysaccharide-degrading) enzymatic treatment was successful in removing biofilms formed by
Bacillus sp. and P. fluorescens. The models developed were successful in estimating real
conditions for the removal of biofilm formed by Bacillus sp. and P. fluorescens using the
enzymes mixture. The optimal conditions for the highest removal (68.1%) of biofilm formed by
Bacillus sp. was achieved by Savinase and Pectinex at concentrations of 19.6 U/mL and 63.8
U/mL, and a pH value of 6. The optimal conditions for the highest removal (84.5%) of biofilm
formed by P. fluorescens was achieved by Savinase and Pectinex at concentrations of 23.7 U/mL
and 48.8 U/mL, and a pH value of 8. Higher biofilm removal was achieved for pH values at or
above neutral (pH 6-8).
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Chapter 4 - Thesis Summary and Conclusions
4.1 Preface
Chapter 4 provides a summary of the experimental work performed in this thesis and
the thesis’ general conclusions.

4.2 Thesis Summary
The control of biofilm formation is of high interest in medical and industrial areas.
Consequently, biofilm control agents are of industrial and academic interest. Therefore, the
goal of this thesis is to investigate the ability of potential treatments to control biofilm
formation.
4.2.1 Biofilm Control Using Norspermidine
Studies that have previously investigated biofilm removal debated the effect of
norspermidine on biofilm formation control. The effect of norspermidine on biofilm formation
was of specific interest for this thesis. The results presented in this study suggest that
norspermidine enhanced biofilm growth for active biofilm communities by 73%, while it caused
disassembly for nonactive (dead) biofilm with 39% biofilm removal. This dual effect is possibly
responsible for the apparent contradiction on the role of norspermidine in the previous
literature.
4.2.2 Biofilm Control Using D-amino Acids
Amino acids have been described as self-produced triggers by bacteria at late stages of
mature biofilm for biofilm disassembly. Varying results have been presented by previous
researchers on the effects of D-amino acids on biofilm formation. Currently, the literature is
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lacking for quantitative studies that investigate the effect of D-amino acids on biofilm
formation. The four D-amino acids investigated in this research (D-tyrosine, D-tryptophan, DMethionine, and D-leucine) could inhibit biofilm growth for Bacillus sp. at concentrations as low
as 5 µM for D-tyrosine and 5 mM for D-methionine, D-tryptophan, and D-leucine. The increase
in the concentration of D-tyrosine (µM) and D-tryptophan (mM) between 10 and 20 had limited
effects on the dispersal (31% and 28%, respectively) of Bacillus sp. pre-existing biofilms. The
concentration of D-tyrosine and D-tryptophan applied was proportional to biofilm removal. Dleucine and D-methionine did not show the ability to remove Bacillus sp. pre-existing biofilm for
treatments concentrations up to 20 mM. D-amino acids mixture treatment consisting of 5 µM
D-tyrosine and 5 mM of D-tryptophan, and D-leucine, and D-Methionine could inhibit biofilm
formation. The increase of D-tryptophan (mM) and D-tyrosine (µM) concentration between 10
and 20 in the D-amino acids mixture resulted in the dispersal (39%) of Bacillus sp. pre-existing
biofilm. The results obtained for the D-amino acid mixture showed limited synergetic effects.
4.2.3 Biofilm Control Using Enzymes
Previous studies have presented promising results on the use of enzymatic treatments
for biofilm removal. Previous studies have approached the problem without a comprehensive
approach to the type of biofilm tested and selected enzymes. Current limitations on the use of
enzymatic treatments for biofilm removal is due to the substrate-specific nature of enzymes
which is met with biofilm composition of high complexity. In this thesis, a comprehensive
approach was used in investigating the efficiency of two different enzyme types
(polysaccharide-degrading and proteases) as biofilm control agents for the removal of two
different composition biofilms formed by Bacillus species and Pseudomonas fluorescens. The
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results obtained suggest that the proteases, Savinase had the highest biofilm removal
capabilities when compared to other tested proteases. Savinase removed 68% and 84% of
biofilm formed by Bacillus sp. and P. fluorescens respectively. The highest biofilm removal by
polysaccharide-degrading enzymes was achieved by Pectinex. Pectinex removed 74% and 55%
of biofilm formed by Bacillus sp. and P. fluorescens respectively. The results obtained suggest
that an optimization of enzymatic treatment containing a mixture of enzymes can be beneficial
for higher removal efficiency for biofilms with different compositions.
4.2.4 Optimization of Biofilm Removal Using Enzymatic Treatments
The use of enzymatic mixture treatments as biofilm control agents have been
recommended by previous researchers. This is due to the promising results enzymes have
shown when used for biofilm removal. The removal of biofilms formed by two different
bacterial strains (different biofilm compositions), using enzymatic mixtures formed from
polysaccharide-degrading enzymes and proteases was optimized using response surface
analysis and central composite design. Ten central composite designs have been used to
evaluate the effect of enzymes concentration and pH on the removal of biofilm formed by
Bacillus sp. and P. fluorescens. The experimental data were fitted with a quadratic model. The
model developed was successful in predicting the biofilm removal as a function of the
concentrations of enzymes used. The quadratic model developed was verified by additional
experiments, there was no significant difference between actual and predicted values of the
biofilm removed. The results obtained in this thesis suggests that enzymatic treatments
containing Savinase and Pectinex were the most effective for biofilm removal. The treatment
containing Pectinex and Savinase at concentrations of 63.8 and 19.6 U/mL, respectively,
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removed 68.1% of Bacillus sp. biofilm at pH 6, and at concentrations of 48.8 and 23.7 U/mL,
respectively, removed 84.5% of P. fluorescens biofilm at pH 8.

4.3 General Conclusions
The main objective of this thesis was to investigate and develop treatments that can be
used for biofilm control. The work presented in Section 3.2 highlights the importance of
considering the biological activity of the tested biofilm. The results presented showed that
active and nonactive biofilms responded differently to the treatment containing norspermidine.
This different response was attributed to the competition between the biological process
(biofilm growth) and the chemical interaction between norspermidine and the polysaccharides
in the biofilm. When norspermidine was added to active biofilm, the biological process was
dominant over the chemical interaction between norspermidine and the polysaccharides in the
biofilm matrix and biofilm growth was enhanced. When the biofilm was nonactive (dead) the
biological process ceased and the chemical interaction between norspermidine and the
polysaccharide was dominant which resulted in biofilm removal.
The results obtained in Section 3.3 suggests that the D-amino acids examined in this work can
be used to inhibit the growth of Bacillus sp. pre-existing biofilm. The use of D-tyrosine and Dtryptophan treatments did result in partial removal of pre-existing biofilm. The D-amino acid
mixture did not show clear synergetic effects in the removal of pre-existing biofilm. Therefore,
the use of D-amino acids can be utilized for inhibiting Bacillus sp. biofilm formation. Due to the
lack of synergetic effects for the combined treatment, an optimization study for biofilm
removal using D-amino acids mixtures was not recommended.
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The results presented in Section 3.4 suggests that the use of proteases and
polysaccharide-degrading enzymes was effective in the removal of biofilms formed by the two
bacterial strains Bacillus sp. and P. fluorescens. The polysaccharide-degrading enzymes CellicCTec2 and Pectinex, and the proteases Protamex and Savinase exhibited the highest biofilm
removal efficiency for pre-existing biofilms formed by Bacillus sp. and P. fluorescens. Higher
biofilm removal was achieved for biofilm formed by P. fluorescens using proteases., while for
biofilm formed by Bacillus sp. the polysaccharide-degrading enzymes exhibited the highest
biofilm removal efficiency. Remarkably, the results obtained in Section 3.4 highlight the
interdependent relationship between the proteins and the polysaccharides in maintaining the
structural integrity of the biofilm formation. The ability of the polysaccharide-degrading
enzymes to remove a considerable amount of biofilm formed by P. fluorescens biofilm
(composed mainly from proteins), and the ability to remove a significant amount of the biofilm
formed by Bacillus sp. (composed mainly from polysaccharide) using proteases, emphasises the
complex interdependent relation between proteins and polysaccharides in maintaining the
integrity of the biofilm structure.
From the results presented in Section 3.5 it could be stated that synergetic effects on
biofilm removal were obtained after combining the protease Savinase and the polysaccharidedegrading enzyme Pectinex in a mixed treatment. The treatment containing Savinase and
Pectinex were more effective than treatments containing two proteases or two polysaccharidedegrading enzymes. Recognizing the optimal concentrations of enzymes used for biofilm
removal is critical. The results presented in Section 3.5 suggests that when the enzyme
concentration exceeded the optimal concentration, adverse effects on biofilm removal were
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obtained, it is hypothesised that this was a result of the increase in the concentration of sugars
and other nutrients that are incorporated in the preparation process of enzymatic mixtures
during the manufacturing process. The results obtained highlighted the effect of the pH on
biofilm removal using enzymes. The pH affects the biofilm removal by affecting the efficiency of
the enzymes used and through its direct effect on biofilm growth. The mixed enzymatic
treatments were successful in removing biofilms formed by the two bacterial strains tested,
Bacillus sp. and P. fluorescens. The quadratic models developed were successful in predicting
actual conditions for removal of biofilms formed by P. fluorescens and Bacillus sp. using the
enzymes mixtures.
A suitable biofilm control agent is expected to enhance, inhibit, or eliminate biofilm
formation on surfaces. The different treatments investigated in this thesis are norspermidine,
D-amino acids, and enzymes. Based on the results presented in chapter 3 and using the
evaluation procedure presented in Figure 1-2, it was concluded that the use of the treatments
containing D-amino acids was found efficient for inhibiting biofilm formation, the ability of Damino acids to remove biofilm formation was found to be limited. The use of norspermidine
was found to be effective in enhancing active biofilm formation which can be utilized in
beneficial biofilm applications. The use of the treatment containing norspermidine enhanced
the biofilm formation for active biofilm. Norspermidine showed limited ability in removing
nonactive biofilm, this required a pre-treatment of the biofilm with methanol to inactivate the
biofilm and this rendered the norspermidine treatment nonpractical for biofilm removal. In
addition, the biofilm removed using norspermidine was limited. The use of enzymatic
treatments was found to be the most efficient method investigated for biofilm removal. In
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specific, the use of optimized enzymatic treatments containing the protease Savinase and the
polysaccharide-degrading enzyme Pectinex were found to be the most effective treatment for
the removal of biofilm. The developed models using the central composite designs and the
response surface methodology were successful in predicting biofilm removal, no significant
difference was found between predicted and actual values of biofilm removal.

4.4 Future Recommendations
The use of norspermidine and D-amino acids returned limited ability in removing preexisting biofilm formed by Bacillus sp. and P. fluorescens, therefore they are not recommended
for the removal of pre-existing biofilm. Based on the resulted presented in this thesis, enzymes
were the most effective treatment tested for the removal of pre-existing biofilm, therefore, it is
recommended that future research on treatments for biofilm removal should be directed
toward the use of enzymes. Future research should be directed toward developing a consistent
and reproducible biofilm in flexible PVC tubes that are used in dental unit water lines (DUWLs)
and other related applications under similar conditions found in DUWLs, this can help in
producing results and comparisons that are statistically sound from biofilm removal
experiments that are conducted on a biofilm that is more analogous to actual biofilm found in
DUWLs. Enzymes are abundant and new enzymes emerge into the market constantly, it is
recommended to continue testing new emerging enzymes for their ability to remove biofilm.
Future research should be directed toward developing short duration treatments for cleaning
DUWLS that can be used in between consecutive patients, this will help in reducing crosscontamination.
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Chapter 5 - Appendices
5.1 Biofilm Production Protocol
The biofilm used for testing the different treatments evaluated in this thesis was grown in 96well microtiter plates. Biofilm production and treatment testing that was used to evaluate the
ability of different treatments to remove pre-existing biofilm is presented in the following eight
steps:
1- Preparing seed culture.
2- Inoculation of microtiter plates.
3- Washing initial biofilm in microtiter plates.
4- Fixing initial biofilm formation.
5- Applying Treatments.
6- Washing final biofilm in microtiter plates.
7- Fixing final biofilm formation.
8- Quantification of biofilm formation using crystal violet stain.
The aforementioned steps are explained in detail in subsections 5.1.1 – 5.1.8. These steps
should be followed in the order they are mentioned.
5.1.1 Prepare Bacterial Seed Culture
1- Add 1 mL of bacterial suspension into a sterile microcentrifuge vial.
2- Centrifuge the vial at 10,000 RPM for 60 seconds.
3- Remove supernatant and add 1 mL wash buffer.
4- Vortex the vial until the bacterial spores are completely dissolved
5- Repeat steps 2-4 twice.
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6- Add 1 milliliter of appropriate biofilm growth media to the vial and vortex.
7- Using a 125-mL glass flask with a stir, half a milliliter of the washed bacterial spores are
re-suspended in 20 mL growth media.
8- The glass flask in then placed on the magnetic stirrer at 300 RPM and incubated at
appropriate temp (37oC for Bacillus sp. And 21 oC for P. fluorescens) until optical
density at 600 nm is between 1 and 1.6 when Milli-Q water is used as blank.

5.1.2 Inoculation of Microtiter Plates with Bacterial Seed Culture
1- A 200-mL glass petri dish with a flat bottom is filled with appropriate biofilm growth
media and a stir bar.
2- The prepared bacterial seed culture is then diluted in a 1:100 ratio in appropriate
biofilm growth media.
3- The petri dish is then placed on a magnetic stirrer at 300 rpm.
4- 100 µL of sterile biofilm growth media are transferred into control wells in the
microtiter plates.
5- 100 µL from the petri dish are transferred into wells in the microtiter plates.
6- Each microtiter plate is then covered with a sterile thin film (25 µm) to seal it and
reduce evaporation.
7- One hole is poked in the center of each well using a 22-gauge sterile needle (separate
needles should be used for each of the inoculated wells and control wells to ensure no
cross contamination will occur).
8- The microtiter plates are then incubated at the appropriate conditions (37oC for Bacillus
sp. and 21 oC for P. Fluorescens) and time (32 h for Bacillus sp. Abd 72 h for P.
Fluorescens, biofilm growth media is replenished daily for P. Fluorescens only) for
biofilm to form in the microtiter plate wells.

5.1.3 Washing Initial Biofilm in Microtiter Plates with Wash Buffer
After the incubation time is over and the biofilm has formed in the microtiter plate, the biofilm will be
ready for washing.
1- The thin film placed on the microplate is removed and then the microplate is placed in

the Tecan Hydroflex Plate Washer. Each well in the plate is filled with 100 µL of wash
buffer solution using the drip mode and then wash buffer is aspirated.
2- Following that 150 µL of wash buffer solution is dispensed and aspirated same as the
previous step, the process is repeated for a total of three times.
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3- The microtiter plate is then gently flicked and the face of the microtiter plate is placed
on a paper towel to release any excess liquid.

5.1.4 Fixing Initial Biofilm Formation
This step in performed to fix initial biofilm growth that will be compared with the biofilm
remaining in other wells after applying treatment to them.
1- 200 µL of methanol (99%) are dispensed into designated initial growth wells only.
2- The microtiter plate is covered with aluminum foil to prevent evaporation for 20 min.
3- The methanol is removed using the multichannel micropipette.

5.1.5 Applying Treatments
1- 125 µL of treatment solution are dispensed into desired wells.
2- The microtiter plates are then covered with thin film.
3- A single hole is poked in the center of each well using the 22-gauge sterile needle.
4- The microtiter plates are then incubated at 21 oC for 24 h in sterile conditions.

5.1.6 Washing Final Biofilm in Microtiter Plates With DI-Water
After the treatment incubation time (24 h) is over the microtiter plate are ready for washing to remove
exhausted media and loosely attached cells.
1- The thin film placed on the microplate is removed and then the microplate is placed in

the Tecan Hydroflex Plate Washer. Each well in the plate is filled with 100 µL of DIWater using the drip mode and then the DI-Water is aspirated.
2- Following that 150 µL of DI-Water is dispensed and aspirated same as the previous step,
the process is repeated for a total of three times.
3- The microtiter plate is then gently flicked and the face of the microtiter plate is placed
on a paper towel to release any excess liquid.

5.1.7 Fixing Final Biofilm Formation
This step in performed to fix the final biofilm formation that will be compared with the initial
biofilm formation in the control wells.
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1- 200 µL of methanol (99%) are dispensed into designated treated wells only.
2- The microtiter plate is covered with aluminum foil to prevent evaporation for 20 min.
3- The methanol is removed by aspiration using the Tecan Hydroflex Plate Washer.
4- The microtiter plates are left to air dry completely on bench top.

5.1.8 Quantification of Biofilm Formation Using Crystal Violet Stain
The crystal violet staining method is an indirect method for quantifying biofilm formation in microtiter
plates.

1- 150 µL of 0.1 % (W/V) crystal violet is dispensed into each well using the multichannel
micropipette.
2- The microtiter plate is covered to prevent evaporation and incubated at room
temperature for 60 min.
3- The microtiter plates are washed 4 times by dispensing 200 µL DI-Water in drip mode
and aspirating using the Tecan Hydroflex plate washer.
4- The microtiter plates are then left to air dry completely on bench top.
5- The crystal violet is then resolubilized by dispensing 200 µl 30% acetic acid into each
well.
6- The microtiter plates are then covered and incubated without shaking at room
temperature for 20 min.
7- 100 µL from each well are transferred to new hard polystyrene plate with the clear flat
bottom for quantification.
8- Absorbance at OD 570 nm is measured using a TECAN infinite M200 Pro plate reader.
The absorbance measured in proportional to the biofilm formed in the plates.
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5.2 Raw Data Used in Section 3.4.
The data used in creating the graphs presented in Section 3.4 is presented in Table A
and Table B presented below.
Table A. The final biofilm formation following 24 h treatment duration of the tested
proteases at different concentrations on biofilm formed by Bacillus sp. and P. fluorescens
with 95% confidence intervals (n=8) (Raw data used in Section 3.4).

0.04
0.09
0.03
0.04
0.08
0.07

0.30
0.20
0.17
0.14
0.25
0.81

0.03
0.05
0.02
0.02
0.03
0.05

1
5
10
15
30
Initial Growth

1.11
0.74
0.64
0.61
0.74
1.89

0.07
0.04
0.06
0.06
0.08
0.05

0.33
0.16
0.18
0.31
0.42
0.98

0.02
0.02
0.02
0.02
0.05
0.07

1
5
10
15
30
Initial Growth

1.29
1.36
1.36
1.41
1.58
1.76

0.07
0.05
0.04
0.05
0.04
0.07

0.34
0.30
0.32
0.32
0.39
0.76

0.02
0.02
0.01
0.03
0.02
0.04

1
5
10
15
30
Initial Growth

1.46
1.55
1.60
1.61
1.59
1.87

0.08
0.08
0.13
0.13
0.09
0.09

0.42
0.37
0.41
0.45
0.52
0.79

0.01
0.01
0.01
0.04
0.02
0.05

Protamex

1.18
0.89
1.11
1.50
1.69
1.89

Savinase

P. fluorescens
Abs. Unit
C.I.
570 nm
95%

Subtilisin A

Bacillus sp.
Abs. Unit
C.I.
570 nm
95%

Trypsin

Name

Enzyme
Conc.
U/mL
1
5
10
15
30
Initial Growth
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Table B. The final biofilm formation following 24 h treatment duration of the tested
polysaccharide degrading enzymes at different concentrations on biofilm formed by Bacillus
sp. and P. fluorescens with 95% confidence intervals (n=8) (Raw data used in Section 3.4).

Pectinex

5
15
25
50
75
Initial Growth

1.21
0.92
0.46
0.53
0.88
1.81

0.07
0.05
0.07
0.08
0.04
0.12

0.51
0.37
0.34
0.35
0.37
0.76

0.05
0.03
0.02
0.03
0.02
0.05

Cellic-CTec2

P. fluorescens
Abs. Unit
C.I.
570 nm
95%

1
5
10
15
30
Initial Growth

1.47
0.94
0.86
1.32
1.44
1.98

0.11
0.08
0.09
0.07
0.12
0.07

1.11
0.74
0.61
0.65
0.70
1.29

0.10
0.04
0.03
0.03
0.06
0.05

Carezyme

Conc.
U/mL

Bacillus sp.
Abs. Unit
C.I.
570 nm
95%

1
5
10
15
30
Initial Growth

1.41
1.22
1.25
1.23
1.34
1.74

0.10
0.06
0.08
0.06
0.06
0.10

0.75
0.68
0.69
0.73
0.75
0.87

0.09
0.04
0.03
0.02
0.04
0.05

Cellic-HTec2

Enzyme
Name

1
5
10
15
30
Initial Growth

1.51
1.52
1.58
1.57
1.70
1.97

0.10
0.09
0.06
0.05
0.06
0.09

0.61
0.63
0.63
0.68
0.74
0.94

0.05
0.03
0.03
0.04
0.02
0.06
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5.3 Copyright Clearance and Approval to Reuse Graphical Material.
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